<?xml version="1.0" ?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.3 20210610//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">elife</journal-id>
<journal-id journal-id-type="publisher-id">eLife</journal-id>
<journal-title-group>
<journal-title>eLife</journal-title>
</journal-title-group>
<issn publication-format="electronic" pub-type="epub">2050-084X</issn>
<publisher>
<publisher-name>eLife Sciences Publications, Ltd</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">98152</article-id>
<article-id pub-id-type="doi">10.7554/eLife.98152</article-id>
<article-id pub-id-type="doi" specific-use="version">10.7554/eLife.98152.1</article-id>
<article-version-alternatives>
<article-version article-version-type="publication-state">reviewed preprint</article-version>
<article-version article-version-type="preprint-version">1.1</article-version>
</article-version-alternatives>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Genetics and Genomics</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>SERBP1 interacts with PARP1 and is present in PARylation-dependent protein complexes regulating splicing, cell division, and ribosome biogenesis</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Breunig</surname>
<given-names>Kira</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="author-notes" rid="n1">†</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lei</surname>
<given-names>Xiufen</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="author-notes" rid="n1">†</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Montalbano</surname>
<given-names>Mauro</given-names>
</name>
<xref ref-type="aff" rid="a2">2</xref>
<xref ref-type="aff" rid="a3">3</xref>
<xref ref-type="author-notes" rid="n1">†</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Guardia</surname>
<given-names>Gabriela D. A.</given-names>
</name>
<xref ref-type="aff" rid="a4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ostadrahimi</surname>
<given-names>Shiva</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Alers</surname>
<given-names>Victoria</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a5">5</xref>
<xref ref-type="aff" rid="a6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kosti</surname>
<given-names>Adam</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chiou</surname>
<given-names>Jennifer</given-names>
</name>
<xref ref-type="aff" rid="a7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Klein</surname>
<given-names>Nicole</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Vinarov</surname>
<given-names>Corina</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Lily</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Mujia</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Song</surname>
<given-names>Weidan</given-names>
</name>
<xref ref-type="aff" rid="a8">8</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8786-2986</contrib-id>
<name>
<surname>Kraus</surname>
<given-names>W. Lee</given-names>
</name>
<xref ref-type="aff" rid="a8">8</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6492-2803</contrib-id>
<name>
<surname>Libich</surname>
<given-names>David S.</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tiziani</surname>
<given-names>Stefano</given-names>
</name>
<xref ref-type="aff" rid="a7">7</xref>
<xref ref-type="aff" rid="a9">9</xref>
<xref ref-type="aff" rid="a10">10</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Weintraub</surname>
<given-names>Susan T.</given-names>
</name>
<xref ref-type="aff" rid="a6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Galante</surname>
<given-names>Pedro A. F.</given-names>
</name>
<xref ref-type="aff" rid="a4">4</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Penalva</surname>
<given-names>Luiz O. F.</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a5">5</xref>
<xref ref-type="corresp" rid="cor1">*</xref>
</contrib>
<aff id="a1"><label>1</label><institution>Children’s Cancer Research Institute, UT Health San Antonio</institution>, San Antonio, Texas, 78229, <country>USA</country></aff>
<aff id="a2"><label>2</label><institution>Mitchell Center for Neurodegenerative Diseases, University of Texas Medical Branch</institution>, Galveston, TX, <country>USA</country></aff>
<aff id="a3"><label>3</label><institution>Department of Neurology, University of Texas Medical Branch</institution>, Galveston, TX, <country>USA</country></aff>
<aff id="a4"><label>4</label><institution>Centro de Oncologia Molecular, Hospital Sírio-Libanês</institution>, São Paulo, São Paulo, 01309-060, <country>Brazil</country></aff>
<aff id="a5"><label>5</label><institution>Department of Cell Systems and Anatomy, UT Health San Antonio</institution>, San Antonio, Texas, 78229, <country>USA</country></aff>
<aff id="a6"><label>6</label><institution>Department of Biochemistry and Structural Biology, UT Health San Antonio</institution>, San Antonio, Texas, 78229, <country>USA</country></aff>
<aff id="a7"><label>7</label><institution>Department of Nutritional Sciences, College of Natural Sciences, University of Texas at Austin</institution>, Austin, TX, <country>USA</country></aff>
<aff id="a8"><label>8</label><institution>Laboratory of Signaling and Gene Regulation, Cecil H. and Ida Green Center for Reproductive Biology Sciences, The University of Texas Southwestern Medical Center</institution>, Dallas, TX, <country>USA</country></aff>
<aff id="a9"><label>9</label><institution>Department of Pediatrics, Dell Medical School, University of Texas at Austin</institution>, Austin, TX, <country>USA</country></aff>
<aff id="a10"><label>10</label><institution>Department of Oncology, Dell Medical School, University of Texas at Austin</institution>, Austin, TX, <country>USA</country></aff>
</contrib-group>
<contrib-group content-type="section">
<contrib contrib-type="editor">
<name>
<surname>Donlin-Asp</surname>
<given-names>Paul</given-names>
</name>
<role>Reviewing Editor</role>
<aff>
<institution-wrap>
<institution>University of Edinburgh</institution>
</institution-wrap>
<city>Edinburgh</city>
<country>United Kingdom</country>
</aff>
</contrib>
<contrib contrib-type="senior_editor">
<name>
<surname>Sussel</surname>
<given-names>Lori</given-names>
</name>
<role>Senior Editor</role>
<aff>
<institution-wrap>
<institution>University of Colorado Anschutz Medical Campus</institution>
</institution-wrap>
<city>Aurora</city>
<country>United States of America</country>
</aff>
</contrib>
</contrib-group>
<author-notes>
<fn id="n1" fn-type="others"><label>†</label><p>Joint Authors</p></fn>
<corresp id="cor1"><label>*</label>To whom correspondence should be addressed. Tel: +12105629049; Fax: +12105629016; Email: <email>penalva@uthscsa.edu</email></corresp>
</author-notes>
<pub-date date-type="original-publication" iso-8601-date="2024-07-02">
<day>02</day>
<month>07</month>
<year>2024</year>
</pub-date>
<volume>13</volume>
<elocation-id>RP98152</elocation-id>
<history>
<date date-type="sent-for-review" iso-8601-date="2024-04-16">
<day>16</day>
<month>04</month>
<year>2024</year>
</date>
</history>
<pub-history>
<event>
<event-desc>Preprint posted</event-desc>
<date date-type="preprint" iso-8601-date="2024-03-25">
<day>25</day>
<month>03</month>
<year>2024</year>
</date>
<self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2024.03.22.586270"/>
</event>
</pub-history>
<permissions>
<copyright-statement>© 2024, Breunig et al</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Breunig et al</copyright-holder>
<ali:free_to_read/>
<license xlink:href="https://creativecommons.org/licenses/by/4.0/">
<ali:license_ref>https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="elife-preprint-98152-v1.pdf"/>
<abstract>
<title>Abstract</title><p>RNA binding proteins (RBPs) containing intrinsically disordered regions (IDRs) are present in diverse molecular complexes where they function as dynamic regulators. Their characteristics promote liquid-liquid phase separation (LLPS) and the formation of membraneless organelles such as stress granules and nucleoli. IDR-RBPs are particularly relevant in the nervous system and their dysfunction is associated with neurodegenerative diseases and brain tumor development. SERBP1 is a unique member of this group, being mostly disordered and lacking canonical RNA-binding domains. Using a proteomics approach followed by functional analysis, we defined SERBP1’s interactome. We uncovered novel SERBP1 roles in splicing, cell division, and ribosomal biogenesis and showed its participation in pathological stress granules and Tau aggregates in Alzheimer’s disease brains. SERBP1 preferentially interacts with other G-quadruplex (G4) binders, implicated in different stages of gene expression, suggesting that G4 binding is a critical component of SERBP1 function in different settings. Similarly, we identified important associations between SERBP1 and PARP1/polyADP-ribosylation (PARylation). SERBP1 interacts with PARP1 and its associated factors and influences PARylation. Moreover, protein complexes in which SERBP1 participates contain mostly PARylated proteins and PAR binders. Based on these results, we propose a feedback regulatory model in which SERBP1 influences PARP1 function and PARylation, while PARylation modulates SERBP1 functions and participation in regulatory complexes.</p>
</abstract>
<kwd-group kwd-group-type="author">
<title>Keywords</title>
<kwd>SERBP1</kwd>
<kwd>RNA binding protein</kwd>
<kwd>PARP1</kwd>
<kwd>G-quadruplex</kwd>
<kwd>interactome</kwd>
<kwd>proteomics</kwd>
<kwd>mass spectrometry</kwd>
</kwd-group>
</article-meta>
<notes>
<notes notes-type="competing-interest-statement">
<title>Competing Interest Statement</title><p>The authors have declared no competing interest.</p></notes>
</notes>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>RNA binding proteins (RBPs) are a diverse group of regulators with 1,500 members cataloged in the human genome (<xref ref-type="bibr" rid="c1">1</xref>, <xref ref-type="bibr" rid="c2">2</xref>). They display a variety of RNA binding domains (RRMs, zinc-fingers, KH domains, dsRBD, etc.) and control multiple stages of gene expression, including RNA processing (splicing, capping, 3’ end processing, and polyadenylation), modification, transport, decay, localization, and translation (<xref ref-type="bibr" rid="c2">2</xref>, <xref ref-type="bibr" rid="c3">3</xref>). RBPs are particularly relevant in the nervous system, where they regulate critical aspects of neurogenesis, neuronal function, and nervous system development (<xref ref-type="bibr" rid="c4">4</xref>, <xref ref-type="bibr" rid="c5">5</xref>). Alterations in RBP expression and function are linked to neurological disorders, neurodegenerative diseases, and brain tumor development (<xref ref-type="bibr" rid="c6">6</xref>–<xref ref-type="bibr" rid="c12">12</xref>).</p>
<p>RBPs assemble in complexes to regulate gene expression. RBP interactions can take place in the context of macromolecular complexes associated with liquid-liquid phase separation (LLPS). This process supports important regulatory environments and is the foundation for membraneless organelles such as stress granules, Cajal bodies, nucleoli, and P-bodies (<xref ref-type="bibr" rid="c13">13</xref>–<xref ref-type="bibr" rid="c15">15</xref>). RBPs in LLPS tend to share characteristics that include intrinsically disordered regions (IDRs) and RGG boxes. IDR-RBPs can interact with RNA without the presence of specific folded RNA-binding domains (<xref ref-type="bibr" rid="c16">16</xref>). These features provide unique structural and biophysical characteristics to dynamically regulate translation, stress response, RNA processing, and neuronal function (<xref ref-type="bibr" rid="c17">17</xref>).</p>
<p>Many RBPs in LLPS share a binding preference for G-quadruplexes (G4s). G4s are complex DNA or RNA structures that display stacked tetrads of guanosines stabilized by Hoogsteen base pairing. They function as regulatory elements in different stages of gene expression, promote LLPS, and are implicated in cancer, viral replication, neurodegenerative diseases, neurological disorders, and prion diseases (<xref ref-type="bibr" rid="c18">18</xref>–<xref ref-type="bibr" rid="c21">21</xref>).</p>
<p>RBPs containing IDRs and RGG motifs are particularly relevant in the nervous system. Their misfolding contributes to the formation of pathological protein aggregates in Alzheimer’s disease (AD), Frontotemporal Lobar Dementia (FTLD), Amyotrophic Lateral Sclerosis (ALS), and Parkinson’s disease (PD) while their aberrant expression has been linked to glioblastoma development (<xref ref-type="bibr" rid="c22">22</xref>–<xref ref-type="bibr" rid="c24">24</xref>). SERBP1 (Serpine1 mRNA-binding protein 1) is a unique member of this group of RBPs. SERBP1 is a highly conserved protein with homologs identified in yeast, plants, invertebrates, and vertebrates. It is mostly disordered and lacks typical RNA binding domains other than two short RG/RGG motifs (<xref ref-type="bibr" rid="c25">25</xref>). SERBP1 is highly expressed in neuronal and glioma stem cells and a decrease in its levels is required for neuronal differentiation (<xref ref-type="bibr" rid="c26">26</xref>). In glioblastoma, SERBP1 functions as a central regulator of metabolic pathways, coordinating the expression of related enzymes and associated factors implicated in serine biosynthesis, one-carbon, and 5’-methylthioadenosine (MTA) cycles. Ultimately, SERBP1 impacts methionine production and subsequently histone methylation and the expression of genes implicated in neuronal differentiation (<xref ref-type="bibr" rid="c26">26</xref>).</p>
<p>In the present study, we investigated the SERBP1 interactome. Overall, our results established SERBP1 as a multi-regulatory protein, corroborating that RBPs containing IDRs are dynamic and can assemble different complexes. Despite its predominant cytoplasmic localization, SERBP1 is associated with proteins in specific nuclear complexes implicated in splicing regulation, cell division, and ribosome biogenesis. Approximately a third of SERBP1-associated proteins bind to G4s. These proteins are implicated in various stages of gene expression, indicating that G4s function as SERBP1 regulatory motifs in different scenarios. Finally, our study has identified important associations between SERBP1 and PARP1 that suggest a regulatory loop, in which SERBP1 influences PARylation, and PARP activity while PARylation of SERBP1 and its partner proteins modulate their association and function.</p>
</sec>
<sec id="s2">
<title>Results</title>
<sec id="s2a">
<title>SERBP1 interactome reveals its associations with diverse regulatory complexes</title>
<p>To identify SERBP1-associated proteins and molecular complexes in which it is involved, we transfected 293T cells with pSBP-SERBP1 or pUltra-SERBP1(control) and conducted pulldown experiments using streptavidin beads. Analysis by mass spectrometry yielded a high-confidence list of 570 SERBP1-associated proteins – <bold>Table S1, Figure S1</bold>. Gene Ontology (GO) analyses (<xref ref-type="bibr" rid="c27">27</xref>–<xref ref-type="bibr" rid="c29">29</xref>) of identified partners indicated that SERBP1 participates in diverse regulatory complexes in the cytoplasm and nucleus – <xref rid="fig1" ref-type="fig">Figure 1A-B</xref> and <bold>Table S1</bold>. We compared our data to the results of two large-scale studies that used proximity-dependent biotinylation (Bio ID) (<xref ref-type="bibr" rid="c30">30</xref>, <xref ref-type="bibr" rid="c31">31</xref>) to identify protein-protein interactions and also checked the datasets in BioGRID (<xref ref-type="bibr" rid="c32">32</xref>), finding that 146 SERBP1 interactors identified in our analysis were also identified in other high-throughput studies – <bold>Table S1</bold>.</p>
<fig id="fig1" position="float" orientation="portrait" fig-type="figure">
<label>Figure 1</label>
<caption><title>Gene ontology (GO) analysis and characterization of SERBP1-interacting proteins.</title>
<p><bold>A)</bold> Selection of enriched GO terms in Biological Processes, Molecular Function, and Cellular Component according to ShinyGO (<xref ref-type="bibr" rid="c27">27</xref>). FE = fold enrichment; FDR = false discovery rate. <bold>B)</bold> Visualization of associated GO enriched terms in three main regulatory branches: translation, ribosome biogenesis and RNA processing. <bold>C)</bold> Top represented PFAM domains (<xref ref-type="bibr" rid="c42">42</xref>) among SERBP1 interactors with counts of 5 or more and significant fold enrichment (FE) and false discovery rate (FDR). The occurrence of each domain within the total human proteome (ALL) is listed as reference. <bold>D)</bold> Presence of intrinsically disordered proteins (IDPs) (<xref ref-type="bibr" rid="c45">45</xref>) among SERBP1 interactors. <bold>E)</bold> Distribution of identified SERBP1-associated proteins in reference to the presence of RGG boxes (<xref ref-type="bibr" rid="c50">50</xref>) and binding to G-quadruplexes (G4s) (<xref ref-type="bibr" rid="c46">46</xref>, <xref ref-type="bibr" rid="c47">47</xref>).</p></caption>
<graphic xlink:href="586270v1_fig1.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>Although SERBP1’s partners indicate its participation in different stages of translation as well as in its regulation, the many associations with translation initiation factors suggest that SERBP1’s primary function is in initiation – <bold>Table S1</bold>. As expected, based on previous studies (<xref ref-type="bibr" rid="c33">33</xref>–<xref ref-type="bibr" rid="c36">36</xref>), we identified several ribosomal proteins associated with SERBP1 – <bold>Table S1</bold>. SERBP1 knockdown in U251 and U343 cells resulted in a decrease of overall translation as shown by puromycin incorporation assays – <bold>Figure S2A</bold>.</p>
<p>SERBP1 is mostly localized in the cytoplasm. SERBP1 nuclear localization increases in response to stress and is regulated by arginine methyltransferases (<xref ref-type="bibr" rid="c37">37</xref>–<xref ref-type="bibr" rid="c39">39</xref>). SERBP1-associated proteins suggest it participates in nuclear functions; out of 570 associated proteins, 344 display cytoplasmic/nuclear localization, while 100 are exclusively found in the nucleus – <bold>Table S1</bold>. GO analyses of this group identified specific nuclear complexes. The functions of SERBP1-associated proteins suggest that SERBP1 is involved in different stages of ribosome biogenesis – <bold>Table S1</bold>. SERBP1 participation in ribosome biogenesis is corroborated by its presence in nucleoli – <bold>Figure S2B-C</bold>. Results of our previous RIP-Seq analysis (<xref ref-type="bibr" rid="c26">26</xref>) and a CLIP-seq study (<xref ref-type="bibr" rid="c36">36</xref>) showed that SERBP1 binds preferentially to multiple snoRNAs (<bold>Table S2</bold>) and at specific sites in 18S and 28S rRNA. These results, aligned with the fact that SERBP1 associates with FBL and DKC1, two critical snoRNP components, strongly indicate SERBP1 involvement in rRNA modification. Besides ribosome biogenesis, SERBP1 is also likely involved in different stages of RNA processing, in particular splicing, and telomere maintenance – <xref rid="fig1" ref-type="fig">Figure 1A-B</xref>.</p>
<p>SERBP1 is a highly conserved protein. In <italic>S. cerevisiae</italic>, SERBP1 homolog is STM1 (<xref ref-type="bibr" rid="c40">40</xref>). According to BioGRID (<xref ref-type="bibr" rid="c32">32</xref>), 183 proteins were identified as STM1 interactors. Of the 144 identified human homologs, we found that 53 were SERBP1 interactors – <bold>Table S3</bold>. GO analyses of STM1 interactors indicated that STM1 is also a multi-functional protein. Comparisons of enriched GO terms from the SERBP1 and STM1 analyses suggest that several regulatory functions assigned to SERBP1 based on its associated proteins are evolutionarily conserved, including translation, ribosome biogenesis, RNA processing and telomere maintenance – <bold>Table S3</bold>. SERBP1 also has homologs in plants. A recent study in <italic>A. thaliana</italic> established that AtRGG proteins (SERBP1 homologs) interact with ribosomal proteins and proteins involved in RNA processing and transport (<xref ref-type="bibr" rid="c41">41</xref>).</p>
</sec>
<sec id="s2b">
<title>SERBP1 preferentially associates with helicases and G-quadruplex binders</title>
<p>We cataloged all protein domains from the Pfam database (<xref ref-type="bibr" rid="c42">42</xref>) present in identified SERBP1-associated proteins and performed an enrichment analysis. RNA binding and helicase are the two domain families that appeared most often – <xref rid="fig1" ref-type="fig">Figure 1C</xref><bold>, Figure S3,</bold> and <bold>Table S4</bold>. Based on the results of the proteomics analyses and gene expression correlation studies, DDX21, DHX9 and DHX15 are SERBP1’s top-associated helicases – <bold>Table S5</bold>.</p>
<p>SERBP1 displays large intrinsically disordered regions (IDRs) (<xref ref-type="bibr" rid="c25">25</xref>). IDRs are ubiquitous within biomolecular condensates in the cytoplasm and nucleus that are created via liquid-liquid phase separation (LLPS). They lead to the formation of membraneless organelles such as stress granules, P-bodies, and nucleoli (<xref ref-type="bibr" rid="c43">43</xref>, <xref ref-type="bibr" rid="c44">44</xref>). Roughly 80% of SERBP1-associated proteins contain IDRs (<xref ref-type="bibr" rid="c45">45</xref>) and are present in different membraneless organelles, as discussed below – <xref rid="fig1" ref-type="fig">Figure 1D</xref> and <bold>Table S4</bold>.</p>
<p>SERBP1 is a G-quadruplex (G4) binder (<xref ref-type="bibr" rid="c26">26</xref>, <xref ref-type="bibr" rid="c46">46</xref>), as are 38% of its associated proteins (<xref ref-type="bibr" rid="c46">46</xref>, <xref ref-type="bibr" rid="c47">47</xref>) – <bold>Table S6</bold>. RBPs, including SERBP1, often use RGG boxes to bind G4 motifs (<xref ref-type="bibr" rid="c48">48</xref>, <xref ref-type="bibr" rid="c49">49</xref>). We found that among 93 SERBP1-associated proteins containing RGG boxes (<xref ref-type="bibr" rid="c50">50</xref>), 44 are G4 binders – <xref rid="fig1" ref-type="fig">Figure 1E</xref> and <bold>Table S6</bold>. G4 binders associated with SERBP1 are mostly proteins implicated in translation, mRNA stability, and splicing, indicating that SERBP1 regulation via G4 binding takes place in different scenarios. Among G4 binders, we identified several RNA helicases (e. g. DDX5, DDX21, DDX3X, and DHX9) that enhance translation by unfolding G4s in 5’ UTRs (<xref ref-type="bibr" rid="c51">51</xref>–<xref ref-type="bibr" rid="c54">54</xref>) – <bold>Figure S3, Tables S1</bold> and <bold>S6</bold>. Since SERBP1 lacks helicase domains, interaction with these proteins could be critical for SERBP1 function in translation.</p>
<p>G4s regulate different aspects of the life cycles of RNA viruses (<xref ref-type="bibr" rid="c55">55</xref>, <xref ref-type="bibr" rid="c56">56</xref>). GO terms related to viral translation are among those with the highest fold enrichment in our analyses – <bold>Table S1</bold>. In a study to define the SARS-CoV-2 RNA interactome, 168 human proteins were identified (after exclusion of ribosomal proteins and EI3F factors) (<xref ref-type="bibr" rid="c57">57</xref>), including SERBP1 and 92 of its associated proteins – <bold>Table S6</bold>. Of those 92 proteins, 52 are G4 binders – <bold>Table S6</bold>.</p>
</sec>
<sec id="s2c">
<title>SERBP1 affects cell division</title>
<p>SERBP1 has been previously implicated in chromosome segregation and shown to localize in M bodies during mitosis (<xref ref-type="bibr" rid="c36">36</xref>). In agreement, GO analyses of SERBP1-associated proteins revealed chromosome segregation as well as several related functions as enriched terms. Examination of proteins linked to these terms indicated that SERBP1 interacts with proteins in chromosomes as well as centrosomes and mitotic spindles – <xref rid="fig2" ref-type="fig">Figure 2A</xref> and <bold>Table S1</bold>. To evaluate SERBP1’s impact on cell division, U251 and U343 SERBP1 knockdown and control cells were exposed to 20 nM of paclitaxel for 24 hours and later stained with α-tubulin and DAPI. In both cases, SERBP1 knockdown cells had markedly increased numbers of polynucleated cells, reflecting mitotic catastrophe – <xref rid="fig2" ref-type="fig">Figure 2B-C</xref>. SERBP1 involvement in cell division appears to be conserved. STM1, the SERBP1 yeast homolog, is a suppressor of mutations in genes regulating mitosis (<xref ref-type="bibr" rid="c58">58</xref>). Confirming that report, our GO analyses of STM1 genetic interactors showed enrichment for cell division – <bold>Table S3</bold>.</p>
<fig id="fig2" position="float" orientation="portrait" fig-type="figure">
<label>Figure 2</label>
<caption><title>SERBP1 and cell division.</title>
<p><bold>A)</bold> Structures relevant to mitosis and pertinent SERBP1-associated proteins. <bold>B)</bold> Western blot showing SERBP1 knockdown in U251 and U343 cells. <bold>C)</bold> Multinucleated cells in U251 and U343 control and SERBP1 knockdown (KD) cells after treatment with paclitaxel. Data are shown as means of triplicate counts of 1000 cells ± standard deviation and statistical significance was determined by Student’s t-test. <bold>D)</bold> Aspect of cells exposed to paclitaxel. On the left staining with anti-α-Tubulin; in the middle staining with DAPI showing an increased number of multinucleated cells after siSERBP1 KD. 100X magnification for detailed visualization of a single multinucleated cell. <bold>E)</bold> Plot shows the results of a cell viability screening (291 drugs) performed in U343 vs. U343 SERBP1 over-expressing (OE) cells. Red dots correspond to drugs whose impact on cell viability was significantly different between U343 and U343 SERBP1 OE. <bold>F)</bold> Highlights of the screening showing cell cycle/division and DNA damage/replication inhibitors whose impact on cell viability was smaller in U343 SERBP1 OE in comparison to control.</p></caption>
<graphic xlink:href="586270v1_fig2.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>We conducted a viability screening with 269 compounds in GBM U343 and U343 over-expressing (OE) SERBP1 (<xref ref-type="bibr" rid="c26">26</xref>). Corroborating SERBP1 involvement in cell division, we determined that SERBP1 OE cells are less sensitive to drugs affecting cell division, cell cycle, and DNA replication. Interestingly, three of these drugs (Mitoxantrone, Flavopiridol, and Doxorubicin) are also known to affect rRNA transcription and processing – <xref rid="fig2" ref-type="fig">Figure 2E-F</xref> and <bold>Table S7</bold>.</p>
</sec>
<sec id="s2d">
<title>SERBP1 interacts with splicing factors and influences splice site selection</title>
<p>Among identified SERBP1 partners, 134 proteins (23%) are implicated in mRNA processing, and from this group, 117 participate in mRNA splicing. They include many well-known alternative splicing regulators such as hnRNPU, KHDRBS1, PTBP1, SRSF6, TRA2B, SRSF2, and hnRNPA1 – <xref rid="fig3" ref-type="fig">Figure 3A</xref>. In particular, hnRNPU, TRA2B, and KHDRBS1 display high expression correlation with SERBP1 in multiple scenarios – <bold>Table S5</bold>. To determine if SERBP1 expression levels influence splicing, we conducted an RNAseq study in U251 cells. SERBP1 knockdown altered the splicing of 1,625 events (PSI &gt; 0.1, FRD &lt; 0.05) with 70% of them being exon skipping events – <xref rid="fig3" ref-type="fig">Figure 3B</xref> and <bold>Table S8</bold>. Next, we examined a SERBP1 CLIPseq dataset (<xref ref-type="bibr" rid="c36">36</xref>) to look for evidence of SERBP1 direct participation in regulated splicing. From the 1,625 splicing events altered in SERBP1 knockdown cells, CLIP sites were observed close to pertinent splice sites (&lt;100 nucleotides) of 443 (27%) of them - <xref rid="fig3" ref-type="fig">Figure 3C</xref><bold> and Table S8</bold>. SERBP1 association with many known regulators of alternative splicing suggests that its impact on regulated splicing requires interaction with other factors. Since hnRNPU was identified as one of SERBP1’s main partners and they display strong expression correlation in multiple instances (<xref rid="fig3" ref-type="fig">Figure 3D</xref>), we decided to conduct additional RNAseq analysis in U251 cells to determine if the two proteins co-regulate splicing events. Circa 30% of the events identified in SERBP1 knockdown cells were also observed upon hnRNPU knockdown, with changes in the same direction – <xref rid="fig3" ref-type="fig">Figure 3E-F</xref> and <bold>Table S8</bold>.</p>
<fig id="fig3" position="float" orientation="portrait" fig-type="figure">
<label>Figure 3</label>
<caption><title>SERBP1 and splicing.</title>
<p><bold>A)</bold> Networks showing splicing factors identified as SERBP1 interactors. <bold>B)</bold> Distribution of splicing events affected by SERBP1 knockdown according to their type. SE, exon skipping; RI, intron retention; MXE, multiple exclusive exons; A5SS, alternative 5’ splice sites; A3SS, alternative 3’ splice site. <bold>C)</bold> The bar graphs show the percentage of splicing events affected by SERBP1 knockdown with evidence of SERBP1 binding sites close (&lt;100nt) to regulated splice sites. <bold>D)</bold> Results of SERBP1 and hnRNPU expression correlation in different studies. <bold>E)</bold> Overlap between splicing events affected by SERBP1 and hnRNPU KDs. <bold>F)</bold> Sashimi plots showing examples of splicing events affected by both SERBP1 and hnRNPU knockdowns in U251 cells. The red arrows indicate affected exons.</p></caption>
<graphic xlink:href="586270v1_fig3.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>The results of the splicing analysis also revealed another potential route by which SERBP1 could affect ribosome biogenesis. Most expressed snoRNAs are embedded in introns of protein-coding genes and lncRNAs. Our analysis indicates that SERBP1 knockdown affects splicing events that include introns containing snoRNAs in 13 host genes – <bold>Table S8</bold>.</p>
</sec>
<sec id="s2e">
<title>SERBP1 has a two-way association with PARP1 and PARylation</title>
<p>We identified important associations between SERBP1 and PARP1, an enzyme that catalyzes the addition of poly(ADP-ribose) (PAR) on target proteins – <xref rid="fig4" ref-type="fig">Figure 4A</xref>. PARP1 is implicated in DNA repair and regulates multiple stages of gene expression, including transcription, splicing, ribosome biogenesis, and translation (<xref ref-type="bibr" rid="c59">59</xref>–<xref ref-type="bibr" rid="c61">61</xref>). SERBP1 and PARP1 showed strong expression correlated in several scenarios and similar expression profiles during cortex development – <xref rid="fig4" ref-type="fig">Figure 4B-C</xref><bold>, Table S5</bold>.</p>
<fig id="fig4" position="float" orientation="portrait" fig-type="figure">
<label>Figure 4</label>
<caption><title>SERBP1 interacts with PARP1 and influences PARylation.</title>
<p><bold>A)</bold> Results of IP-western in U251 cells with control and anti-SERBP1 antibodies confirm SERBP1 interaction with PARP1, NNNCL and SYNCRIP. <bold>B)</bold> Correlation of SERBP1 and PARP1 expression in different studies. <bold>C)</bold> Similarity of SERBP1 and PARP1 expression profiles during cortex development according to Cortecon (<xref ref-type="bibr" rid="c141">141</xref>). <bold>D)</bold> PARylation sites observed in SERBP1 protein according to (<xref ref-type="bibr" rid="c62">62</xref>, <xref ref-type="bibr" rid="c63">63</xref>). <bold>E)</bold> PARP1 ADP-ribosylates SERBP1 <italic>in vitro</italic>. Purified recombinant PARP1 (0.1 µM) and SERBP1 (0.6 µM) were combined in a reaction with or without sheared salmon sperm DNA (sssDNA) (100 ng/µL) and NAD+ (100 µM) as indicated. The reaction products were analyzed by SDS-PAGE with silver staining (left) and Western blotting for PAR (right). <bold>F)</bold> Venn diagram showing the overlap between SERBP1 interactors, PARylated proteins and PAR binders (<xref ref-type="bibr" rid="c62">62</xref>–<xref ref-type="bibr" rid="c64">64</xref>). <bold>G)</bold> Increase of PARylation levels in 293T and U251 GBM cells after H<sub>2</sub>O<sub>2</sub> treatment. <bold>H)</bold> SBP-SERBP1 pulldown in 293T cells shows increased SERBP1 association with PARP1 after H<sub>2</sub>O<sub>2</sub> treatment. SBP-SERBP1-His detected by His antibody; Flag-PARP1 detected by Flag antibody. <bold>I)</bold> SERBP1 transgenic expression (mGreen-SERBP1) in 293T cells increased the levels of PARylated proteins.</p></caption>
<graphic xlink:href="586270v1_fig4.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>Results of high throughput studies established that SERBP1 gets PARylated and binds to PAR (<xref ref-type="bibr" rid="c62">62</xref>–<xref ref-type="bibr" rid="c64">64</xref>) – <xref rid="fig4" ref-type="fig">Figure 4D</xref><bold>, Table S6</bold>. SERBP1 PARylation by PARP1 was confirmed in an <italic>in vitro</italic> assay – <xref rid="fig4" ref-type="fig">Figure 4E</xref>. Moreover, we determined that circa 56% of all identified SERBP1 interactors get PARylated and/or bind PAR (<xref rid="fig4" ref-type="fig">Figure 4F</xref><bold>, Table S6</bold>), suggesting that PARylation is an important component in the assembly of protein complexes in which SERBP1 participates. We further investigated SERBP1-PARP1 interaction in 293T and U251 cells in the context of PARP activation. Cell exposure to H<sub>2</sub>O<sub>2</sub> enhances PARP1 activity and protein PARylation as shown by Western blots probed with an anti-poly-ADP-ribose binding reagent - <xref rid="fig4" ref-type="fig">Figure 4G</xref>. In U251 cells, H<sub>2</sub>O<sub>2</sub> treatment caused SERBP1 to shift to the nucleus, where it co-localized with PARP1 – <bold>Figure S4A</bold>. Next, we co-transfected SBP-SERBP1-His and Flag-PARP1 in 293T cells and conducted pull-down experiments with streptavidin beads using extracts from cells treated with H<sub>2</sub>O<sub>2</sub> and control. An increase in SERBP1-PARP1 interaction was observed in cells treated with H<sub>2</sub>O<sub>2</sub> - <xref rid="fig4" ref-type="fig">Figure 4H</xref>. On the other hand, transgenic SERBP1 expression in 293T cells increased PARylation, as revealed by western blot probed with PAR detecting reagent – <xref rid="fig4" ref-type="fig">Figure 4I</xref>. To determine if PARylation/PAR binding affects SERBP1 interactions, we transfected 293T cells with an SBP-SERBP1 expressing vector. The experimental group was treated later with PJ34. SERBP1-associated proteins were isolated via pulldown with streptavidin beads and the presence of PARylated proteins was evaluated by Western blot. PARP inhibition decreased the amount of PARylated proteins associated with SERBP1 as shown in the pulldown lanes - <bold>Figure S4B</bold>.</p>
<p>A recently published screening identified genes conferring sensitivity to PARP inhibitors, Olaparib, Rucaparib, and Talazoparib (<xref ref-type="bibr" rid="c65">65</xref>). From this study, we generated a list with top hitters for each drug and compiled the results to identify genes appearing in two or more analyses. The 424 identified genes include SERBP1 and 82 of its interactors - <bold>Table S7</bold>. In agreement, using a proliferation assay, we determined that SERBP1 partial knockdown makes U251 and U343 GBM cells more sensitive to the PARP inhibitor PJ34 – <bold>Figure S4C</bold>.</p>
<p>PARP1 and several of its characterized interactors were determined to be associated with SERBP1 – <bold>Table S1</bold>. Our investigation has determined that the list of PARP1-SERBP1 shared factors is in fact more extensive. A comparison between SERBP1-associated factors and PARP1 interactors detected via proximity labeling (<xref ref-type="bibr" rid="c66">66</xref>) identified 199 common factors (including SERBP1 and PARP1), of which about 80% are also PARylated and/or bind PAR (<xref ref-type="bibr" rid="c62">62</xref>–<xref ref-type="bibr" rid="c64">64</xref>) – <xref rid="fig5" ref-type="fig">Figure 5A</xref> and <bold>Table S6</bold>. These proteins are implicated in splicing regulation, ribosome biogenesis, and DNA repair – <xref rid="fig5" ref-type="fig">Figure 5B</xref> and <bold>Table S6</bold>. Among shared SERBP1-PARP1 interactors that get PARylated and/or bind to PAR are multiple key factors implicated in rRNA transcription, processing, and modification, including NOLC1, NOP16, NAT10, DKC1, DDX21, NCL, SMARCA4 and TCOF1 – <xref rid="fig5" ref-type="fig">Figure 5C</xref><bold> and Table S6.</bold> The binding of snoRNAs to PARP1 stimulates its catalytic activity in the nucleolus independent of DNA damage. Activated PARP1 PARylates the RNA helicase DDX21 to promote rDNA transcription (<xref ref-type="bibr" rid="c67">67</xref>). DDX21 was identified as a top SERBP1-associated factor, and expression of the two proteins was highly correlated in several scenarios – <bold>Tables S1</bold> and <bold>S6</bold>. Moreover, we and others have determined that SERBP1 preferentially binds snoRNAs (including snoRA37, snoRA74A, and snoRA18), which have been implicated in PARP1 activation (<xref ref-type="bibr" rid="c67">67</xref>). Out of 58 snoRNAs bound by PARP1 (<xref ref-type="bibr" rid="c68">68</xref>), 32 of them are also targeted by SERBP1 – <bold>Table S2</bold>.</p>
<fig id="fig5" position="float" orientation="portrait" fig-type="figure">
<label>Figure 5</label>
<caption><title>Shared SERBP1 and PARP1 interactors.</title>
<p><bold>A)</bold> Overlap between PARP1 (<xref ref-type="bibr" rid="c66">66</xref>) and SERBP1 interactomes and data on PAR binding (<xref ref-type="bibr" rid="c64">64</xref>) and PARylation (<xref ref-type="bibr" rid="c62">62</xref>, <xref ref-type="bibr" rid="c63">63</xref>) of shared interactors. <bold>B)</bold> Selection of enriched GO terms (biological processes) related to SERBP1-PARP1 shared interactors according to ShinyGO (<xref ref-type="bibr" rid="c27">27</xref>). FE = fold enrichment; FDR = false discovery rate. <bold>C)</bold> Network showing shared SERBP1 and PARP1 interactors implicated in ribosome biogenesis. <bold>D)</bold> Proposed SERBP1-PARP1 feedback model; SERBP1 function and association with partner proteins is modulated by PARylation while SERBP1 influences PARP activity.</p></caption>
<graphic xlink:href="586270v1_fig5.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>Adding up to SERBP1-PARP1 strong functional association, we determined that about 50% of SERBP1 interactors known to bind PAR, are also G4 binders – <bold>Figure S5A, Table S6</bold>. Different types of protein domains bind to PAR, including RGG boxes and RRMs (<xref ref-type="bibr" rid="c69">69</xref>, <xref ref-type="bibr" rid="c70">70</xref>). These two types of domains are also among the ones that bind G4s. About half of SERBP1-associated proteins that were identified as both PAR and G4 binders contain RGG boxes and/or RRMs (<xref ref-type="bibr" rid="c50">50</xref>, <xref ref-type="bibr" rid="c71">71</xref>) – <bold>Figure S5B</bold> and <bold>Table S6</bold>. Based on our findings, we propose the existence of a feedback regulatory model in which SERBP1 influences PARP1 function and PARylation, while PARylation modulates SERBP1 functions and association with its protein partners – <xref rid="fig5" ref-type="fig">Figure 5D</xref>.</p>
</sec>
<sec id="s2f">
<title>SERBP1 is in association with proteins present in membraneless organelles and Tau aggregates</title>
<p>GO analysis of SERBP1-associated proteins based on cellular compartment (<xref ref-type="bibr" rid="c72">72</xref>) determined that SERBP1 interacts with factors often present in membraneless organelles, including stress granules, P bodies, Cajal bodies, nuclear speckles, paraspeckles, and nucleoli, which suggests SERBP1’s likely participation in protein complexes present these organelles – <bold>Table S9</bold> and <xref rid="fig6" ref-type="fig">Figure 6</xref>. SERBP1 binding to snoRNAs and scaRNAs further supports its presence in Cajal bodies and nucleolus – <bold>Table S2</bold>. Liquid-liquid phase separation (LLPS) is an important mechanism in the formation of these membraneless organelles or granules (<xref ref-type="bibr" rid="c73">73</xref>). We have previously established that SERBP1 forms biomolecular condensates <italic>in vitro</italic> that are modulated by RNA (<xref ref-type="bibr" rid="c25">25</xref>). A characteristic of proteins in LLPS is the presence of IDRs (<xref ref-type="bibr" rid="c74">74</xref>, <xref ref-type="bibr" rid="c75">75</xref>). Of all SERBP1-associated proteins present in membraneless organelles, 77% of them contain IDRs – <bold>Table S9</bold>.</p>
<fig id="fig6" position="float" orientation="portrait" fig-type="figure">
<label>Figure 6</label>
<caption><title>SERBP1-associated proteins are prevalent in membraneless organelles.</title>
<p><bold>A)</bold> Different types of membraneless organelles in a cell and examples of SERBP1-associated proteins present in each structure. <bold>B)</bold> Membraneless organelles identified in the GO enrichment analysis (cellular component) of SERBP1 interactors (<xref ref-type="bibr" rid="c72">72</xref>). FE = fold enrichment; FDR = false discovery rate. <bold>C)</bold> Bar graph showing the distribution of SERBP1-associated proteins in different membraneless organelles. <bold>D)</bold> Prevalence of G4 binders (<xref ref-type="bibr" rid="c46">46</xref>, <xref ref-type="bibr" rid="c47">47</xref>), PAR binders (<xref ref-type="bibr" rid="c64">64</xref>), and PARylated proteins (<xref ref-type="bibr" rid="c62">62</xref>, <xref ref-type="bibr" rid="c63">63</xref>) among SERBP1-associated proteins present in membraneless organelles.</p></caption>
<graphic xlink:href="586270v1_fig6.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>SERBP1 has been observed in Tau aggregates in Alzheimer’s disease (AD) brains and is part of a group of 261 proteins detected in several studies that examined the composition of Tau aggregates (<xref ref-type="bibr" rid="c9">9</xref>). We further investigated SERBP1’s association with pathological Tau by co-staining SERBP1 in AD tissues with phospho-tau (Thr231), which is associated with large inclusion and paired helical filaments (PHF) (<xref ref-type="bibr" rid="c76">76</xref>). We found a signal overlap between large hyperphosphorylated Tau inclusions and SERBP1 puncta (<xref rid="fig7" ref-type="fig">Figure 7A</xref>), confirming their close interaction in AD tissue. Western blot analysis showed that SERBP1 displays increased expression in AD brains in comparison to normal controls. Interestingly, SERBP1 appears to be often present as a dimer – <xref rid="fig7" ref-type="fig">Figure 7B</xref>. Overall, our data suggest that SERBP1 shows increased accumulation in AD brains and condenses in hyperphosphorylated Tau aggregates.</p>
<fig id="fig7" position="float" orientation="portrait" fig-type="figure">
<label>Figure 7</label>
<caption><title>SERBP1 is present in Tau aggregates.</title>
<p><bold>A)</bold> Representative co-immunofluorescence of SERBP1 and Phospho-Tau (Thr231) in AD brain tissues. Merged channel is represented. DAPI was used to stain nuclei. Magnification 20x and white scale bar: 50 µm. Three different Insets selected from merged channels are represented in zoomed images as merged, SERBP1 (green) and Phospho-Tau (red). <bold>B)</bold> Western blot showing SERBP1 expression in normal and AD brains and presence of oligomers. <bold>C)</bold> Venn diagram shows overlap between proteins identified in Tau aggregates and SERBP1 associated proteins (top). Selection of enriched GO terms in Biological Processes according to ShinyGO (<xref ref-type="bibr" rid="c27">27</xref>) related to proteins present in the overlap (bottom). FE = fold enrichment; FDR = false discovery rate.</p></caption>
<graphic xlink:href="586270v1_fig7.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>146 proteins present in Tau aggregates were also identified as SERBP1 interactors – <xref rid="fig7" ref-type="fig">Figure 7C</xref> and <bold>Table S9</bold>. GO analysis indicated that this group is strongly associated with ribosome biogenesis, translation, and splicing - <xref rid="fig7" ref-type="fig">Figure 7C</xref>. snoRNAs are also aberrantly located in Tau aggregates (<xref ref-type="bibr" rid="c77">77</xref>). Adding to SERBP1 participation in Tau aggregates, we determined that 66% of the snoRNAs enriched in Tau aggregates were bound by SERBP1 according to our study – <bold>Table S9</bold>. Ribosome biogenesis and translation are impaired in AD (<xref ref-type="bibr" rid="c78">78</xref>, <xref ref-type="bibr" rid="c79">79</xref>). SERBP1 may help trap snoRNAs and factors implicated in ribosome biogenesis and translation in Tau aggregates, but further investigation is required.</p>
<p>PARP1 activity is increased in AD brains. Immunostaining of PARP1 and PAR indicates that PARylation is hyperactivated in AD neurons. Ultimately, this hyperactivation can trigger proteins to condense into toxic aggregates that contribute to neurodegeneration (<xref ref-type="bibr" rid="c80">80</xref>). We investigated PARP1-SERBP1 association in normal vs. AD brains. PARP1 exhibited a stronger presence in AD cortices compared to controls. Furthermore, PARP1 appeared to co-localize with SERBP1 in the cytoplasmic fraction of AD samples (white arrowhead) – <xref rid="fig8" ref-type="fig">Figure 8A</xref>. In control samples, PARP1 and SERBP1 also co-localized, albeit to a lesser extent compared to AD samples (confirmed by PCC analysis) - <xref rid="fig8" ref-type="fig">Figure 8A-B</xref>. Fluorescence profiles corroborate their association – <xref rid="fig8" ref-type="fig">Figure 8C</xref>.</p>
<fig id="fig8" position="float" orientation="portrait" fig-type="figure">
<label>Figure 8</label>
<caption><title>SERBP1 association with PARP1 in Alzheimer’s brains.</title>
<p><bold>A)</bold> Representative co-immunofluorescence of SERBP1 and PARP1 in AD and age-matched control brain tissues. PARP1 and SERBP1 are represented in gray while merged images represent PARP1 (red), SERBP1 (green). DAPI was used to stain nuclei (blue). Magnification 20x and white scale bar: 100 µm. Each frame has a zoomed inset representing the detailed distribution of each target. <bold>B)</bold> Pearson Coefficient (PCC) of co-localizing SERBP1 and PARP1 between in cells of age-matched control and AD brains (CTR vs. AD, **** p&lt;0.001 paired t-test). <bold>C</bold>) Fluorescence intensity profiles of PARP1 (red), SERBP1 (green), and DAPI (blue) in representative cells from age-matched control and AD brains. Distance is represented in pixels and fluorescence intensity as Grey value obtained using ImageJ FIJI software.</p></caption>
<graphic xlink:href="586270v1_fig8.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>G3BP1, a well-established regulator of stress granule assembly, has been identified here as a SERBP1-associated protein (<bold>Table S1</bold>). In AD brains, G3BP1 is present in pathological stress granules (<xref ref-type="bibr" rid="c81">81</xref>, <xref ref-type="bibr" rid="c82">82</xref>). Co-immunofluorescence (IF) experiments in control and AD brain sections revealed a stronger fluorescent signal for SERBP1 and G3BP1 in AD compared to controls, indicating higher levels of SERBP1 protein in stress granules in pathological condition – <bold>Figure S6A</bold>. Moreover, SERBP1 IF showed a high density of puncta with some large aggregates in AD samples. To quantify the level of SERBP1 in stress granules in control and AD samples, we measured the number of positive SERBP1 puncta in G3BP1 stress granules, observing a significant increment of SERBP1 in stress granules in AD cases. The total number of G3BP1 and SERBP1 puncta indicated greater accumulation in AD tissues compared to control – <bold>Figure S6B</bold>. SERBP1 and G3BP1 also show strong co-localization in glioblastoma cells and highly correlated expression in different scenarios – <bold>Figure S6C, Table S5</bold>.</p>
</sec>
</sec>
<sec id="s3">
<title>Discussion</title>
<p>SERBP1’s name relates to its function as a regulator of the gene SERPINE1, which encodes the plasminogen activator inhibitor 1 (PAI-1) (<xref ref-type="bibr" rid="c83">83</xref>), a protein implicated in senescence and migration. SERBP1 is localized mostly in the cytoplasm, but it is also present in the nucleus. SERBP1 cytoplasmic/nuclear balance changes during the cell cycle, and its nuclear presence intensifies upon stress (<xref ref-type="bibr" rid="c35">35</xref>, <xref ref-type="bibr" rid="c37">37</xref>, <xref ref-type="bibr" rid="c39">39</xref>). We have identified SERBP1’s interactome and expanded its regulatory roles – particularly in the nucleus, where it is associated with specific complexes implicated in splicing, cell division, chromosome structure, and different aspects of ribosome biogenesis.</p>
<p>Most SERBP1-associated proteins are also RBPs. However, SERBP1 has unique characteristics; it is mostly disordered and does not display classic RNA binding domains other than RGG boxes (<xref ref-type="bibr" rid="c25">25</xref>). Two commonalities between SERBP1 and its associated proteins are their preference for G4 binding and the fact that they get PARylated and/or bind to PAR. These results indicate that complexes in which SERBP1 participates are assembled via G4 or PAR binding. Since SERBP1 does not display any apparent functional domains and is involved in very distinct regulatory complexes, we suggest that SERBP1 acts in the initial steps of their assembly via recognition of interacting sites in RNA, DNA, and proteins.</p>
<sec id="s3a">
<title>SERBP1 in translation regulation and ribosomal biogenesis</title>
<p>SERBP1 interacts with ribosomal proteins and regulates translation (<xref ref-type="bibr" rid="c33">33</xref>–<xref ref-type="bibr" rid="c36">36</xref>), functioning as a repressor or activator depending on the context. For instance, SERBP1 binding to CtIP mRNA during the S phase increases its translation (<xref ref-type="bibr" rid="c35">35</xref>), while changes in binding to the 40S ribosomal subunit during mitosis lead to PKCε pathway-mediated translation repression (<xref ref-type="bibr" rid="c36">36</xref>). Additionally, the SERBP1 yeast homolog, STM1, is required for optimal translation under nutritional stress (<xref ref-type="bibr" rid="c84">84</xref>). SERBP1 migrates to stress granules under stress conditions (<xref ref-type="bibr" rid="c37">37</xref>). Recent findings indicated that translation in these organelles is not uncommon (<xref ref-type="bibr" rid="c85">85</xref>), suggesting the possibility of a similar role for SERBP1 as a modulator of translation in stress conditions.</p>
<p>Our GO analyses revealed that SERBP1 interacts with proteins participating in all stages of translation – initiation, elongation, and termination – including both negative and positive regulators. We found that 17% of SERBP1-associated proteins are implicated in translation initiation, including several subunits of the eukaryotic initiation factor 3 (eIF3A-I, L, and M) and CSDE1, among others. These data suggest that SERBP1’s primary function in translation regulation lies in initiation. CSDE1 is a known regulator of both cap-dependent and cap-independent translation, functioning either as an enhancer (<xref ref-type="bibr" rid="c86">86</xref>, <xref ref-type="bibr" rid="c87">87</xref>) or repressor (<xref ref-type="bibr" rid="c88">88</xref>, <xref ref-type="bibr" rid="c89">89</xref>). The expression of CSDE1 is highly correlated with SERBP1 in multiple instances. CSDE1 was proposed to function as a “protein-RNA connector” enabling interactions between RNAs and regulators to control RNA’s translational fate (<xref ref-type="bibr" rid="c90">90</xref>). A similar role could be ascribed to SERBP1, possibly explaining its different effects on translation.</p>
<p>Multiple SERBP1-associated proteins are involved in viral translation. For instance, the aforementioned interactors, components of the eIF3 complex and CSDE1, are both implicated in IRES-mediated viral translation in a variety of viruses (<xref ref-type="bibr" rid="c91">91</xref>–<xref ref-type="bibr" rid="c93">93</xref>). SERBP1 itself has also recently been shown to interact with dengue virus RNA and regulate its translation (<xref ref-type="bibr" rid="c94">94</xref>). Finally, we observed a significant overlap between SERBP1-associated proteins and the SARS-CoV-2 interactome, with 82 proteins out of 145 shared interactors being involved in translation.</p>
<p>SERBP1’s interactors and its presence in the nucleolus suggest its participation in ribosome biogenesis. Besides binding to mRNA, SERBP1 binds to rRNA and snoRNAs, which play a role in pre-rRNA processing and modification (<xref ref-type="bibr" rid="c95">95</xref>). SERBP1, and 98 of its associated proteins, were previously identified in a screening for factors affecting rRNA processing (<xref ref-type="bibr" rid="c96">96</xref>). SERBP1’s binding profile to rRNA and snoRNA is dynamic, as shown by differences in iCLIP sites in mitotic vs. asynchronous cells (<xref ref-type="bibr" rid="c36">36</xref>), hinting that SERBP1’s participation in these processes is cell cycle-dependent as seen for translation. FBL, a SERBP1-associated protein, is involved in pre-rRNA processing, pre-rRNA methylation, and ribosome assembly (<xref ref-type="bibr" rid="c97">97</xref>). Recently, it has been shown that FBL also modulates rDNA transcription during the cell cycle according to its acetylation status, leading to higher levels of rRNA synthesis in interphase and lower levels during mitosis (<xref ref-type="bibr" rid="c98">98</xref>). SERBP1 also interacts with multiple proteins of the cohesin complex (SMC1, SMC3, and PDS5B) plus the associated factor, CTCF. Cohesin forms an enhancer boundary complex whose binding upstream of the 47S rDNA has been suggested as an early event in the activation of rDNA transcription (<xref ref-type="bibr" rid="c99">99</xref>). In accordance with this finding, mutations in cohesin components have been linked to defects in both rRNA production and processing in yeast and human cells (<xref ref-type="bibr" rid="c100">100</xref>). Two of SERBP1’s top interactors, the RNA helicase DDX21 and NCL, also promote rDNA transcription (<xref ref-type="bibr" rid="c101">101</xref>, <xref ref-type="bibr" rid="c102">102</xref>)</p>
<p>Overall, these findings indicate a rather fluid role for SERBP1 in translation regulation, promoting or repressing different translational steps and acting in rRNA processing/modification and ribosome biogenesis through diverse pathways.</p>
</sec>
<sec id="s3b">
<title>SERBP1 and PARylation</title>
<p>PARylation of SERBP1 was described in several different studies (<xref ref-type="bibr" rid="c62">62</xref>, <xref ref-type="bibr" rid="c63">63</xref>, <xref ref-type="bibr" rid="c103">103</xref>–<xref ref-type="bibr" rid="c106">106</xref>). Moreover, the expression of human PARP1 in <italic>S. cerevisae,</italic> which does not naturally express PARP proteins, caused PARylation of many proteins implicated in ribosomal biogenesis, including STM1, SERBP1 homolog (<xref ref-type="bibr" rid="c107">107</xref>). Our results suggest a two-way association between SERBP1 and PARP1. First, SERBP1 and 56% of its identified associated proteins either get PARylated and/or bind PAR (<xref ref-type="bibr" rid="c62">62</xref>–<xref ref-type="bibr" rid="c64">64</xref>). This result suggests that SERBP1 participates in several regulatory complexes modulated via PARylation.</p>
<p>PARylation of RBPs ultimately influences RNA processing and expression (<xref ref-type="bibr" rid="c59">59</xref>, <xref ref-type="bibr" rid="c108">108</xref>). In particular, PARylation of splicing regulators is known to affect alternative splicing. For instance, PARylation of HRP38’s RNA binding domain decreases its binding activity and subsequently its ability to inhibit splicing (<xref ref-type="bibr" rid="c59">59</xref>). PARylation also affects protein-protein interaction as observed in the case of hnRNPA1 (<xref ref-type="bibr" rid="c109">109</xref>). Finally, PARP1 itself is involved in splicing. PARP1 binds RNA with a preference for intronic regions, while its knockdown affected many splicing events (<xref ref-type="bibr" rid="c110">110</xref>). Several splicing regulators known to get PARylated and/or bind to PAR were identified as SERBP1-associated proteins, including hnRNPs (A1, H1, A2B1, H3, K, I, and U) and SR proteins (SRSF2, SRSF3, and SRSF9). In particular, most splicing alterations observed in SERBP1 KD cells were also present upon hnRNPU KD, suggesting that they work as co-factors in splicing regulation. Altogether, the data suggest that SERBP1 is directly implicated in splicing regulation and is present in complexes modulated by PARylation.</p>
<p>PAR induces phase separation of proteins containing IDRs and the formation of molecular condensates or membraneless organelles such as stress granules, mitotic spindles, DNA repair foci, and nucleoli (<xref ref-type="bibr" rid="c111">111</xref>). Similarly, ADP-ribose can be conjugated to polar and charged amino acids, which are often found in IDRs (<xref ref-type="bibr" rid="c111">111</xref>). Ultimately, PAR serves as a scaffold to assemble protein complexes in different contexts where PAR length and structure influence their composition (<xref ref-type="bibr" rid="c111">111</xref>). The large number of PARylated proteins and PAR binders found among SERBP1-associated proteins strongly indicates that PAR is a critical component of the regulatory complex in which SERBP1 participates, especially in membraneless organelles. As a protein that interacts with PARP1, promotes PARP activity, gets PARylated, and binds PAR, we suggest that SERBP1 acts as a critical factor in the assembly of PARylation-dependent complexes. Additional analyses are required to assess whether the formation of such complexes depends on SERBP1 and if inhibition of SERBP1 PAR binding activity could be explored as a therapeutic strategy.</p>
<p>SERBP1 exhibited a punctate distribution in normal brain, indicating its presence as functional singlet condensate. However, in AD brain tissues, SERBP1 appeared to accumulate in large cytoplasmic aggregates and to strongly co-localize with PARP1. This result suggests that PARP1 modulates liquid-liquid phase separation (LLPS) and a PARylation-mediated mechanism is likely involved in SERBP1’s pathological transition from condensate to aggregate. Several RBPs containing intrinsically disordered regions, like SERBP1, have been shown to display alterations in LLPS in neurodegenerative diseases (<xref ref-type="bibr" rid="c112">112</xref>, <xref ref-type="bibr" rid="c113">113</xref>)</p>
</sec>
<sec id="s3c">
<title>SERBP1 and G4 binders</title>
<p>SERBP1 belongs to a group of neuronal-related RBPs that share structural characteristics and preferentially bind to G quadruplexes (G4s). G4s are complex DNA or RNA structures that display stacked tetrads of guanosines stabilized by Hoogsteen base pairing. rG4s function as regulatory elements in different stages of gene expression, including splicing, mRNA decay, polyadenylation, and translation. G4s have been linked to cancer, viral replication, and in particular neurodegenerative diseases and neurological disorders (<xref ref-type="bibr" rid="c114">114</xref>–<xref ref-type="bibr" rid="c116">116</xref>).</p>
<p>The SERBP1 interactome shows an interesting parallel between PAR and G4 binding. Almost half of the SERBP1-associated proteins that bind G4 also bind PAR. PAR and G4s occupy the same regulatory space that includes DNA repair and stress response, and both induce phase separation. However, not much is known regarding the association between G-quadruplex and PAR binding/PARylation, aside from the fact that PARP1 binds G4s, and this leads to the activation of its enzymatic activity (<xref ref-type="bibr" rid="c117">117</xref>). We envision two possible scenarios for SERBP1 and its associated proteins. Two types of domains have been implicated in both PAR and G4 binding, RGG boxes and RRMs. Among 105 SERBP1-associated factors that bind PAR and G4, 51 contain RGG and/or RRM domains. Proteins that employ the same domain to bind PAR and G4 could transit from G4 to PAR binding complexes, depending on the cellular state. In a different setting, binding to G4 motifs in DNA or RNA could serve as a starting point for the assembly of PAR binding/PARylated protein complexes. Further investigation on PAR- and G4-dependent interactions and identification of G4 and PAR binding domains in proteins present in these complexes are needed to elucidate the relationship between PAR and G4 binding.</p>
</sec>
<sec id="s3d">
<title>SERBP1 potential role in neurodegenerative diseases and neurological disorders</title>
<p>SERBP1 expression in the brain is lower than in other organs and is increased in glioblastoma (<xref ref-type="bibr" rid="c26">26</xref>) and Alzheimer’s brains, as shown in this study. SERBP1 is present in Tau aggregates (<xref ref-type="bibr" rid="c9">9</xref>) and in pathological stress granules in connection with G3BP1. PAR levels regulate the dynamics of RNPs and aberrant PARP1 activity promotes aggregation (<xref ref-type="bibr" rid="c109">109</xref>). Over 60% of SERBP1-associated proteins detected in Tau aggregates get PARylated and/or bind PAR (<xref ref-type="bibr" rid="c62">62</xref>–<xref ref-type="bibr" rid="c64">64</xref>) and increased SERBP1-PARP1 interaction was observed in AD brains. Besides its potential role in aggregate formation, increased expression of SERBP1 in Alzheimer’s brains could lead to important changes in gene expression. SERBP1 is highly expressed in neuronal and glioma stem cells and its levels drop significantly during neurogenesis. SERBP1 transgenic expression disrupted neuronal differentiation while its knockdown increased the expression of genes implicated in nervous system development, synaptic signaling, organization, memory, learning, and behavior (<xref ref-type="bibr" rid="c26">26</xref>).</p>
<p>SERBP1-associated proteins contain several factors involved in neurological disorders and neurodegenerative diseases, including FMR1, SMN1, and PABPN1. SERBP1 interaction with FMRP (FMR1) has been previously described (<xref ref-type="bibr" rid="c36">36</xref>, <xref ref-type="bibr" rid="c37">37</xref>). Not only was this interaction validated, but we also determined that SERBP1 associates with FMRP partner proteins FXR1 and FXR2. FMRP is the main driver of Fragile X mental retardation but has also been linked to Alzheimer’s disease and autism (<xref ref-type="bibr" rid="c118">118</xref>, <xref ref-type="bibr" rid="c119">119</xref>). FMRP is a complex protein that binds different RNA motifs (including G4s) and regulates translation, splicing, RNA editing, and miRNA function, affecting synapse formation and plasticity, stress granule formation, channel signaling, and differentiation (<xref ref-type="bibr" rid="c120">120</xref>–<xref ref-type="bibr" rid="c123">123</xref>). Previous results indicate that SERBP1 and FMRP interact in different contexts (<xref ref-type="bibr" rid="c36">36</xref>, <xref ref-type="bibr" rid="c37">37</xref>), suggesting that they function together in diverse stages of gene expression.</p>
<p>Spinal Muscular Atrophy (SMA) is caused by mutations in the SMN1 gene. Patients show progressive lower motor neuron loss (<xref ref-type="bibr" rid="c6">6</xref>). We observed associations between SERBP1, SMN1, and other members of the SMN complex, GEMIN4 and 5. SMN1 brings together the complex and is essential for spliceosome assembly. Since motor neurons are particularly sensitive to SMN1 mutations, additional roles for the SMN complex in these cells are proposed (<xref ref-type="bibr" rid="c6">6</xref>).</p>
<p>SYNCRIP and hnRNPU were identified among the top proteins associated with SERBP1 based on our proteomics analyses and gene expression correlations. SYNCRIP plays multiple roles in neuronal cells, including dendritic translation, synaptic plasticity, axonogenesis, and morphology (<xref ref-type="bibr" rid="c124">124</xref>–<xref ref-type="bibr" rid="c128">128</xref>). hnRNPU has been implicated in cortex development (<xref ref-type="bibr" rid="c129">129</xref>). Mutations in both hnRNPU and SYNCRIP are linked to intellectual disability (<xref ref-type="bibr" rid="c130">130</xref>–<xref ref-type="bibr" rid="c132">132</xref>) and neurodevelopmental disorders (<xref ref-type="bibr" rid="c133">133</xref>, <xref ref-type="bibr" rid="c134">134</xref>), and were the two top candidates in an IBM Watson-based study to identify RBPs altered in amyotrophic lateral sclerosis (ALS) (<xref ref-type="bibr" rid="c135">135</xref>).</p>
<p>SERBP1 has not been studied in the context of the nervous system, and its contribution to neurodegenerative diseases and neurological disorders remains to be investigated. Our results suggest that SERBP1 is “guilty by association” as it interacts with several RBPs that function as key players in these scenarios. Moreover, SERBP1 regulates the expression of genes implicated in neuronal differentiation and synaptogenesis, processes often compromised in disease states. In the case of Alzheimer’s disease, increased expression of SERBP1 and its presence in pathological aggregates hint at a potential involvement. Additional studies are necessary to establish causal connections that link SERBP1 to AD phenotypes.</p>
</sec>
</sec>
<sec id="s4">
<title>Material and methods</title>
<sec id="s4a">
<title>Cell culture, transfection, knockdown</title>
<p>U251 and U343 glioblastoma cell lines were obtained from Uppsala University (Uppsala, Sweden). 293T cells were obtained from the American Type Tissue Collection (ATCC). All cell lines were cultured in DMEM medium (HyClone, Cat# SH30243.01) supplemented with 10% FBS (Corning, Cat# 35015CV) and 1% penicillin/streptomycin (Gibco, Cat# 10378016). Cells were maintained at 37 °C in a 5% CO<sub>2</sub> atmosphere. Knockdown of SERBP1 (siSERBP1 KD) in U251 and U343 cells was performed by reverse transfection with 25 nM of control or SERBP1 SMARTpool siRNA (Dharmacon, Cat# L-020528-01-0005) using Lipofectamine RNAiMAX (Invitrogen, Cat# 13778150).</p>
</sec>
<sec id="s4b">
<title>Plasmid constructs</title>
<p>A vector containing the Streptavidin-Binding Peptide (SBP)-Tag was prepared in pEF1 (Thermo Fisher, Cat# V 92120), and SERBP1 ORF was cloned in frame with the His-Myc-tag present in the vector to create pSBP-SERBP1. pUltra-SERBP1 lentiviral vector (<xref ref-type="bibr" rid="c26">26</xref>) was used as a control in pulldown experiments. SERBP1 ORF was inserted into the pcDNA3.1-mGreenLantern plasmid (Addgene Plasmid #161912) to make mGreen-SERBP1. Flag-PARP1 was obtained from Addgene (#111575).</p>
</sec>
<sec id="s4c">
<title>Identification of SERBP1 interactors</title>
<p>293T cells were seeded (triplicate) in 10 cm dishes the day before transfection. pSBP-SERBP1 or pUltra-SERBP1(control) plasmids were transfected using CaCl<sub>2</sub>. 48 hours later, cells were collected and washed twice in cold PBS. Total protein extract was prepared by using TNE buffer (Tris pH 7.4 10 mM, NP-40 1%, NaCl 150 mM, and phosphatase inhibitor cocktails, Thermo Fisher Scientific, Cat #78430), incubating cells for 30 minutes on ice, and then sonicating five times for 3 seconds at 20% amplitude and 10-second intervals. A second batch of samples was prepared by using polysomal lysis buffer (KCl 100 mM, EDTA 25 mM, MgCl<sub>2</sub> 5 mM, HEPES pH 7.0 10 mM, NP-40 0.5%, DTT 2 mM, VRC 0.4 mM, glycerol 10%, and phosphatase inhibitor cocktails, Thermo Fisher Scientific). Cell lysates were centrifuged at 4°C to eliminate debris and supernatants were collected and used later in pulldown assays.</p>
<p>50 µl of packed streptavidin beads (GE Healthcare Life Sciences, Cat# 17-5113-01) were washed two times in PBS and subsequently blocked in 1% BSA/PBS for 30 minutes at 4°C. Beads were finally washed five times in TNE buffer and then combined with cell extracts. The solution was incubated at room temperature for 2 hours and beads were later recovered via centrifugation at 4°C. The supernatant was discarded, and beads were washed five times with 1 ml of TNE buffer. To elute proteins, samples were resuspended in elution buffer (Tris pH 7.4 50 mM, NaCl 250 mM, NP-40 0.5%, deoxycholate 0.1%, 10 mM biotin), mixed, and incubated for 45 min at 37°C in a thermo-shaker. The supernatant was collected after centrifugation for mass spectrometry analysis.</p>
</sec>
<sec id="s4d">
<title>Protein identification by mass spectrometry</title>
<sec id="s4d1">
<title>Analysis of proteins associated with SERBP1</title>
<p>Proteins were separated by 1D SDS-PAGE using a Criterion XT 12% gel that was electrophoresed for ∼1.5 cm and then stained with Coomassie blue (one experiment per gel). The protein-containing region of each gel lane was divided into six slices which were individually reduced <italic>in situ</italic> with TCEP [tris(2-carboxyethyl)phosphine] and alkylated in the dark with iodoacetamide prior to treatment with trypsin. Each digest was analyzed by capillary HPLC-electrospray ionization tandem mass spectrometry on a Thermo Scientific Orbitrap Fusion Lumos mass spectrometer. On-line HPLC separation was accomplished with an RSLC NANO HPLC system (Thermo Scientific/Dionex): column, PicoFrit™ (New Objective; 75 μm i.d.) packed to 15 cm with C18 adsorbent (Vydac; 218MS 5 μm, 300 Å). Precursor ions were acquired in the Orbitrap mass spectrometer in centroid mode at 120,000 resolution (<italic>m/z</italic> 200); data-dependent higher-energy C-trap dissociation (HCD) spectra were acquired at the same time in the linear trap using the “top speed” option (30% normalized collision energy). Mascot (v2.7.0; Matrix Science) was used to search the spectra against a combination of the human subset of the UniProt database plus a database of common contaminants [UniProt_Human 20181204 (95,936 sequences; 38,067,061 residues)]; contaminants 20120713 (247 sequences; 128,130 residues)]. Subset search of the identified proteins by X! Tandem, cross-correlation with the Mascot results, and determination of protein and peptide identity probabilities were accomplished by Scaffold (v4.9.0; Proteome Software). The thresholds for acceptance of peptide and protein assignments in Scaffold were set to yield &lt; 1% protein FDR. Corresponding UniProt IDs for the proteins were obtained using the UniProt ID mapping service (<xref ref-type="bibr" rid="c71">71</xref>).</p>
</sec>
</sec>
<sec id="s4e">
<title>Western blots</title>
<sec id="s4e1">
<title>Cells</title>
<p>Cells were harvested and lysed in Laemmli sample buffer (BioRad, Cat# 1610737). Cell extracts were separated on an SDS-PAGE gel, and transferred to PVDF membranes, previously activated with methanol. Membranes were blocked in 5% milk Tris-buffered saline with Tween 20 and probed with a collection of different antibodies listed below. Horseradish peroxidase (HRP)-conjugated goat anti-rabbit antibody (Santa Cruz Biotechnology, Cat# sc-2030) or HRP-conjugated goat anti-mouse (Santa Cruz Biotechnology, Cat# sc-2005) were used as secondary antibodies. Immobilon Western chemo-luminescence substrate (Millipore, Cat# WBKLS0500) was used to detect selected proteins.</p>
</sec>
<sec id="s4e2">
<title>Human samples</title>
<p>Western blots were performed with proteins extracted from control and Alzheimer’s brains. Approximately 10 µg protein were loaded into precast NuPAGE 4-12% Bis-Tris gels (Invitrogen) for analysis by sodium dodecyl sulfate–polyacrylamide gel electrophoresis. The separated proteins were subsequently transferred onto nitrocellulose membranes and blocked overnight at 4°C with 10% nonfat dry milk. The membranes were then probed for 1 hour at room temperature with primary antibodies - anti-SERBP1 (1:100, sc100800) and anti-glyceraldehyde 3-phosphate dehydrogenase (GAPDH) (1:1000, ab9485, Abcam) - diluted in 5% nonfat dry milk. SERBP1 immunoreactivity was detected with a horseradish peroxidase– conjugated anti-mouse IgG (1:5000, GE Healthcare). GAPDH immunoreactivity was detected using an anti-mouse IgG (1:6000, GE Healthcare) diluted in 5% nonfat dry milk. An enhanced chemiluminescence reagent (ECL Plus, Amersham) was used to visualize the bands. The amount of protein was normalized and quantified using the loading control GAPDH.</p>
</sec>
</sec>
<sec id="s4f">
<title>Antibodies</title>
<p>anti-SERBP1 (Santa Cruz Biotechnology, Cat# SC100800), anti-G3BP1 (Cell Signaling, Cat# 17798S), anti-PARP1 (Cell Signaling, Cat# 9532S), anti-SYNCRIP (Invitrogen, Cat# PA5-59501), anti-hnRNPU (Cell Signaling, Cat# 34095), anti-Puromycin (Kerafast, Cat# EQ0001), anti-His (Santa Cruz Biotechnology, Cat# sc-53073), anti-Flag (Invitrogen, Cat# MA1-91878), anti-GAPDH (Santa Cruz Biotechnology, Cat# SC32233), anti-β-Actin (Abcam, Cat# ab8227), anti-β-Tubulin (Sigma-Aldrich, Cat# T8328), anti-α-Tubulin (Invitrogen, Cat# 236-10501), FBL (Cell Signaling, Cat# C13C3), NCL (Cell Signaling, Cat# D4C70).</p>
</sec>
<sec id="s4g">
<title>High-throughput drug screening</title>
<p>High-throughput screening was conducted with the Cambridge Cancer Compound Library (Selleck Chem, Cat# L2300) of 269 compounds with the addition of 23 compounds of interest (<bold>Table S7</bold>). All compounds were dissolved in DMSO to a stock concentration of 10mM and further diluted in PBS to achieve a final treatment concentration of 100 nM and a final DMSO concentration of 0.1%. Four replicates of both U343 OE and U343 Control cells were plated in 384 well white polystyrene microplates (Thermo Scientific) at a seeding density of 5.0 x 10<sup>3</sup> cells/well 12 hours before treatment. Cell seeding and treatment was conducted by an automated electronic pipetting system to increase pipetting accuracy and to minimize variability between replicates (Integra VIAFLO 384). Following 24 hours of treatment, cells were incubated with Cell Titer Glo 2.0 (Promega, Cat# G9243) according to the manufacturer’s protocol to lyse the cells and introduce a luminescent signal. Within 10 minutes of Cell Titer Glo 2.0 reagent addition, ATP measurements were then collected as luminescence intensities by a Tecan Spark microplate reader. Dixon’s Q test was used to eliminate outliers prior to statistical annalysis. ATP intensities were normalized to respective vehicle controls to assess cell viability following drug treatment.</p>
</sec>
<sec id="s4h">
<title>Puromycin assays</title>
<p>siSERBP1 KD in U251 and U343 cells was performed as described above. 72 hours after transfection, cells were incubated with 10 µg/ml Puromycin (Sigma-Aldrich, Cat# P7255) for 15 minutes at 37 °C and 5% CO<sub>2</sub>. Cells were then placed on ice and washed twice with cold PBS before being harvested in Laemmli sample buffer. Western blots were performed as described above with 15 µg protein extracts.</p>
</sec>
<sec id="s4i">
<title>Protein co-localization</title>
<p>U251 cells were cultured on glass coverslips until 80% confluent and fixed in 4% paraformaldehyde followed by permeabilization with 0.1% TritonX-100 for 2 minutes. Cells were then stained with primary antibody for 1 hour followed by the secondary antibody conjugated to Alexa Fluor 488 or 568 (Invitrogen, Invitrogen, Cat# A11004 and A11008). After washing with PBS, cells were stained with DAPI and mounted onto glass slides with FluorSave (Invitrogen, Cat# 345789) before being analyzed by fluorescence microscopy.</p>
</sec>
<sec id="s4j">
<title>Impact of SERBP1 on cell division</title>
<p>24 hours after siSERBP1 KD in U251 and U343, cells were exposed to 20 nM of Paclitaxel (Cayman Chem, Cat# 10461) for 24 hours. Cells were fixed in 4% PFA and stained with α-Tubulin and DAPI. The experiment was performed in triplicates and 1000 cells were counted per replicate. Statistical significance was evaluated by Student’s t-test.</p>
</sec>
<sec id="s4k">
<title><italic>In vitro</italic> PARylation assay</title>
<p>Flag-tagged PARP1 was expressed in insect cells and purified as previously described (<xref ref-type="bibr" rid="c136">136</xref>). 6xHis-tagged SERBP1 was purified as in (<xref ref-type="bibr" rid="c25">25</xref>). Briefly, purified recombinant PARP1 (0.1 µM) and SERBP1 (0.6 µM) were combined in an ADP-ribosylation reaction (20 µL) with or without sheared salmon sperm DNA (sssDNA) (100 ng/µL) and NAD<sup>+</sup> (100 µM). The reactions were incubated at room temperature for 15 minutes. The reaction products were analyzed on 8% PAGE-SDS gels with silver staining or Western blotting for PAR using a recombinant anti-poly-ADP-ribose binding reagent (Millipore, Cat# MABE1031; RRID: AB_2665467).</p>
</sec>
<sec id="s4l">
<title>SERBP1 impact on PARylation</title>
<p>pcDNA3.1-EF1a-mGreenLantern-SERBP1 or control plasmid pcDNA3.1-EF1a-mGreenLantern was transfected into 293T cells. 48 hours later, cells were collected and lysed in Laemmli sample buffer. 10 µg of extracted proteins were separated on SDS-PAGE gel and Western blot was performed as described. Poly-ADP-ribose binding reagent (Sigma-Aldrich, Cat# MABE1031) was used to detect oligo- and poly-ADP-ribosylated (PARylated) proteins.</p>
</sec>
<sec id="s4m">
<title>Sensitivity to PARP inhibitor</title>
<p>U251 and U343 siSERBP1 knockdown was performed as described above. 5 µM of PARP inhibitor PJ34 (Enzo, Cat# ALX-270-289) was used to treat the cells 24 hours later. The Essen Bioscience IncuCyte automated microscope system was used to follow proliferation of U251 and U343 glioblastoma cells over 150 hours. Differences in proliferation between single and combined treatment at 100 or 150 hours were analyzed graphically. Statistical significance was calculated by Student’s t-test and the combination treatment was evaluated with the Combination Index (<xref ref-type="bibr" rid="c137">137</xref>).</p>
</sec>
<sec id="s4n">
<title>Immunolabeling of fixed human brain sections</title>
<p>Frozen cortical sections were first fixed in chilled 20% methanol. To eliminate autofluorescence from lipofuscin, we incubated the sections with TrueBlack® Lipofuscin Autofluorescence Quencher (#23007, Biotium) for 10 minutes at room temperature. After three washes with ethanol 70%, the sections were permeabilized in PBS/0.4% Triton-X100 for 5 minutes. After 1 hour blocking in PBS/10% NGS/0.2% Triton at room temperature, the sections were incubated in primary antibodies diluted in PBS/10% NGS overnight at 4°C. Immunolabeling for G3BP1 (5 μg/ml, 2F3, Abcam Cat# ab56574), Phospho-Tau (Thr231) (1:500, AT180, Thermo Fisher Scientific #MN1040) and SERBP1 (1:50, 1B9, Santa Cruz Bio Cat# sc-100800) was performed in all control (N=3) and AD (N=3, Braak Stage V-VI) human brains. The next day, sections were washed three times in PBS (5 minutes each), and secondary antibodies were applied for 45 minutes: Alexa Fluor 488 and 568 (1:200, Life Technologies). After further washing in PBS, slides were then mounted with Prolong Gold Antifade with DAPI (Thermo Fisher Scientific Cat# P36931) to stain the nuclei. Granule density of G3BP1 and SERBP1 were measured in 3 Ctr and 3 AD cases, and images in triplicate from each case were analyzed by ImageJ FIJI (NIH) software. SERBP1 associated with stress granules was measured as the ratio between colocalizing SERBP1/G3BP1 puncta and G3BP1 total granules in the cortical section using ImageJ FIJI (NIH) software.</p>
</sec>
<sec id="s4o">
<title>Venn diagram statistics</title>
<p>Venn diagrams were created using an online software (<ext-link ext-link-type="uri" xlink:href="https://bioinforx.com/apps/venn.php">https://bioinforx.com/apps/venn.php</ext-link>). P-values for overlaps between two groups were calculated with a separate online tool (<ext-link ext-link-type="uri" xlink:href="http://nemates.org/MA/progs/overlap_stats.html">http://nemates.org/MA/progs/overlap_stats.html</ext-link>).</p>
</sec>
<sec id="s4p">
<title>Gene ontology and network analyses</title>
<p>Gene Ontology (GO) enrichment analyses were performed using ShinyGO (versions 0.67 and 0.77), Metascape (version 3.5), and Panther (version 17.0) (<xref ref-type="bibr" rid="c27">27</xref>, <xref ref-type="bibr" rid="c28">28</xref>, <xref ref-type="bibr" rid="c72">72</xref>). Associations between GO terms were established using Revigo (<xref ref-type="bibr" rid="c29">29</xref>). Network analyses were conducted using STRING (version 11.5) and Metascape (<xref ref-type="bibr" rid="c28">28</xref>, <xref ref-type="bibr" rid="c138">138</xref>) and visualized using Cytoscape (version 3.9.1) (<xref ref-type="bibr" rid="c139">139</xref>).</p>
</sec>
<sec id="s4q">
<title>Expression correlation analyses</title>
<p>We performed expression correlation analyses using resources in R2 (<ext-link ext-link-type="uri" xlink:href="http://r2.amc.nl">http://r2.amc.nl</ext-link>) to identify genes with a strong positive correlation with SERBP1 (R ≥ 0.3, p-value ≤ 0.05, Pearson correlation) in the TCGA glioblastoma set (RNA-Seq samples), sarcoma (TCGA), bladder urothelial carcinoma (TCGA), neuroblastoma (SEQC), pancreatic adenocarcinoma (TCGA), and normal brain (Hardy, R ≥ 0.5 was selected in this case due to the high number of correlated genes). Additional analyses were conducted using the Ivy GAP glioblastoma dataset (<xref ref-type="bibr" rid="c140">140</xref>) following their default parameters (R ≥ 0.3).</p>
<p>The Cortecon resource (<xref ref-type="bibr" rid="c141">141</xref>) was used to identify genes that share similarity with SERBP1 regarding their expression profile during <italic>in vitro</italic> cortex development. SERBP1 is part of cluster 5 which is linked to pluripotency. Genes that were in clusters related to pluripotency and whose overall profile resembles cluster 5 were selected for further analyses.</p>
</sec>
<sec id="s4r">
<title>Identification of protein features and domain</title>
<p>Pfam accession numbers were obtained using the UniProt ID mapping service (<xref ref-type="bibr" rid="c71">71</xref>). R code was used to count the frequency of each accession number and create the consolidated data with fold enrichment and fdr-values. All accession numbers with a count above the average were analyzed with the dcGO Enrichment mining service (<xref ref-type="bibr" rid="c142">142</xref>).</p>
</sec>
<sec id="s4s">
<title>Databases and datasets used for characterization of SERBP1-associated proteins</title>
<p>STM1 interactors were downloaded from BioGRID (version 4.4) (<xref ref-type="bibr" rid="c32">32</xref>) and human orthologs were obtained using the WORMHOLE website (<xref ref-type="bibr" rid="c143">143</xref>). Proximity-dependent biotinylation (Bio-ID) data for SERBP1 were taken from (<xref ref-type="bibr" rid="c30">30</xref>, <xref ref-type="bibr" rid="c31">31</xref>). Proteins of the SARS-CoV-RNA interactome were derived from (<xref ref-type="bibr" rid="c57">57</xref>) and those of the PARP1 interactome from (<xref ref-type="bibr" rid="c66">66</xref>). RGG box-containing proteins were obtained from (<xref ref-type="bibr" rid="c50">50</xref>), and RRM motif-containing proteins from UniProt (<xref ref-type="bibr" rid="c71">71</xref>). G4 binding proteins were extracted from (<xref ref-type="bibr" rid="c46">46</xref>, <xref ref-type="bibr" rid="c47">47</xref>), PAR binding proteins were obtained from (<xref ref-type="bibr" rid="c64">64</xref>), and PARylated proteins were identified by high-throughput studies described in (<xref ref-type="bibr" rid="c62">62</xref>, <xref ref-type="bibr" rid="c63">63</xref>). The MobiDB database (version 5.0) (<xref ref-type="bibr" rid="c45">45</xref>) was used for identifying IDR-containing proteins. Data on the Tau aggregate interactome were derived from different studies compiled by (<xref ref-type="bibr" rid="c9">9</xref>).</p>
</sec>
<sec id="s4t">
<title>Splicing analyses</title>
<p>To identify splicing alterations induced by SERBP1 and hnRNPU knockdown, adapter sequences were first trimmed from raw RNA-Seq reads of control and knockdown samples (<xref ref-type="bibr" rid="c26">26</xref>). RNA-Seq reads were then aligned against the human reference genome (version GRCh38) (<xref ref-type="bibr" rid="c144">144</xref>) and matching GENCODE transcriptome (v29) (<xref ref-type="bibr" rid="c145">145</xref>) using STAR (default parameters; version 2.7.7.a) (<xref ref-type="bibr" rid="c146">146</xref>). High-quality mapped reads (q &gt; 20) from control and knockdown samples were processed using rMATS (default parameters; version v4.1.2) (<xref ref-type="bibr" rid="c147">147</xref>) to characterize splicing events. Events were classified into exon skipping (SE), mutually exclusive exons (MXE), intron retention (RI), alternative donor site (A5SS) or alternative acceptor site (A3SS). Splicing events were considered significant if their FDR-adjusted p-values were below 0.05 and absolute delta Percent Splice Inclusion (deltaPSI) above 0.1. Sashimi plots of splicing events were created using the rmats2sashimiplot tool (<ext-link ext-link-type="uri" xlink:href="https://github.com/Xinglab/rmats2sashimiplot">https://github.com/Xinglab/rmats2sashimiplot</ext-link>). To assess SERBP1 binding to the identified splicing alterations, we obtained processed iCLIP data from (<xref ref-type="bibr" rid="c36">36</xref>). The presence of iCLIP sites in the splicing alterations induced by SERBP1 knockdown was evaluated considering a window of 100 nt around splicing events using the bedtools intersect software (<xref ref-type="bibr" rid="c148">148</xref>).</p>
</sec>
<sec id="s4u">
<title>Identification of snoRNAs and scaRNAs bound by SERBP1</title>
<p>RIP-sequencing results for SERBP1 were obtained from (<xref ref-type="bibr" rid="c26">26</xref>). Sequencing reads were processed using Kallisto (default parameters, version 0.46.1) (<xref ref-type="bibr" rid="c149">149</xref>) with an index of 31 k-mers and GENCODE (v28) as the reference for the human transcriptome (<xref ref-type="bibr" rid="c145">145</xref>). Transcript abundance estimates were then collapsed into gene-level counts using the R package tximport (<xref ref-type="bibr" rid="c150">150</xref>). Differential gene expression analyses were performed using DESeq2 (<xref ref-type="bibr" rid="c151">151</xref>). We compared SBP-SERBP1 versus SBP-GST samples and used log2 fold change ≥ 0.5 and adjusted (false discovery rate, FDR) p-value &lt; 0.05 to identify snoRNAs and scaRNAs preferentially associated with SERBP1.</p>
</sec>
</sec>
<sec id="d1e2041" sec-type="supplementary-material">
<title>Supporting information</title>
<supplementary-material id="d1e2141">
<label>Supplementary Material</label>
<media xlink:href="supplements/586270_file02.pdf"/>
</supplementary-material>
<supplementary-material id="d1e2148">
<label>Supplementary Table 1</label>
<media xlink:href="supplements/586270_file03.xlsx"/>
</supplementary-material>
<supplementary-material id="d1e2155">
<label>Supplementary Table 2</label>
<media xlink:href="supplements/586270_file04.xlsx"/>
</supplementary-material>
<supplementary-material id="d1e2162">
<label>Supplementary Table 3</label>
<media xlink:href="supplements/586270_file05.xlsx"/>
</supplementary-material>
<supplementary-material id="d1e2170">
<label>Supplementary Table 4</label>
<media xlink:href="supplements/586270_file06.xlsx"/>
</supplementary-material>
<supplementary-material id="d1e2177">
<label>Supplementary Table 5</label>
<media xlink:href="supplements/586270_file07.xlsx"/>
</supplementary-material>
<supplementary-material id="d1e2184">
<label>Supplementary Table 6</label>
<media xlink:href="supplements/586270_file08.xlsx"/>
</supplementary-material>
<supplementary-material id="d1e2191">
<label>Supplementary Table 7</label>
<media xlink:href="supplements/586270_file09.xlsx"/>
</supplementary-material>
<supplementary-material id="d1e2198">
<label>Supplementary Table 8</label>
<media xlink:href="supplements/586270_file10.xlsx"/>
</supplementary-material>
<supplementary-material id="d1e2205">
<label>Supplementary Table 9</label>
<media xlink:href="supplements/586270_file11.xlsx"/>
</supplementary-material>
</sec>
</body>
<back>
<sec id="s5">
<title>Data availability</title>
<p>The Mass Spectroscopy datasets generated and analyzed during this study are available in the MassIVE repository and can be accessed by reviewers at <ext-link ext-link-type="uri" xlink:href="http://massive.ucsd.edu">http://massive.ucsd.edu</ext-link> (username: MSV000091749_reviewer and MSV000093355_reviewer, password: SERBP1interacts) before being made publicly available at time of publication. RNAseq datasets are available at the European Nucleotide Archive (ENA) with the accession number PRJEB69681.</p>
</sec>
<sec id="s6">
<title>Funding</title>
<p>This work was supported by the Cancer Prevention and Research Institute of Texas [RP200595 to LP], Alzheimer’s Association [AARGD-NTF-22-968603 to LP] and a Mays Cancer Center Pilot Grant [to LP]. PAFG was supported by grants from Serrapilheira Foundation and Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) [2018/15579-8]. MM was sponsored by the Alzheimer’s Association [AARF-21-720991]. GDAG was supported by a fellowship from FAPESP [2017/19541-2] and Young Scientist program, Hospital Sírio-Libanês. KB and ML were sponsored by the The German Academic Exchange Service (DAAD). AK was supported by NIH Supplement 2R01 HG006015 and the Greehey Foundation. AB was partially supported by a Voelker Fund Young Investigator Grant to DSL.</p>
</sec>
<sec id="s7">
<title>Conflict of interest</title>
<p>The authors declare no competing interests.</p>
</sec>
<ack>
<title>Acknowledgements</title>
<p>Mass spectrometry analyses were conducted at the Institutional Mass Spectrometry Laboratory, University of Texas Health Science Center, supported in part by NIH grant P30 CA54174-23 (S.T. Weintraub, Mays Cancer Center Mass Spectrometry Shared Resource) and the University of Texas System Proteomics Core Network for purchase of the Orbitrap Fusion Lumos mass spectrometer, with expert technical assistance of Sammy Pardo and Dana Molleur. We would like to thank Dr. Jernej Ule and Dr. Rupert Faraway for sharing the SERBP1 CLIP data and their valuable input. The authors would like to acknowledge Karen Klein for excellent editorial service.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="c1"><label>1.</label><mixed-citation publication-type="journal"><string-name><surname>Gerstberger</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Hafner</surname>, <given-names>M.</given-names></string-name> and <string-name><surname>Tuschl</surname>, <given-names>T</given-names></string-name>. (<year>2014</year>) <article-title>A census of human RNA-binding proteins</article-title>. <source>Nat Rev Genet</source>, <volume>15</volume>, <fpage>829</fpage>–<lpage>845</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nrg3813</pub-id>.</mixed-citation></ref>
<ref id="c2"><label>2.</label><mixed-citation publication-type="journal"><string-name><surname>Corley</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Burns</surname>, <given-names>M.C.</given-names></string-name> and <string-name><surname>Yeo</surname>, <given-names>G.W</given-names></string-name>. (<year>2020</year>) <article-title>How RNA-binding proteins interact with RNA: molecules and mechanisms</article-title>. <source>Mol Cell</source>, <volume>78</volume>, <fpage>9</fpage>–<lpage>29</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.molcel.2020.03.011</pub-id>.</mixed-citation></ref>
<ref id="c3"><label>3.</label><mixed-citation publication-type="journal"><string-name><surname>Kelaini</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Chan</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Cornelius</surname>, <given-names>V.A.</given-names></string-name> and <string-name><surname>Margariti</surname>, <given-names>A</given-names></string-name>. (<year>2021</year>) <article-title>RNA-binding proteins hold key roles in function, dysfunction, and disease</article-title>. <source>Biology (Basel</source><italic>)</italic>, <volume>10</volume>, <fpage>366</fpage>. doi: <pub-id pub-id-type="doi">10.3390/biology10050366</pub-id>.</mixed-citation></ref>
<ref id="c4"><label>4.</label><mixed-citation publication-type="journal"><string-name><surname>Chan</surname>, <given-names>J.N.</given-names></string-name>, <string-name><surname>Sánchez-Vidaña</surname>, <given-names>D.I.</given-names></string-name>, <string-name><surname>Anoopkumar-Dukie</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>Y.</given-names></string-name> and <string-name><surname>Benson Wui-Man</surname>, <given-names>L</given-names></string-name>. (<year>2022</year>) <article-title>RNA-binding protein signaling in adult neurogenesis</article-title>. <source>Front Cell Dev Biol</source>, <volume>10</volume>, <fpage>982549</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fcell.2022.982549</pub-id>.</mixed-citation></ref>
<ref id="c5"><label>5.</label><mixed-citation publication-type="journal"><string-name><surname>Bryant</surname>, <given-names>C.D.</given-names></string-name> and <string-name><surname>Yazdani</surname>, <given-names>N</given-names></string-name>. (<year>2016</year>) <article-title>RNA-binding proteins, neural development and the addictions</article-title>. <source>Genes Brain Behav</source>, <volume>15</volume>, <fpage>169</fpage>–<lpage>186</lpage>. doi: <pub-id pub-id-type="doi">10.1111/gbb.12273</pub-id>.</mixed-citation></ref>
<ref id="c6"><label>6.</label><mixed-citation publication-type="journal"><string-name><surname>Prashad</surname>, <given-names>S.</given-names></string-name> and <string-name><surname>Gopal</surname>, <given-names>P.P</given-names></string-name>. (<year>2021</year>) <article-title>RNA-binding proteins in neurological development and disease</article-title>. <source>RNA Biol</source>, <volume>18</volume>, <fpage>972</fpage>–<lpage>987</lpage>. doi: <pub-id pub-id-type="doi">10.1080/15476286.2020.1809186</pub-id>.</mixed-citation></ref>
<ref id="c7"><label>7.</label><mixed-citation publication-type="journal"><string-name><surname>Marcelino Meliso</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Hubert</surname>, <given-names>C.G.</given-names></string-name>, <string-name><surname>Favoretto Galante</surname>, <given-names>P.A.</given-names></string-name> and <string-name><surname>Penalva</surname>, <given-names>L.O.</given-names></string-name> (<year>2017</year>) <article-title>RNA processing as an alternative route to attack glioblastoma</article-title>. <source>Hum Genet</source>, <volume>136</volume>, <fpage>1129</fpage>–<lpage>1141</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00439-017-1819-2</pub-id>.</mixed-citation></ref>
<ref id="c8"><label>8.</label><mixed-citation publication-type="journal"><string-name><surname>Sanya</surname>, <given-names>D.R.A.</given-names></string-name>, <string-name><surname>Cava</surname>, <given-names>C.</given-names></string-name> and <string-name><surname>Onésime</surname>, <given-names>D</given-names></string-name>. (<year>2023</year>) <article-title>Roles of RNA-binding proteins in neurological disorders, COVID-19, and cancer</article-title>. <source>Hum Cell</source>, <volume>36</volume>, <fpage>493</fpage>–<lpage>514</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s13577-022-00843-w</pub-id>.</mixed-citation></ref>
<ref id="c9"><label>9.</label><mixed-citation publication-type="journal"><string-name><surname>Kavanagh</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Halder</surname>, <given-names>A.</given-names></string-name> and <string-name><surname>Drummond</surname>, <given-names>E</given-names></string-name>. (<year>2022</year>) <article-title>Tau interactome and RNA binding proteins in neurodegenerative diseases</article-title>. <source>Mol Neurodegener</source>, <volume>17</volume>, <fpage>66</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s13024-022-00572-6</pub-id>.</mixed-citation></ref>
<ref id="c10"><label>10.</label><mixed-citation publication-type="journal"><string-name><surname>Velasco</surname> <given-names>MX</given-names></string-name>, <string-name><surname>Kosti</surname> <given-names>A</given-names></string-name>, <string-name><surname>Penalva</surname> <given-names>LOF</given-names></string-name> and <string-name><surname>Hernández</surname> <given-names>G</given-names></string-name> (<year>2019</year>) <article-title>The diverse roles of RNA-binding proteins in glioma development</article-title>. <source>Adv Exp Med Biol</source>, <volume>1157</volume>, <fpage>29</fpage>–<lpage>39</lpage>.</mixed-citation></ref>
<ref id="c11"><label>11.</label><mixed-citation publication-type="journal"><string-name><surname>Gebauer</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Schwarzl</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Valcárcel</surname>, <given-names>J.</given-names></string-name> and <string-name><surname>Hentze</surname>, <given-names>M.W</given-names></string-name>. (<year>2021</year>) <article-title>RNA-binding proteins in human genetic disease</article-title>. <source>Nat Rev Genet</source>, <volume>22</volume>, <fpage>185</fpage>–<lpage>198</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41576-020-00302-y</pub-id>.</mixed-citation></ref>
<ref id="c12"><label>12.</label><mixed-citation publication-type="journal"><string-name><surname>Nussbacher</surname>, <given-names>J.K.</given-names></string-name>, <string-name><surname>Batra</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Lagier-Tourenne</surname>, <given-names>C.</given-names></string-name> and <string-name><surname>Yeo</surname>, <given-names>G.W</given-names></string-name>. (<year>2015</year>) <article-title>RNA-binding proteins in neurodegeneration: seq and you shall receive</article-title>. <source>Trends Neurosci</source>, <volume>38</volume>, <fpage>226</fpage>–<lpage>236</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.tins.2015.02.003</pub-id>.</mixed-citation></ref>
<ref id="c13"><label>13.</label><mixed-citation publication-type="journal"><string-name><surname>An</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>de Meritens</surname>, <given-names>C.R.</given-names></string-name> and <string-name><surname>Shelkovnikova</surname>, <given-names>T.A.</given-names></string-name> (<year>2021</year>) <article-title>Connecting the “dots”: RNP granule network in health and disease</article-title>. <source>Biochim Biophys Acta Mol Cell Res</source>, <volume>1868</volume>, <fpage>119058</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.bbamcr.2021.119058</pub-id>.</mixed-citation></ref>
<ref id="c14"><label>14.</label><mixed-citation publication-type="journal"><string-name><surname>Drino</surname>, <given-names>A.</given-names></string-name> and <string-name><surname>Schaefer</surname>, <given-names>M.R</given-names></string-name>. (<year>2018</year>) <article-title>RNAs, phase separation, and membrane-less organelles: are post-transcriptional modifications modulating organelle dynamics?</article-title> <source>Bioessays</source>, <volume>40</volume>, <fpage>e1800085</fpage>. doi: <pub-id pub-id-type="doi">10.1002/bies.201800085</pub-id>.</mixed-citation></ref>
<ref id="c15"><label>15.</label><mixed-citation publication-type="journal"><string-name><surname>Gomes</surname>, <given-names>E.</given-names></string-name> and <string-name><surname>Shorter</surname>, <given-names>J</given-names></string-name>. (<year>2019</year>) <article-title>The molecular language of membraneless organelles</article-title>. <source>J Biol Chem</source>, <volume>294</volume>, <fpage>7115</fpage>–<lpage>7127</lpage>. doi: <pub-id pub-id-type="doi">10.1074/jbc.TM118.001192</pub-id>.</mixed-citation></ref>
<ref id="c16"><label>16.</label><mixed-citation publication-type="journal"><string-name><surname>Zeke</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Schád</surname>, <given-names>É.</given-names></string-name>, <string-name><surname>Horváth</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Abukhairan</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Szabó</surname>, <given-names>B.</given-names></string-name> and <string-name><surname>Tantos</surname>, <given-names>A</given-names></string-name>. (<year>2022</year>) <article-title>Deep structural insights into RNA-binding disordered protein regions</article-title>. <source>Wiley Interdiscip Rev RNA</source>, <volume>13</volume>, <fpage>e1714</fpage>. doi: <pub-id pub-id-type="doi">10.1002/wrna.1714</pub-id>.</mixed-citation></ref>
<ref id="c17"><label>17.</label><mixed-citation publication-type="journal"><string-name><surname>Roden</surname>, <given-names>C.</given-names></string-name> and <string-name><surname>Gladfelter</surname>, <given-names>A.S</given-names></string-name>. (<year>2021</year>) <article-title>RNA contributions to the form and function of biomolecular condensates</article-title>. <source>Nat Rev Mol Cell Biol</source>, <volume>22</volume>, <fpage>183</fpage>–<lpage>195</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41580-020-0264-6</pub-id>.</mixed-citation></ref>
<ref id="c18"><label>18.</label><mixed-citation publication-type="journal"><string-name><surname>Cave</surname>, <given-names>J.W.</given-names></string-name> and <string-name><surname>Willis</surname>, <given-names>D.E</given-names></string-name>. (<year>2022</year>) <article-title>33905176 G-quadruplex regulation of neural gene expression</article-title>. <source>FEBS J</source>, <volume>289</volume>, <fpage>3284</fpage>–<lpage>3303</lpage>. doi: <pub-id pub-id-type="doi">10.1111/febs.15900</pub-id>.</mixed-citation></ref>
<ref id="c19"><label>19.</label><mixed-citation publication-type="journal"><string-name><surname>Masai</surname>, <given-names>H.</given-names></string-name> and <string-name><surname>Tanaka</surname>, <given-names>T</given-names></string-name>. (<year>2020</year>) <article-title>G-quadruplex DNA and RNA: their roles in regulation of DNA replication and other biological functions</article-title>. <source>Biochem Biophys Res Commun</source>, <volume>531</volume>, <fpage>25</fpage>–<lpage>38</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.bbrc.2020.05.132</pub-id>.</mixed-citation></ref>
<ref id="c20"><label>20.</label><mixed-citation publication-type="journal"><string-name><surname>Nakanishi</surname>, <given-names>C.</given-names></string-name> and <string-name><surname>Seimiya</surname>, <given-names>H</given-names></string-name>. (<year>2020</year>) <article-title>G-quadruplex in cancer biology and drug discovery</article-title>. <source>Biochem Biophys Res Commun</source>, <volume>531</volume>, <fpage>45</fpage>–<lpage>50</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.bbrc.2020.03.178</pub-id>.</mixed-citation></ref>
<ref id="c21"><label>21.</label><mixed-citation publication-type="journal"><string-name><surname>Kosiol</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Juranek</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Brossart</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Heine</surname>, <given-names>A.</given-names></string-name> and <string-name><surname>Paeschke</surname>, <given-names>K</given-names></string-name>. (<year>2021</year>) <article-title>G-quadruplexes: a promising target for cancer therapy</article-title>. <source>Mol Cancer</source>, <volume>20</volume>, <fpage>40</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12943-021-01328-4</pub-id>.</mixed-citation></ref>
<ref id="c22"><label>22.</label><mixed-citation publication-type="journal"><string-name><surname>Darling</surname>, <given-names>A.L.</given-names></string-name> and <string-name><surname>Shorter</surname>, <given-names>J</given-names></string-name>. (<year>2021</year>) <article-title>Combating deleterious phase transitions in neurodegenerative disease</article-title>. <source>Biochim Biophys Acta Mol Cell Res</source>, <volume>1868</volume>, <fpage>118984</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.bbamcr.2021.118984</pub-id>.</mixed-citation></ref>
<ref id="c23"><label>23.</label><mixed-citation publication-type="journal"><string-name><surname>Webber</surname>, <given-names>C.J.</given-names></string-name>, <string-name><surname>Lei</surname>, <given-names>S.</given-names></string-name> (Eric) and <string-name><surname>Wolozin</surname>, <given-names>B.</given-names></string-name> (<year>2020</year>) <article-title>The pathophysiology of neurodegenerative disease: disturbing the balance between phase separation and irreversible aggregation</article-title>. <source>Prog Mol Biol Transl Sci</source>, <volume>174</volume>, <fpage>187</fpage>–<lpage>223</lpage>. doi: <pub-id pub-id-type="doi">10.1016/bs.pmbts.2020.04.021</pub-id>.</mixed-citation></ref>
<ref id="c24"><label>24.</label><mixed-citation publication-type="journal"><string-name><surname>Uversky</surname>, <given-names>V.N</given-names></string-name>. (<year>2017</year>) <article-title>The roles of intrinsic disorder-based liquid-liquid phase transitions in the “Dr. Jekyll–Mr. Hyde” behavior of proteins involved in amyotrophic lateral sclerosis and frontotemporal lobar degeneration</article-title>. <source>Autophagy</source>, <volume>13</volume>, <fpage>2115</fpage>–<lpage>2162</lpage>. doi: <pub-id pub-id-type="doi">10.1080/15548627.2017.1384889</pub-id>.</mixed-citation></ref>
<ref id="c25"><label>25.</label><mixed-citation publication-type="journal"><string-name><surname>Baudin</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Moreno-Romero</surname>, <given-names>A.K.</given-names></string-name>, <string-name><surname>Xu</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Selig</surname>, <given-names>E.E.</given-names></string-name>, <string-name><surname>Penalva</surname>, <given-names>L.O.F.</given-names></string-name> and <string-name><surname>Libich</surname>, <given-names>D.S</given-names></string-name>. (<year>2021</year>) <article-title>Structural characterization of the RNA-binding protein SERBP1 reveals intrinsic disorder and atypical RNA binding modes</article-title>. <source>Front Mol Biosci</source>, <volume>8</volume>, <fpage>744707</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fmolb.2021.744707</pub-id>.</mixed-citation></ref>
<ref id="c26"><label>26.</label><mixed-citation publication-type="journal"><string-name><surname>Kosti</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>De Araujo</surname>, <given-names>P.R.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>W.Q.</given-names></string-name>, <string-name><surname>Guardia</surname>, <given-names>G.D.A.</given-names></string-name>, <string-name><surname>Chiou</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Yi</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Ray</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Meliso</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>Y.M.</given-names></string-name>, <string-name><surname>Delambre</surname>, <given-names>T.</given-names></string-name>, <etal>et al.</etal> (<year>2020</year>) <article-title>The RNA-binding protein SERBP1 functions as a novel oncogenic factor in glioblastoma by bridging cancer metabolism and epigenetic regulation</article-title>. <source>Genome Biol</source>, <volume>21</volume>, <fpage>195</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s13059-020-02115-y</pub-id>.</mixed-citation></ref>
<ref id="c27"><label>27.</label><mixed-citation publication-type="journal"><string-name><surname>Xijin Ge</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Jung</surname>, <given-names>D.</given-names></string-name> and <string-name><surname>Yao</surname>, <given-names>R.</given-names></string-name> (<year>2020</year>) <article-title>ShinyGO: a graphical gene-set enrichment tool for animals and plants</article-title>. <source>Bioinformatics</source>, <volume>36</volume>, <fpage>2628</fpage>–<lpage>2629</lpage>. doi: <pub-id pub-id-type="doi">10.1093/bioinformatics/btz931</pub-id>.</mixed-citation></ref>
<ref id="c28"><label>28.</label><mixed-citation publication-type="journal"><string-name><surname>Zhou</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Zhou</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Pache</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Chang</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Khodabakhshi</surname>, <given-names>A.H.</given-names></string-name>, <string-name><surname>Tanaseichuk</surname>, <given-names>O.</given-names></string-name>, <string-name><surname>Benner</surname>, <given-names>C.</given-names></string-name> and <string-name><surname>Chanda</surname>, <given-names>S.K.</given-names></string-name> (<year>2019</year>) <article-title>Metascape provides a biologist-oriented resource for the analysis of systems-level datasets</article-title>. <source>Nat Commun</source>, <volume>10</volume>, <fpage>1523</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41467-019-09234-6</pub-id>.</mixed-citation></ref>
<ref id="c29"><label>29.</label><mixed-citation publication-type="journal"><string-name><surname>Supek</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Bošnjak</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Škunca</surname>, <given-names>N.</given-names></string-name> and <string-name><surname>Šmuc</surname>, <given-names>T</given-names></string-name>. (<year>2011</year>) <article-title>Revigo summarizes and visualizes long lists of gene ontology terms</article-title>. <source>PLoS One</source>, <volume>6</volume>, <fpage>e21800</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0021800</pub-id>.</mixed-citation></ref>
<ref id="c30"><label>30.</label><mixed-citation publication-type="journal"><string-name><surname>Go</surname>, <given-names>C.D.</given-names></string-name>, <string-name><surname>Knight</surname>, <given-names>J.D.R.</given-names></string-name>, <string-name><surname>Rajasekharan</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Rathod</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Hesketh</surname>, <given-names>G.G.</given-names></string-name>, <string-name><surname>Abe</surname>, <given-names>K.T.</given-names></string-name>, <string-name><surname>Youn</surname>, <given-names>J.Y.</given-names></string-name>, <string-name><surname>Samavarchi-Tehrani</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Zhang</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Zhu</surname>, <given-names>L.Y.</given-names></string-name>, <etal>et al.</etal> (<year>2021</year>) <article-title>A proximity-dependent biotinylation map of a human cell</article-title>. <source>Nature</source>, <volume>595</volume>, <fpage>120</fpage>–<lpage>124</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41586-021-03592-2</pub-id>.</mixed-citation></ref>
<ref id="c31"><label>31.</label><mixed-citation publication-type="journal"><string-name><surname>Youn</surname>, <given-names>J.Y.</given-names></string-name>, <string-name><surname>Dunham</surname>, <given-names>W.H.</given-names></string-name>, <string-name><surname>Hong</surname>, <given-names>S.J.</given-names></string-name>, <string-name><surname>Knight</surname>, <given-names>J.D.R.</given-names></string-name>, <string-name><surname>Bashkurov</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Chen</surname>, <given-names>G.I.</given-names></string-name>, <string-name><surname>Bagci</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Rathod</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>MacLeod</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Eng</surname>, <given-names>S.W.M.</given-names></string-name>, <etal>et al.</etal> (<year>2018</year>) <article-title>High-density proximity mapping reveals the subcellular organization of mRNA-associated granules and bodies</article-title>. <source>Mol Cell</source>, <volume>69</volume>, <fpage>517</fpage>–<lpage>532</lpage>.e11. doi: <pub-id pub-id-type="doi">10.1016/j.molcel.2017.12.020</pub-id>.</mixed-citation></ref>
<ref id="c32"><label>32.</label><mixed-citation publication-type="journal"><string-name><surname>Stark</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Breitkreutz</surname>, <given-names>B.J.</given-names></string-name>, <string-name><surname>Reguly</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Boucher</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Breitkreutz</surname>, <given-names>A.</given-names></string-name> and <string-name><surname>Tyers</surname>, <given-names>M.</given-names></string-name> (<year>2006</year>) <article-title>BioGRID: a general repository for interaction datasets</article-title>. <source>Nucleic Acids Res</source>, <volume>34</volume>, <fpage>D535</fpage>–<lpage>D539</lpage>. doi: <pub-id pub-id-type="doi">10.1093/nar/gkj109</pub-id>.</mixed-citation></ref>
<ref id="c33"><label>33.</label><mixed-citation publication-type="journal"><string-name><surname>Brown</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Baird</surname>, <given-names>M.R.</given-names></string-name>, <string-name><surname>Cj Yip</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Murray</surname>, <given-names>J.</given-names></string-name> and <string-name><surname>Shao</surname>, <given-names>S</given-names></string-name>. (<year>2018</year>) <article-title>Structures of translationally inactive mammalian ribosomes</article-title>. <source>Elife</source>, <volume>7</volume>, <fpage>e40486</fpage>. doi: <pub-id pub-id-type="doi">10.7554/eLife.40486</pub-id>.</mixed-citation></ref>
<ref id="c34"><label>34.</label><mixed-citation publication-type="journal"><string-name><surname>Muto</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Sugihara</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Shibakawa</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Oshima</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Matsuda</surname>, <given-names>T.</given-names></string-name> and <string-name><surname>Nadano</surname>, <given-names>D</given-names></string-name>. (<year>2018</year>) <article-title>The mRNA-binding protein Serbp1 as an auxiliary protein associated with mammalian cytoplasmic ribosomes</article-title>. <source>Cell Biochem Funct</source>, <volume>36</volume>, <fpage>312</fpage>–<lpage>322</lpage>. doi: <pub-id pub-id-type="doi">10.1002/cbf.3350</pub-id>.</mixed-citation></ref>
<ref id="c35"><label>35.</label><mixed-citation publication-type="journal"><string-name><surname>Ahn</surname>, <given-names>J.W.</given-names></string-name>, <string-name><surname>Kim</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Na</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Baek</surname>, <given-names>S.J.</given-names></string-name>, <string-name><surname>Kim</surname>, <given-names>J.H.</given-names></string-name>, <string-name><surname>Min</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Yeom</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Kwak</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Jeong</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Lee</surname>, <given-names>C.</given-names></string-name>, <etal>et al.</etal> (<year>2015</year>) <article-title>SERBP1 affects homologous recombination-mediated DNA repair by regulation of CtIP translation during S phase</article-title>. <source>Nucleic Acids Res</source>, <volume>43</volume>, <fpage>6321</fpage>–<lpage>6333</lpage>. doi: <pub-id pub-id-type="doi">10.1093/nar/gkv592</pub-id>.</mixed-citation></ref>
<ref id="c36"><label>36.</label><mixed-citation publication-type="journal"><string-name><surname>Martini</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Davis</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Faraway</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Elze</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Lockwood</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Jones</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Xie</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>McDonald</surname>, <given-names>N.Q.</given-names></string-name>, <string-name><surname>Mann</surname>, <given-names>D.J.</given-names></string-name>, <string-name><surname>Armstrong</surname>, <given-names>A.</given-names></string-name>, <etal>et al.</etal> (<year>2021</year>) <article-title>A genetically-encoded crosslinker screen identifies SERBP1 as a PKCε substrate influencing translation and cell division</article-title>. <source>Nat Commun</source>, <volume>12</volume>, <fpage>6934</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41467-021-27189-5</pub-id>.</mixed-citation></ref>
<ref id="c37"><label>37.</label><mixed-citation publication-type="journal"><string-name><surname>Lee</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Jen</surname></string-name>, <string-name><surname>Wei</surname>, <given-names>H.M.</given-names></string-name>, <string-name><surname>Chen</surname>, <given-names>L.Y.</given-names></string-name> and <string-name><surname>Li</surname>, <given-names>C.</given-names></string-name> (<year>2014</year>) <article-title>Localization of SERBP1 in stress granules and nucleoli</article-title>. <source>FEBS J</source>, <volume>281</volume>, <fpage>352</fpage>–<lpage>364</lpage>. doi: <pub-id pub-id-type="doi">10.1111/febs.12606</pub-id>.</mixed-citation></ref>
<ref id="c38"><label>38.</label><mixed-citation publication-type="journal"><string-name><surname>Lee</surname>, <given-names>Y.J.</given-names></string-name>, <string-name><surname>Hsieh</surname>, <given-names>W.Y.</given-names></string-name>, <string-name><surname>Chen</surname>, <given-names>L.Y.</given-names></string-name> and <string-name><surname>Li</surname>, <given-names>C</given-names></string-name>. (<year>2012</year>) <article-title>Protein arginine methylation of SERBP1 by protein arginine methyltransferase 1 affects cytoplasmic/nuclear distribution</article-title>. <source>J Cell Biochem</source>, <volume>113</volume>, <fpage>2721</fpage>–<lpage>2728</lpage>. doi: <pub-id pub-id-type="doi">10.1002/jcb.24151</pub-id>.</mixed-citation></ref>
<ref id="c39"><label>39.</label><mixed-citation publication-type="journal"><string-name><surname>Passos</surname>, <given-names>D.O.</given-names></string-name>, <string-name><surname>Bressan</surname>, <given-names>G.C.</given-names></string-name>, <string-name><surname>Nery</surname>, <given-names>F.C.</given-names></string-name> and <string-name><surname>Kobarg</surname>, <given-names>J</given-names></string-name>. (<year>2006</year>) <article-title>Ki-1/57 interacts with PRMT1 and is a substrate for arginine methylation</article-title>. <source>FEBS J</source>, <volume>273</volume>, <fpage>3946</fpage>–<lpage>3961</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1742-4658.2006.05399.x</pub-id>.</mixed-citation></ref>
<ref id="c40"><label>40.</label><mixed-citation publication-type="journal"><string-name><surname>Coppolecchia</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Buser</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Stotz</surname>, <given-names>A.</given-names></string-name> and <string-name><surname>Linder</surname>, <given-names>P</given-names></string-name>. (<year>1993</year>) <article-title>A new yeast translation initiation factor suppresses a mutation in the elF-4A RNA helicase</article-title>. <source>EMBO J</source>, <volume>12</volume>, <fpage>4005</fpage>–<lpage>4011</lpage>.</mixed-citation></ref>
<ref id="c41"><label>41.</label><mixed-citation publication-type="journal"><string-name><surname>Bleckmann</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Spitzlberger</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Denninger</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Ehrnsberger</surname>, <given-names>H.F.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Bruckmann</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Reich</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Holzinger</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Medenbach</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Grasser</surname>, <given-names>K.D.</given-names></string-name>, <etal>et al.</etal> (<year>2023</year>) <article-title>Cytosolic RGG RNA-binding proteins are temperature sensitive flowering time regulators in Arabidopsis</article-title>. <source>Biol Chem</source>, <volume>404</volume>, <fpage>1069</fpage>–<lpage>1084</lpage>. doi: <pub-id pub-id-type="doi">10.1515/hsz-2023-0171</pub-id>.</mixed-citation></ref>
<ref id="c42"><label>42.</label><mixed-citation publication-type="journal"><string-name><surname>Sonnhammer</surname>, <given-names>E.L.</given-names></string-name>, <string-name><surname>Eddy</surname>, <given-names>S.R.</given-names></string-name> and <string-name><surname>Durbin</surname>, <given-names>R</given-names></string-name>. (<year>1997</year>) <article-title>Pfam: a comprehensive database of protein domain families based on seed alignments</article-title>. <source>Proteins</source>, <volume>28</volume>, <fpage>405</fpage>–<lpage>420</lpage>. doi: <pub-id pub-id-type="doi">10.1002/(SICI)1097-0134(199707)28:3&lt;405::AID-PROT10&gt;3.0.CO;2-L</pub-id>.</mixed-citation></ref>
<ref id="c43"><label>43.</label><mixed-citation publication-type="journal"><string-name><surname>Fonin</surname>, <given-names>A. V.</given-names></string-name>, <string-name><surname>Antifeeva</surname>, <given-names>I.A.</given-names></string-name>, <string-name><surname>Kuznetsova</surname>, <given-names>I.M.</given-names></string-name>, <string-name><surname>Turoverov</surname>, <given-names>K.K.</given-names></string-name>, <string-name><surname>Zaslavsky</surname>, <given-names>B.Y.</given-names></string-name>, <string-name><surname>Kulkarni</surname>, <given-names>P.</given-names></string-name> and <string-name><surname>Uversky</surname>, <given-names>V.N</given-names></string-name>. (<year>2022</year>) <article-title>Biological soft matter: intrinsically disordered proteins in liquid-liquid phase separation and biomolecular condensates</article-title>. <source>Essays Biochem</source>, <volume>66</volume>, <fpage>831</fpage>–<lpage>847</lpage>. doi: <pub-id pub-id-type="doi">10.1042/EBC20220052</pub-id>.</mixed-citation></ref>
<ref id="c44"><label>44.</label><mixed-citation publication-type="journal"><string-name><surname>Su</surname>, <given-names>Q.</given-names></string-name>, <string-name><surname>Mehta</surname>, <given-names>S.</given-names></string-name> and <string-name><surname>Zhang</surname>, <given-names>J</given-names></string-name>. (<year>2021</year>) <article-title>Liquid-liquid phase separation: orchestrating cell signaling through time and space</article-title>. <source>Mol Cell</source>, <volume>81</volume>, <fpage>4137</fpage>–<lpage>4146</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.molcel.2021.09.010</pub-id>.</mixed-citation></ref>
<ref id="c45"><label>45.</label><mixed-citation publication-type="journal"><string-name><surname>Piovesan</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Del Conte</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Clementel</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Monzon</surname>, <given-names>A.M.</given-names></string-name>, <string-name><surname>Bevilacqua</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Aspromonte</surname>, <given-names>M.C.</given-names></string-name>, <string-name><surname>Iserte</surname>, <given-names>J.A.</given-names></string-name>, <string-name><surname>Orti</surname>, <given-names>F.E.</given-names></string-name>, <string-name><surname>Marino-Buslje</surname>, <given-names>C.</given-names></string-name> and <string-name><surname>Tosatto</surname>, <given-names>S.C.E</given-names></string-name>. (<year>2023</year>) <article-title>MobiDB: 10 years of intrinsically disordered proteins</article-title>. <source>Nucleic Acids Res</source>, <volume>51</volume>, <fpage>D438</fpage>–<lpage>D444</lpage>. doi: <pub-id pub-id-type="doi">10.1093/nar/gkac1065</pub-id>.</mixed-citation></ref>
<ref id="c46"><label>46.</label><mixed-citation publication-type="journal"><string-name><surname>Su</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Xu</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Chen</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>Q.</given-names></string-name>, <string-name><surname>Lu</surname>, <given-names>Z.</given-names></string-name>, <string-name><surname>Chen</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Chen</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Han</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Fang</surname>, <given-names>Z.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>P.</given-names></string-name>, <etal>et al.</etal> (<year>2021</year>) <article-title>Photoactive G-quadruplex ligand identifies multiple G-quadruplex-related proteins with extensive sequence tolerance in the cellular environment</article-title>. <source>J Am Chem Soc</source>, <volume>143</volume>, <fpage>1917</fpage>–<lpage>1923</lpage>. doi: <pub-id pub-id-type="doi">10.1021/jacs.0c10792</pub-id>.</mixed-citation></ref>
<ref id="c47"><label>47.</label><mixed-citation publication-type="journal"><string-name><surname>Herviou</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Le Bras</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Dumas</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Hieblot</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Gilhodes</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Cioci</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Hugnot</surname>, <given-names>J.P.</given-names></string-name>, <string-name><surname>Ameadan</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Guillonneau</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Dassi</surname>, <given-names>E.</given-names></string-name>, <etal>et al.</etal> (<year>2020</year>) <article-title>hnRNP H/F drive RNA G-quadruplex-mediated translation linked to genomic instability and therapy resistance in glioblastoma</article-title>. <source>Nat Commun</source>, <volume>11</volume>, <fpage>2661</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41467-020-16168-x</pub-id>.</mixed-citation></ref>
<ref id="c48"><label>48.</label><mixed-citation publication-type="journal"><string-name><surname>Huang</surname>, <given-names>Z.L.</given-names></string-name>, <string-name><surname>Dai</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Luo</surname>, <given-names>W.H.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>X.G.</given-names></string-name>, <string-name><surname>Tan</surname>, <given-names>J.H.</given-names></string-name>, <string-name><surname>Chen</surname>, <given-names>S. Bin</given-names></string-name> and <string-name><surname>Huang</surname>, <given-names>Z.S.</given-names></string-name> (<year>2018</year>) <article-title>Identification of G-quadruplex-binding protein from the exploration of RGG motif/G-quadruplex interactions</article-title>. <source>J Am Chem Soc</source>, <volume>140</volume>, <fpage>17945</fpage>–<lpage>17955</lpage>. doi: <pub-id pub-id-type="doi">10.1021/jacs.8b09329</pub-id>.</mixed-citation></ref>
<ref id="c49"><label>49.</label><mixed-citation publication-type="journal"><string-name><surname>Patra</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Claude</surname>, <given-names>J.B.</given-names></string-name>, <string-name><surname>Naubron</surname>, <given-names>J.V.</given-names></string-name> and <string-name><surname>Wenger</surname>, <given-names>J</given-names></string-name>. (<year>2021</year>) <article-title>Fast interaction dynamics of G-quadruplex and RGG-rich peptides unveiled in zero-mode waveguides</article-title>. <source>Nucleic Acids Res</source>, <volume>49</volume>, <fpage>12348</fpage>–<lpage>12357</lpage>. doi: <pub-id pub-id-type="doi">10.1093/nar/gkab1002</pub-id>.</mixed-citation></ref>
<ref id="c50"><label>50.</label><mixed-citation publication-type="journal"><string-name><surname>Thandapani</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>O’Connor</surname>, <given-names>T.R.</given-names></string-name>, <string-name><surname>Bailey</surname>, <given-names>T.L.</given-names></string-name> and <string-name><surname>Richard</surname>, <given-names>S</given-names></string-name>. (<year>2013</year>) <article-title>Defining the RGG/RG Motif</article-title>. <source>Mol Cell</source>, <volume>50</volume>, <fpage>613</fpage>–<lpage>623</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.molcel.2013.05.021</pub-id>.</mixed-citation></ref>
<ref id="c51"><label>51.</label><mixed-citation publication-type="journal"><string-name><surname>Herdy</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Mayer</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Varshney</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Marsico</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Murat</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Taylor</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>D’Santos</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Tannahill</surname>, <given-names>D.</given-names></string-name> and <string-name><surname>Balasubramanian</surname>, <given-names>S</given-names></string-name>. (<year>2018</year>) <article-title>Analysis of NRAS RNA G-quadruplex binding proteins reveals DDX3X as a novel interactor of cellular G-quadruplex containing transcripts</article-title>. <source>Nucleic Acids Res</source>, <volume>46</volume>, <fpage>11592</fpage>–<lpage>11604</lpage>. doi: <pub-id pub-id-type="doi">10.1093/nar/gky861</pub-id>.</mixed-citation></ref>
<ref id="c52"><label>52.</label><mixed-citation publication-type="journal"><string-name><surname>McRae</surname>, <given-names>E.K.S.</given-names></string-name>, <string-name><surname>Dupas</surname>, <given-names>S.J.</given-names></string-name>, <string-name><surname>Booy</surname>, <given-names>E.P.</given-names></string-name>, <string-name><surname>Piragasam</surname>, <given-names>R.S.</given-names></string-name>, <string-name><surname>Fahlman</surname>, <given-names>R.P.</given-names></string-name> and <string-name><surname>McKenna</surname>, <given-names>S.A</given-names></string-name>. (<year>2020</year>) <article-title>An RNA guanine quadruplex regulated pathway to TRAIL-sensitization by DDX21</article-title>. <source>RNA</source>, <volume>26</volume>, <fpage>44</fpage>–<lpage>57</lpage>. doi: <pub-id pub-id-type="doi">10.1261/rna.072199.119</pub-id>.</mixed-citation></ref>
<ref id="c53"><label>53.</label><mixed-citation publication-type="journal"><string-name><surname>Murat</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Marsico</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Herdy</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Ghanbarian</surname>, <given-names>A.T.</given-names></string-name>, <string-name><surname>Portella</surname>, <given-names>G.</given-names></string-name> and <string-name><surname>Balasubramanian</surname>, <given-names>S</given-names></string-name>. (<year>2018</year>) <article-title>RNA G-quadruplexes at upstream open reading frames cause DHX36- and DHX9-dependent translation of human mRNAs</article-title>. <source>Genome Biol</source>, <volume>19</volume>, <fpage>229</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s13059-018-1602-2</pub-id>.</mixed-citation></ref>
<ref id="c54"><label>54.</label><mixed-citation publication-type="journal"><string-name><surname>Varshney</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Cuesta</surname>, <given-names>S.M.</given-names></string-name>, <string-name><surname>Herdy</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Abdullah</surname>, <given-names>U.B.</given-names></string-name>, <string-name><surname>Tannahill</surname>, <given-names>D.</given-names></string-name> and <string-name><surname>Balasubramanian</surname>, <given-names>S</given-names></string-name>. (<year>2021</year>) <article-title>RNA G-quadruplex structures control ribosomal protein production</article-title>. <source>Sci Rep</source>, <volume>11</volume>, <fpage>22735</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41598-021-01847-6</pub-id>.</mixed-citation></ref>
<ref id="c55"><label>55.</label><mixed-citation publication-type="journal"><string-name><surname>Ruggiero</surname>, <given-names>E.</given-names></string-name> and <string-name><surname>Richter</surname>, <given-names>S.N</given-names></string-name>. (<year>2018</year>) <article-title>G-quadruplexes and G-quadruplex ligands: Targets and tools in antiviral therapy</article-title>. <source>Nucleic Acids Res</source>, <volume>46</volume>, <fpage>3270</fpage>–<lpage>3283</lpage>. doi: <pub-id pub-id-type="doi">10.1093/nar/gky187</pub-id>.</mixed-citation></ref>
<ref id="c56"><label>56.</label><mixed-citation publication-type="journal"><string-name><surname>Xu</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Huang</surname>, <given-names>H.</given-names></string-name> and <string-name><surname>Zhou</surname>, <given-names>X</given-names></string-name>. (<year>2021</year>) <article-title>G-Quadruplexes in neurobiology and virology: functional roles and potential therapeutic approaches</article-title>. <source>JACS Au</source>, <volume>1</volume>, <fpage>2146</fpage>–<lpage>2161</lpage>. doi: <pub-id pub-id-type="doi">10.1021/jacsau.1c00451</pub-id>.</mixed-citation></ref>
<ref id="c57"><label>57.</label><mixed-citation publication-type="journal"><string-name><surname>Lee</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Lee</surname>, <given-names>Y.S.</given-names></string-name>, <string-name><surname>Choi</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Son</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Park</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Lee</surname>, <given-names>K.M.</given-names></string-name>, <string-name><surname>Kim</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Kim</surname>, <given-names>J.S.</given-names></string-name> and <string-name><surname>Kim</surname>, <given-names>V.N</given-names></string-name>. (<year>2021</year>) <article-title>The SARS-CoV-2 RNA interactome</article-title>. <source>Mol Cell</source>, <volume>81</volume>, <fpage>2838</fpage>–<lpage>2850</lpage>.e6. doi: <pub-id pub-id-type="doi">10.1016/j.molcel.2021.04.022</pub-id>.</mixed-citation></ref>
<ref id="c58"><label>58.</label><mixed-citation publication-type="journal"><string-name><surname>Chung</surname>, <given-names>K.S.</given-names></string-name>, <string-name><surname>Won</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Lee</surname>, <given-names>J.J.</given-names></string-name>, <string-name><surname>Ahn</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Hoe</surname>, <given-names>K.L.</given-names></string-name>, <string-name><surname>Kim</surname>, <given-names>D.U.</given-names></string-name>, <string-name><surname>Song</surname>, <given-names>K. Bin</given-names></string-name> and <string-name><surname>Yoo</surname>, <given-names>H.S.</given-names></string-name> (<year>2007</year>) <article-title>17346842 Yeast-based screening to identify modulators of G-protein signaling using uncontrolled cell division cycle by overexpression of Stm1</article-title>. <source>J Biotechnol</source>, <volume>129</volume>, <fpage>547</fpage>–<lpage>554</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jbiotec.2007.01.007</pub-id>.</mixed-citation></ref>
<ref id="c59"><label>59.</label><mixed-citation publication-type="journal"><string-name><surname>Kim</surname>, <given-names>D.S.</given-names></string-name>, <string-name><surname>Challa</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Jones</surname>, <given-names>A.</given-names></string-name> and <string-name><surname>Kraus</surname>, <given-names>W.L</given-names></string-name>. (<year>2020</year>) <article-title>PARPs and ADP-ribosylation in RNA biology: from RNA expression and processing to protein translation and proteostasis</article-title>. <source>Genes Dev</source>, <volume>34</volume>, <fpage>302</fpage>–<lpage>320</lpage>. doi: <pub-id pub-id-type="doi">10.1101/gad.334433.119</pub-id>.</mixed-citation></ref>
<ref id="c60"><label>60.</label><mixed-citation publication-type="journal"><string-name><surname>Gupte</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Liu</surname>, <given-names>Z.</given-names></string-name> and <string-name><surname>Kraus</surname>, <given-names>W.L</given-names></string-name>. (<year>2017</year>) <article-title>PARPs and ADP-ribosylation: recent advances linking molecular functions to biological outcomes</article-title>. <source>Genes Dev</source>, <volume>31</volume>, <fpage>101</fpage>–<lpage>126</lpage>. doi: <pub-id pub-id-type="doi">10.1101/gad.291518</pub-id>.</mixed-citation></ref>
<ref id="c61"><label>61.</label><mixed-citation publication-type="journal"><string-name><surname>Huang</surname>, <given-names>D.</given-names></string-name> and <string-name><surname>Kraus</surname>, <given-names>W.L</given-names></string-name>. (<year>2022</year>) <article-title>The expanding universe of PARP1-mediated molecular and therapeutic mechanisms</article-title>. <source>Mol Cell</source>, <volume>82</volume>, <fpage>2315</fpage>–<lpage>2334</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.molcel.2022.02.021</pub-id>.</mixed-citation></ref>
<ref id="c62"><label>62.</label><mixed-citation publication-type="journal"><string-name><surname>Gibson</surname>, <given-names>B.A.</given-names></string-name>, <string-name><surname>Zhang</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Jiang</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Hussey</surname>, <given-names>K.M.</given-names></string-name>, <string-name><surname>Shrimp</surname>, <given-names>J.H.</given-names></string-name>, <string-name><surname>Lin</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Schwede</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Yu</surname>, <given-names>Y.</given-names></string-name> and <string-name><surname>Kraus</surname>, <given-names>W.L</given-names></string-name>. (<year>2016</year>) <article-title>Chemical genetic discovery of PARP targets reveals a role for PARP-1 in transcription elongation</article-title>. <source>Science</source>, <volume>353</volume>, <fpage>45</fpage>–<lpage>50</lpage>. doi: <pub-id pub-id-type="doi">10.1126/science.aaf7865</pub-id>.</mixed-citation></ref>
<ref id="c63"><label>63.</label><mixed-citation publication-type="journal"><string-name><surname>Martello</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Leutert</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Jungmichel</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Bilan</surname>, <given-names>V.</given-names></string-name>, <string-name><surname>Larsen</surname>, <given-names>S.C.</given-names></string-name>, <string-name><surname>Young</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Hottiger</surname>, <given-names>M.O.</given-names></string-name> and <string-name><surname>Nielsen</surname>, <given-names>M.L</given-names></string-name>. (<year>2016</year>) <article-title>Proteome-wide identification of the endogenous ADP-ribosylome of mammalian cells and tissue</article-title>. <source>Nat Commun</source>, <volume>7</volume>, <fpage>12917</fpage>. doi: <pub-id pub-id-type="doi">10.1038/ncomms12917</pub-id>.</mixed-citation></ref>
<ref id="c64"><label>64.</label><mixed-citation publication-type="journal"><string-name><surname>Dasovich</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Beckett</surname>, <given-names>M.Q.</given-names></string-name>, <string-name><surname>Bailey</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Ong</surname>, <given-names>S.E.</given-names></string-name>, <string-name><surname>Greenberg</surname>, <given-names>M.M.</given-names></string-name> and <string-name><surname>Leung</surname>, <given-names>A.K.L</given-names></string-name>. (<year>2021</year>) <article-title>Identifying poly(ADP-ribose)-binding proteins with photoaffinity-based proteomics</article-title>. <source>J Am Chem Soc</source>, <volume>143</volume>, <fpage>3037</fpage>–<lpage>3042</lpage>. doi: <pub-id pub-id-type="doi">10.1021/jacs.0c12246</pub-id>.</mixed-citation></ref>
<ref id="c65"><label>65.</label><mixed-citation publication-type="journal"><string-name><surname>Zhang</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Guo</surname>, <given-names>Q.</given-names></string-name>, <string-name><surname>Chen</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Wu</surname>, <given-names>Z.</given-names></string-name>, <string-name><surname>Yan</surname>, <given-names>X.J.</given-names></string-name>, <string-name><surname>Zou</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Zhang</surname>, <given-names>Q.</given-names></string-name>, <string-name><surname>Tan</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Fang</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Rao</surname>, <given-names>Q.</given-names></string-name>, <etal>et al.</etal> (<year>2023</year>) <article-title>A ribosomal gene panel predicting a novel synthetic lethality in non-BRCAness tumors</article-title>. <source>Signal Transduct Target Ther</source>, <volume>8</volume>, <fpage>183</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41392-023-01401-y</pub-id>.</mixed-citation></ref>
<ref id="c66"><label>66.</label><mixed-citation publication-type="journal"><string-name><surname>Mosler</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Baymaz</surname>, <given-names>H.I.</given-names></string-name>, <string-name><surname>Gräf</surname>, <given-names>J.F.</given-names></string-name>, <string-name><surname>Mikicic</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Blattner</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Bartlett</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Ostermaier</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Piccinno</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Yang</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Voigt</surname>, <given-names>A.</given-names></string-name>, <etal>et al.</etal> (<year>2022</year>) <article-title>PARP1 proximity proteomics reveals interaction partners at stressed replication forks</article-title>. <source>Nucleic Acids Res</source>, <volume>50</volume>, <fpage>11600</fpage>–<lpage>11618</lpage>. doi: <pub-id pub-id-type="doi">10.1093/nar/gkac948</pub-id>.</mixed-citation></ref>
<ref id="c67"><label>67.</label><mixed-citation publication-type="journal"><string-name><surname>Kim</surname>, <given-names>D.S.</given-names></string-name>, <string-name><surname>Camacho</surname>, <given-names>C. V.</given-names></string-name>, <string-name><surname>Nagari</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Malladi</surname>, <given-names>V.S.</given-names></string-name>, <string-name><surname>Challa</surname>, <given-names>S.</given-names></string-name> and <string-name><surname>Kraus</surname>, <given-names>W.L</given-names></string-name>. (<year>2019</year>) <article-title>Activation of PARP-1 by snoRNAs controls ribosome biogenesis and cell growth via the RNA helicase DDX21</article-title>. <source>Mol Cell</source>, <volume>75</volume>, <fpage>1270</fpage>–<lpage>1285</lpage>.e14. doi: <pub-id pub-id-type="doi">10.1016/j.molcel.2019.06.020</pub-id>.</mixed-citation></ref>
<ref id="c68"><label>68.</label><mixed-citation publication-type="journal"><string-name><surname>Mekishvili</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Matveeva</surname>, <given-names>E.</given-names></string-name> and <string-name><surname>Fondufe-Mittendorf</surname>, <given-names>Y</given-names></string-name>. (<year>2017</year>) <article-title>Methodology to identify poly-ADP-ribose polymerase 1 (PARP1)-mRNA targets by PAR-CLiP</article-title>. <source>Methods Mol Biol</source>, <volume>1608</volume>, <fpage>211</fpage>–<lpage>228</lpage>. doi: <pub-id pub-id-type="doi">10.1007/978-1-4939-6993-7_15</pub-id>.</mixed-citation></ref>
<ref id="c69"><label>69.</label><mixed-citation publication-type="journal"><string-name><surname>Wei</surname>, <given-names>H.</given-names></string-name> and <string-name><surname>Yu</surname>, <given-names>X</given-names></string-name>. (<year>2016</year>) <article-title>Functions of PARylation in DNA damage repair pathways</article-title>. <source>Genomics Proteomics Bioinformatics</source>, <volume>14</volume>, <fpage>131</fpage>–<lpage>139</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.gpb.2016.05.001</pub-id>.</mixed-citation></ref>
<ref id="c70"><label>70.</label><mixed-citation publication-type="journal"><string-name><surname>Žaja</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Mikoč</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Barkauskaite</surname>, <given-names>E.</given-names></string-name> and <string-name><surname>Ahel</surname>, <given-names>I.</given-names></string-name> (<year>2012</year>) <article-title>Molecular insights into poly(ADP-ribose) recognition and processing</article-title>. <source>Biomolecules</source>, <volume>3</volume>, <fpage>1</fpage>–<lpage>17</lpage>. doi: <pub-id pub-id-type="doi">10.3390/biom3010001</pub-id>.</mixed-citation></ref>
<ref id="c71"><label>71.</label><mixed-citation publication-type="journal"><collab>UniProt Consortium</collab> (<year>2023</year>) <article-title>UniProt: The universal protein knowledgebase in 2023</article-title>. <source>Nucleic Acids Res</source>, <volume>51</volume>, <fpage>D523</fpage>–<lpage>D531</lpage>. doi: <pub-id pub-id-type="doi">10.1093/nar/gkac1052</pub-id>.</mixed-citation></ref>
<ref id="c72"><label>72.</label><mixed-citation publication-type="journal"><string-name><surname>Thomas</surname>, <given-names>P.D.</given-names></string-name>, <string-name><surname>Ebert</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Muruganujan</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Mushayahama</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Albou</surname>, <given-names>L.P.</given-names></string-name> and <string-name><surname>Mi</surname>, <given-names>H</given-names></string-name>. (<year>2022</year>) <article-title>PANTHER: Making genome-scale phylogenetics accessible to all</article-title>. <source>Protein Sci</source>, <volume>31</volume>, <fpage>8</fpage>–<lpage>22</lpage>. doi: <pub-id pub-id-type="doi">10.1002/pro.4218</pub-id>.</mixed-citation></ref>
<ref id="c73"><label>73.</label><mixed-citation publication-type="journal"><string-name><surname>Li</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Jiang</surname>, <given-names>C.</given-names></string-name> and <string-name><surname>Zhang</surname>, <given-names>E</given-names></string-name>. (<year>2021</year>) <article-title>Advances in the phase separation-organized membraneless organelles in cells: a narrative review</article-title>. <source>Transl Cancer Res</source>, <volume>10</volume>, <fpage>4929</fpage>–<lpage>4946</lpage>. doi: <pub-id pub-id-type="doi">10.21037/tcr-21-1111</pub-id>.</mixed-citation></ref>
<ref id="c74"><label>74.</label><mixed-citation publication-type="journal"><string-name><surname>Kastano</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Mier</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Dosztányi</surname>, <given-names>Z.</given-names></string-name>, <string-name><surname>Promponas</surname>, <given-names>V.J.</given-names></string-name> and <string-name><surname>Andrade-Navarro</surname>, <given-names>M.A</given-names></string-name>. (<year>2022</year>) <article-title>Functional tuning of intrinsically disordered regions in human proteins by composition bias</article-title>. <source>Biomolecules</source>, <volume>12</volume>, <fpage>1486</fpage>. doi: <pub-id pub-id-type="doi">10.3390/biom12101486</pub-id>.</mixed-citation></ref>
<ref id="c75"><label>75.</label><mixed-citation publication-type="journal"><string-name><surname>Feng</surname>, <given-names>Z.</given-names></string-name>, <string-name><surname>Jia</surname>, <given-names>B.</given-names></string-name> and <string-name><surname>Zhang</surname>, <given-names>M</given-names></string-name>. (<year>2021</year>) <article-title>Liquid-liquid phase separation in biology: specific stoichiometric molecular interactions vs promiscuous interactions mediated by disordered sequences</article-title>. <source>Biochemistry</source>, <volume>60</volume>, <fpage>2397</fpage>–<lpage>2406</lpage>. doi: <pub-id pub-id-type="doi">10.1021/acs.biochem.1c00376</pub-id>.</mixed-citation></ref>
<ref id="c76"><label>76.</label><mixed-citation publication-type="journal"><string-name><surname>Kimura</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Sharma</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Ishiguro</surname>, <given-names>K.</given-names></string-name> and <string-name><surname>Hisanaga</surname>, <given-names>S.I</given-names></string-name>. (<year>2018</year>) <article-title>Phospho-Tau bar code: analysis of phosphoisotypes of Tau and its application to tauopathy</article-title>. <source>Front Neurosci</source>, <volume>12</volume>, <fpage>44</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fnins.2018.00044</pub-id>.</mixed-citation></ref>
<ref id="c77"><label>77.</label><mixed-citation publication-type="journal"><string-name><surname>Lester</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Ooi</surname>, <given-names>F.K.</given-names></string-name>, <string-name><surname>Bakkar</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Ayers</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Woerman</surname>, <given-names>A.L.</given-names></string-name>, <string-name><surname>Wheeler</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Bowser</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Carlson</surname>, <given-names>G.A.</given-names></string-name>, <string-name><surname>Prusiner</surname>, <given-names>S.B.</given-names></string-name> and <string-name><surname>Parker</surname>, <given-names>R</given-names></string-name>. (<year>2021</year>) <article-title>Tau aggregates are RNA-protein assemblies that mislocalize multiple nuclear speckle components</article-title>. <source>Neuron</source>, <volume>109</volume>, <fpage>1675</fpage>–<lpage>1691</lpage>.e9. doi: <pub-id pub-id-type="doi">10.1016/j.neuron.2021.03.026</pub-id>.</mixed-citation></ref>
<ref id="c78"><label>78.</label><mixed-citation publication-type="journal"><string-name><surname>Hernández-Ortega</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Garcia-Esparcia</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Gil</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Lucas</surname>, <given-names>J.J.</given-names></string-name> and <string-name><surname>Ferrer</surname>, <given-names>I</given-names></string-name>. (<year>2016</year>) <article-title>Altered machinery of protein synthesis in Alzheimer’s: from the nucleolus to the ribosome</article-title>. <source>Brain Pathol</source>, <volume>26</volume>, <fpage>593</fpage>–<lpage>605</lpage>. doi: <pub-id pub-id-type="doi">10.1111/bpa.12335</pub-id>.</mixed-citation></ref>
<ref id="c79"><label>79.</label><mixed-citation publication-type="journal"><string-name><surname>Evans</surname>, <given-names>H.T.</given-names></string-name>, <string-name><surname>Taylor</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Kneynsberg</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Bodea</surname>, <given-names>L.G.</given-names></string-name> and <string-name><surname>Götz</surname>, <given-names>J</given-names></string-name>. (<year>2021</year>) <article-title>Altered ribosomal function and protein synthesis caused by tau</article-title>. <source>Acta Neuropathol Commun</source>, <volume>9</volume>, <fpage>110</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s40478-021-01208-4</pub-id>.</mixed-citation></ref>
<ref id="c80"><label>80.</label><mixed-citation publication-type="journal"><string-name><surname>Mao</surname>, <given-names>K.</given-names></string-name> and <string-name><surname>Zhang</surname>, <given-names>G</given-names></string-name>. (<year>2022</year>) <article-title>The role of PARP1 in neurodegenerative diseases and aging</article-title>. <source>FEBS J</source>, <volume>289</volume>, <fpage>2013</fpage>–<lpage>2024</lpage>. doi: <pub-id pub-id-type="doi">10.1111/febs.15716</pub-id>.</mixed-citation></ref>
<ref id="c81"><label>81.</label><mixed-citation publication-type="journal"><string-name><surname>Ash</surname>, <given-names>P.E.A.</given-names></string-name>, <string-name><surname>Vanderweyde</surname>, <given-names>T.E.</given-names></string-name>, <string-name><surname>Youmans</surname>, <given-names>K.L.</given-names></string-name>, <string-name><surname>Apicco</surname>, <given-names>D.J.</given-names></string-name> and <string-name><surname>Wolozin</surname>, <given-names>B</given-names></string-name>. (<year>2014</year>) <article-title>Pathological stress granules in Alzheimer’s disease</article-title>. <source>Brain Res</source>, <volume>1584</volume>, <fpage>52</fpage>–<lpage>58</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.brainres.2014.05.052</pub-id>.</mixed-citation></ref>
<ref id="c82"><label>82.</label><mixed-citation publication-type="journal"><string-name><surname>Vanderweyde</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Yu</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Varnum</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Liu-Yesucevitz</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Citro</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Ikezu</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Duff</surname>, <given-names>K.</given-names></string-name> and <string-name><surname>Wolozin</surname>, <given-names>B</given-names></string-name>. (<year>2012</year>) <article-title>Contrasting pathology of the stress granule proteins TIA-1 and G3BP in tauopathies</article-title>. <source>J Neurosci</source>, <volume>32</volume>, <fpage>8270</fpage>–<lpage>8283</lpage>. doi: <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1592-12.2012</pub-id>.</mixed-citation></ref>
<ref id="c83"><label>83.</label><mixed-citation publication-type="journal"><string-name><surname>Heaton</surname>, <given-names>J.H.</given-names></string-name>, <string-name><surname>Dlakic</surname>, <given-names>W.M.</given-names></string-name>, <string-name><surname>Dlakic</surname>, <given-names>M.</given-names></string-name> and <string-name><surname>Gelehrter</surname>, <given-names>T.D</given-names></string-name>. (<year>2001</year>) <article-title>Identification and cDNA cloning of a novel RNA-binding protein that interacts with the cyclic nucleotide-responsive sequence in the Type-1 plasminogen activator Inhibitor mRNA</article-title>. <source>J Biol Chem</source>, <volume>276</volume>, <fpage>3341</fpage>–<lpage>3347</lpage>. doi: <pub-id pub-id-type="doi">10.1074/jbc.M006538200</pub-id>.</mixed-citation></ref>
<ref id="c84"><label>84.</label><mixed-citation publication-type="journal"><string-name><surname>Van Dyke</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Baby</surname>, <given-names>J.</given-names></string-name> and <string-name><surname>Van Dyke</surname>, <given-names>M.W.</given-names></string-name> (<year>2006</year>) <article-title>Stm1p, a ribosome-associated protein, is important for protein synthesis in Saccharomyces cerevisiae under nutritional stress conditions</article-title>. <source>J Mol Biol</source>, <volume>358</volume>, <fpage>1023</fpage>–<lpage>1031</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jmb.2006.03.018</pub-id>.</mixed-citation></ref>
<ref id="c85"><label>85.</label><mixed-citation publication-type="journal"><string-name><surname>Mateju</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Eichenberger</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Voigt</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Eglinger</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Roth</surname>, <given-names>G.</given-names></string-name> and <string-name><surname>Chao</surname>, <given-names>J.A</given-names></string-name>. (<year>2020</year>) <article-title>Single-molecule imaging reveals translation of mRNAs localized to stress granules</article-title>. <source>Cell</source>, <volume>183</volume>, <fpage>1801</fpage>–<lpage>1812</lpage>.e13. doi: <pub-id pub-id-type="doi">10.1016/j.cell.2020.11.010</pub-id>.</mixed-citation></ref>
<ref id="c86"><label>86.</label><mixed-citation publication-type="journal"><string-name><surname>Ray</surname>, <given-names>S.</given-names></string-name> and <string-name><surname>Anderson</surname>, <given-names>E.C</given-names></string-name>. (<year>2016</year>) <article-title>Stimulation of translation by human Unr requires cold shock domains 2 and 4, and correlates with poly(A) binding protein interaction</article-title>. <source>Sci Rep</source>, <volume>6</volume>, <fpage>22461</fpage>. doi: <pub-id pub-id-type="doi">10.1038/srep22461</pub-id>.</mixed-citation></ref>
<ref id="c87"><label>87.</label><mixed-citation publication-type="journal"><string-name><surname>Mitchell</surname>, <given-names>S.A.</given-names></string-name>, <string-name><surname>Brown</surname>, <given-names>E.C.</given-names></string-name>, <string-name><surname>Coldwell</surname>, <given-names>M.J.</given-names></string-name>, <string-name><surname>Jackson</surname>, <given-names>R.J.</given-names></string-name> and <string-name><surname>Willis</surname>, <given-names>A.E</given-names></string-name>. (<year>2001</year>) <article-title>Protein factor requirements of the Apaf-1 internal ribosome entry segment: Roles of polypyrimidine tract binding protein and upstream of N-ras</article-title>. <source>Mol Cell Biol</source>, <volume>21</volume>, <fpage>3364</fpage>–<lpage>3374</lpage>. doi: <pub-id pub-id-type="doi">10.1128/mcb.21.10.3364-3374.2001</pub-id>.</mixed-citation></ref>
<ref id="c88"><label>88.</label><mixed-citation publication-type="journal"><string-name><surname>Dormoy-Raclet</surname>, <given-names>V.</given-names></string-name>, <string-name><surname>Markovits</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Jacquemin-Sablon</surname>, <given-names>A.</given-names></string-name> and <string-name><surname>Jacquemin-Sablon</surname>, <given-names>H</given-names></string-name>. (<year>2005</year>) <article-title>Regulation of Unr expression by 5′- and 3′-untranslated regions of its mRNA through modulation of stability and IRES mediated translation</article-title>. <source>RNA Biol</source>, <volume>2</volume>, <fpage>e27</fpage>–<lpage>35</lpage>. doi: <pub-id pub-id-type="doi">10.4161/rna.2.3.2203</pub-id>.</mixed-citation></ref>
<ref id="c89"><label>89.</label><mixed-citation publication-type="journal"><string-name><surname>Abaza</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Coll</surname>, <given-names>O.</given-names></string-name>, <string-name><surname>Patalano</surname>, <given-names>S.</given-names></string-name> and <string-name><surname>Gebauer</surname>, <given-names>F</given-names></string-name>. (<year>2006</year>) <article-title>Drosophila UNR is required for translational repression of male-specific lethal 2 mRNA during regulation of X-chromosome dosage compensation</article-title>. <source>Genes Dev</source>, <volume>20</volume>, <fpage>380</fpage>–<lpage>389</lpage>. doi: <pub-id pub-id-type="doi">10.1101/gad.371906</pub-id>.</mixed-citation></ref>
<ref id="c90"><label>90.</label><mixed-citation publication-type="journal"><string-name><surname>Guo</surname>, <given-names>A.X.</given-names></string-name>, <string-name><surname>Cui</surname>, <given-names>J.J.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>L.Y.</given-names></string-name> and <string-name><surname>Yin</surname>, <given-names>J.Y</given-names></string-name>. (<year>2020</year>) <article-title>The role of CSDE1 in translational reprogramming and human diseases</article-title>. <source>Cell Commun Signal</source>, <volume>18</volume>, <fpage>14</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12964-019-0496-2</pub-id>.</mixed-citation></ref>
<ref id="c91"><label>91.</label><mixed-citation publication-type="journal"><string-name><surname>Walsh</surname>, <given-names>D.</given-names></string-name> and <string-name><surname>Mohr</surname>, <given-names>I</given-names></string-name>. (<year>2011</year>) <article-title>Viral subversion of the host protein synthesis machinery</article-title>. <source>Nat Rev Microbiol</source>, <volume>9</volume>, <fpage>860</fpage>–<lpage>875</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nrmicro2655</pub-id>.</mixed-citation></ref>
<ref id="c92"><label>92.</label><mixed-citation publication-type="journal"><string-name><surname>Locker</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Chamond</surname>, <given-names>N.</given-names></string-name> and <string-name><surname>Sargueil</surname>, <given-names>B</given-names></string-name>. (<year>2011</year>) <article-title>A conserved structure within the HIV gag open reading frame that controls translation initiation directly recruits the 40S subunit and eIF3</article-title>. <source>Nucleic Acids Res</source>, <volume>39</volume>, <fpage>2367</fpage>–<lpage>2377</lpage>. doi: <pub-id pub-id-type="doi">10.1093/nar/gkq1118</pub-id>.</mixed-citation></ref>
<ref id="c93"><label>93.</label><mixed-citation publication-type="journal"><string-name><surname>Boussadia</surname>, <given-names>O.</given-names></string-name>, <string-name><surname>Niepmann</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Créancier</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Prats</surname>, <given-names>A.C.</given-names></string-name>, <string-name><surname>Dautry</surname>, <given-names>F.</given-names></string-name> and <string-name><surname>Jacquemin-Sablon</surname>, <given-names>H</given-names></string-name>. (<year>2003</year>) <article-title>Unr is required in vivo for efficient initiation of translation from the internal ribosome entry sites of both rhinovirus and poliovirus</article-title>. <source>J Virol</source>, <volume>77</volume>, <fpage>3353</fpage>–<lpage>3359</lpage>. doi: <pub-id pub-id-type="doi">10.1128/jvi.77.6.3353-3359.2003</pub-id>.</mixed-citation></ref>
<ref id="c94"><label>94.</label><mixed-citation publication-type="journal"><string-name><surname>Brugier</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Hafirrassou</surname>, <given-names>M.L.</given-names></string-name>, <string-name><surname>Pourcelot</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Baldaccini</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Kril</surname>, <given-names>V.</given-names></string-name>, <string-name><surname>Couture</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Kümmerer</surname>, <given-names>B.M.</given-names></string-name>, <string-name><surname>Gallois-Montbrun</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Bonnet-Madin</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Vidalain</surname>, <given-names>P.O.</given-names></string-name>, <etal>et al.</etal> (<year>2022</year>) <article-title>RACK1 associates with RNA-binding proteins Vigilin and SERBP1 to facilitate dengue virus replication</article-title>. <source>J Virol</source>, <volume>96</volume>, <fpage>e0196221</fpage>. doi: <pub-id pub-id-type="doi">10.1128/jvi.01962-21</pub-id>.</mixed-citation></ref>
<ref id="c95"><label>95.</label><mixed-citation publication-type="journal"><string-name><surname>Tollervey</surname>, <given-names>D.</given-names></string-name> and <string-name><surname>Kiss</surname>, <given-names>T</given-names></string-name>. (<year>1997</year>) <article-title>Function and synthesis of small nucleolar RNAs</article-title>. <source>Curr Opin Cell Biol</source>, <volume>9</volume>, <fpage>337</fpage>–<lpage>342</lpage>. doi: <pub-id pub-id-type="doi">10.1016/s0955-0674(97)80005-1</pub-id>.</mixed-citation></ref>
<ref id="c96"><label>96.</label><mixed-citation publication-type="journal"><string-name><surname>Tafforeau</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Zorbas</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Langhendries</surname>, <given-names>J.L.</given-names></string-name>, <string-name><surname>Mullineux</surname>, <given-names>S.T.</given-names></string-name>, <string-name><surname>Stamatopoulou</surname>, <given-names>V.</given-names></string-name>, <string-name><surname>Mullier</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Wacheul</surname>, <given-names>L.</given-names></string-name> and <string-name><surname>Lafontaine</surname>, <given-names>D.L.J</given-names></string-name>. (<year>2013</year>) <article-title>The complexity of human ribosome biogenesis revealed by systematic nucleolar screening of pre-rRNA processing factors</article-title>. <source>Mol Cell</source>, <volume>51</volume>, <fpage>539</fpage>–<lpage>551</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.molcel.2013.08.011</pub-id>.</mixed-citation></ref>
<ref id="c97"><label>97.</label><mixed-citation publication-type="journal"><string-name><surname>Tollervey</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Lehtonen</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Jansen</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Kern</surname>, <given-names>H.</given-names></string-name> and <string-name><surname>Hurt</surname>, <given-names>E.C</given-names></string-name>. (<year>1993</year>) <article-title>Temperature-sensitive mutations demonstrate roles for yeast fibrillarin in pre-rRNA processing, pre-rRNA methylation, and ribosome assembly</article-title>. <source>Cell</source>, <volume>72</volume>, <fpage>443</fpage>–<lpage>457</lpage>. doi: <pub-id pub-id-type="doi">10.1016/0092-8674(93)90120-F</pub-id>.</mixed-citation></ref>
<ref id="c98"><label>98.</label><mixed-citation publication-type="journal"><string-name><surname>Iyer-Bierhoff</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Krogh</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Tessarz</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Ruppert</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Nielsen</surname>, <given-names>H.</given-names></string-name> and <string-name><surname>Grummt</surname>, <given-names>I</given-names></string-name>. (<year>2018</year>) <article-title>SIRT7-dependent deacetylation of Fibrillarin controls Histone H2A methylation and rRNA synthesis during the cell cycle</article-title>. <source>Cell Rep</source>, <volume>25</volume>, <fpage>2946</fpage>–<lpage>2954</lpage>.e5. doi: <pub-id pub-id-type="doi">10.1016/j.celrep.2018.11.051</pub-id>.</mixed-citation></ref>
<ref id="c99"><label>99.</label><mixed-citation publication-type="journal"><string-name><surname>Herdman</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Mars</surname>, <given-names>J.C.</given-names></string-name>, <string-name><surname>Stefanovsky</surname>, <given-names>V.Y.</given-names></string-name>, <string-name><surname>Tremblay</surname>, <given-names>M.G.</given-names></string-name>, <string-name><surname>Sabourin-Felix</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Lindsay</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Robinson</surname>, <given-names>M.D.</given-names></string-name> and <string-name><surname>Moss</surname>, <given-names>T</given-names></string-name>. (<year>2017</year>) <article-title>A unique enhancer boundary complex on the mouse ribosomal RNA genes persists after loss of Rrn3 or UBF and the inactivation of RNA polymerase I transcription</article-title>. <source>PLoS Genet</source>, <volume>13</volume>, <fpage>e1006899</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pgen.1006899</pub-id>.</mixed-citation></ref>
<ref id="c100"><label>100.</label><mixed-citation publication-type="journal"><string-name><surname>Bose</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Lee</surname>, <given-names>K.K.</given-names></string-name>, <string-name><surname>Lu</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Xu</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Harris</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Slaughter</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Unruh</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Garrett</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>McDowell</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Box</surname>, <given-names>A.</given-names></string-name>, <etal>et al.</etal> (<year>2012</year>) <article-title>Cohesin proteins promote ribosomal RNA production and protein translation in yeast and human cells</article-title>. <source>PLoS Genet</source>, <volume>8</volume>, <fpage>e1002749</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pgen.1002749</pub-id>.</mixed-citation></ref>
<ref id="c101"><label>101.</label><mixed-citation publication-type="journal"><string-name><surname>Calo</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Flynn</surname>, <given-names>R.A.</given-names></string-name>, <string-name><surname>Martin</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Spitale</surname>, <given-names>R.C.</given-names></string-name>, <string-name><surname>Chang</surname>, <given-names>H.Y.</given-names></string-name> and <string-name><surname>Wysocka</surname>, <given-names>J</given-names></string-name>. (<year>2015</year>) <article-title>25470060 RNA helicase DDX21 coordinates transcription and ribosomal RNA processing</article-title>. <source>Nature</source>, <volume>518</volume>, <fpage>249</fpage>–<lpage>253</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nature13923</pub-id>.</mixed-citation></ref>
<ref id="c102"><label>102.</label><mixed-citation publication-type="journal"><string-name><surname>Ugrinova</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Petrova</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Chalabi-Dchar</surname>, <given-names>M.</given-names></string-name> and <string-name><surname>Bouvet</surname>, <given-names>P</given-names></string-name>. (<year>2018</year>) <article-title>Multifaceted Nucleolin protein and its molecular partners in oncogenesis</article-title>. <source>Adv Protein Chem Struct Biol</source>, <volume>111</volume>, <fpage>133</fpage>–<lpage>164</lpage>. doi: <pub-id pub-id-type="doi">10.1016/bs.apcsb.2017.08.001</pub-id>.</mixed-citation></ref>
<ref id="c103"><label>103.</label><mixed-citation publication-type="journal"><string-name><surname>Hendriks</surname>, <given-names>I.A.</given-names></string-name>, <string-name><surname>Larsen</surname>, <given-names>S.C.</given-names></string-name> and <string-name><surname>Nielsen</surname>, <given-names>M.L</given-names></string-name>. (<year>2019</year>) <article-title>An advanced strategy for comprehensive profiling of ADP-ribosylation sites using mass spectrometry-based proteomics</article-title>. <source>Mol Cell Proteomics</source>, <volume>18</volume>, <fpage>1010</fpage>–<lpage>1026</lpage>. doi: <pub-id pub-id-type="doi">10.1074/mcp.TIR119.001315</pub-id>.</mixed-citation></ref>
<ref id="c104"><label>104.</label><mixed-citation publication-type="journal"><string-name><surname>Bonfiglio</surname>, <given-names>J.J.</given-names></string-name>, <string-name><surname>Fontana</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Zhang</surname>, <given-names>Q.</given-names></string-name>, <string-name><surname>Colby</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Gibbs-Seymour</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Atanassov</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Bartlett</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Zaja</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Ahel</surname>, <given-names>I.</given-names></string-name> and <string-name><surname>Matic</surname>, <given-names>I</given-names></string-name>. (<year>2017</year>) <article-title>Serine ADP-ribosylation depends on HPF1</article-title>. <source>Mol Cell</source>, <volume>65</volume>, <fpage>932</fpage>–<lpage>940</lpage>.e6. doi: <pub-id pub-id-type="doi">10.1016/j.molcel.2017.01.003</pub-id>.</mixed-citation></ref>
<ref id="c105"><label>105.</label><mixed-citation publication-type="journal"><string-name><surname>Bilan</surname>, <given-names>V.</given-names></string-name>, <string-name><surname>Selevsek</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Kistemaker</surname>, <given-names>H.A. V.</given-names></string-name>, <string-name><surname>Abplanalp</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Feurer</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Filippov</surname>, <given-names>D. V.</given-names></string-name> and <string-name><surname>Hottiger</surname>, <given-names>M.O</given-names></string-name>. (<year>2017</year>) <article-title>New quantitative mass spectrometry approaches reveal different ADP-ribosylation phases dependent on the levels of oxidative stress</article-title>. <source>Mol Cell Proteomics</source>, <volume>16</volume>, <fpage>949</fpage>–<lpage>958</lpage>. doi: <pub-id pub-id-type="doi">10.1074/mcp.O116.065623</pub-id>.</mixed-citation></ref>
<ref id="c106"><label>106.</label><mixed-citation publication-type="journal"><string-name><surname>Larsen</surname>, <given-names>S.C.</given-names></string-name>, <string-name><surname>Hendriks</surname>, <given-names>I.A.</given-names></string-name>, <string-name><surname>Lyon</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Jensen</surname>, <given-names>L.J.</given-names></string-name> and <string-name><surname>Nielsen</surname>, <given-names>M.L</given-names></string-name>. (<year>2018</year>) <article-title>Systems-wide analysis of Serine ADP-ribosylation reveals widespread occurrence and site-specific overlap with phosphorylation</article-title>. <source>Cell Rep</source>, <volume>24</volume>, <fpage>2493</fpage>–<lpage>2505</lpage>.e4. doi: <pub-id pub-id-type="doi">10.1016/j.celrep.2018.07.083</pub-id>.</mixed-citation></ref>
<ref id="c107"><label>107.</label><mixed-citation publication-type="journal"><string-name><surname>Tao</surname>, <given-names>Z.</given-names></string-name>, <string-name><surname>Gao</surname>, <given-names>P.</given-names></string-name> and <string-name><surname>Liu</surname>, <given-names>H.W</given-names></string-name>. (<year>2009</year>) <article-title>Studies of the expression of human poly(ADP-ribose) polymerase-1 in Saccharomyces cerevisiae and identification of PARP-1 substrates by yeast proteome microarray screening</article-title>. <source>Biochemistry</source>, <volume>48</volume>, <fpage>11745</fpage>–<lpage>11754</lpage>. doi: <pub-id pub-id-type="doi">10.1021/bi901387k</pub-id>.</mixed-citation></ref>
<ref id="c108"><label>108.</label><mixed-citation publication-type="journal"><string-name><surname>Manco</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Lacerra</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Porzio</surname>, <given-names>E.</given-names></string-name> and <string-name><surname>Catara</surname>, <given-names>G</given-names></string-name>. (<year>2022</year>) <article-title>ADP-ribosylation post-translational modification: an overview with a focus on RNA biology and new pharmacological perspectives</article-title>. <source>Biomolecules</source>, <volume>12</volume>, <fpage>443</fpage>. doi: <pub-id pub-id-type="doi">10.3390/biom12030443</pub-id>.</mixed-citation></ref>
<ref id="c109"><label>109.</label><mixed-citation publication-type="journal"><string-name><surname>Duan</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Du</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Gu</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Duan</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Gui</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Ma</surname>, <given-names>Z.</given-names></string-name>, <string-name><surname>Qian</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Deng</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Zhang</surname>, <given-names>K.</given-names></string-name>, <etal>et al.</etal> (<year>2019</year>) <article-title>PARylation regulates stress granule dynamics, phase separation, and neurotoxicity of disease-related RNA-binding proteins</article-title>. <source>Cell Res</source>, <volume>29</volume>, <fpage>233</fpage>–<lpage>247</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41422-019-0141-z</pub-id>.</mixed-citation></ref>
<ref id="c110"><label>110.</label><mixed-citation publication-type="journal"><string-name><surname>Melikishvili</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Chariker</surname>, <given-names>J.H.</given-names></string-name>, <string-name><surname>Rouchka</surname>, <given-names>E.C.</given-names></string-name> and <string-name><surname>Fondufe-Mittendorf</surname>, <given-names>Y.N</given-names></string-name>. (<year>2017</year>) <article-title>Transcriptome-wide identification of the RNA-binding landscape of the chromatin-associated protein PARP1 reveals functions in RNA biogenesis</article-title>. <source>Cell Discov</source>, <volume>3</volume>, <fpage>17043</fpage>. doi: <pub-id pub-id-type="doi">10.1038/celldisc.2017.43</pub-id>.</mixed-citation></ref>
<ref id="c111"><label>111.</label><mixed-citation publication-type="journal"><string-name><surname>Leung</surname>, <given-names>A.K.L</given-names></string-name>. (<year>2020</year>) <article-title>Poly(ADP-ribose): a dynamic trigger for biomolecular condensate formation</article-title>. <source>Trends Cell Biol</source>, <volume>30</volume>, <fpage>370</fpage>–<lpage>383</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.tcb.2020.02.002</pub-id>.</mixed-citation></ref>
<ref id="c112"><label>112.</label><mixed-citation publication-type="journal"><string-name><surname>Ottoz</surname>, <given-names>D.S.M.</given-names></string-name> and <string-name><surname>Berchowitz</surname>, <given-names>L.E</given-names></string-name>. (<year>2020</year>) <article-title>The role of disorder in RNA binding affinity and specificity: the role of disorder in RNA binding</article-title>. <source>Open Biol</source>, <volume>10</volume>, <fpage>200328</fpage>. doi: <pub-id pub-id-type="doi">10.1098/rsob.200328</pub-id>.</mixed-citation></ref>
<ref id="c113"><label>113.</label><mixed-citation publication-type="journal"><string-name><surname>Naskar</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Nayak</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Salaikumaran</surname>, <given-names>M.R.</given-names></string-name>, <string-name><surname>Vishal</surname>, <given-names>S.S.</given-names></string-name> and <string-name><surname>Gopal</surname>, <given-names>P.P</given-names></string-name>. (<year>2023</year>) <article-title>Phase separation and pathologic transitions of RNP condensates in neurons: implications for amyotrophic lateral sclerosis, frontotemporal dementia and other neurodegenerative disorders</article-title>. <source>Front Mol Neurosci</source>, <volume>16</volume>, <fpage>1242925</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fnmol.2023.1242925</pub-id>.</mixed-citation></ref>
<ref id="c114"><label>114.</label><mixed-citation publication-type="journal"><string-name><surname>Lyu</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Chow</surname>, <given-names>E.Y.C.</given-names></string-name>, <string-name><surname>Mou</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Chan</surname>, <given-names>T.F.</given-names></string-name> and <string-name><surname>Kwok</surname>, <given-names>C.K</given-names></string-name>. (<year>2021</year>) <article-title>RNA G-quadruplexes (rG4s): genomics and biological functions</article-title>. <source>Nucleic Acids Res</source>, <volume>49</volume>, <fpage>5426</fpage>–<lpage>5450</lpage>. doi: <pub-id pub-id-type="doi">10.1093/nar/gkab187</pub-id>.</mixed-citation></ref>
<ref id="c115"><label>115.</label><mixed-citation publication-type="journal"><string-name><surname>Banco</surname>, <given-names>M.T.</given-names></string-name> and <string-name><surname>Ferré-D’Amaré</surname>, <given-names>A.R</given-names></string-name>. (<year>2021</year>) <article-title>The emerging structural complexity of G-quadruplex RNAs</article-title>. <source>RNA</source>, <volume>27</volume>, <fpage>390</fpage>–<lpage>402</lpage>. doi: <pub-id pub-id-type="doi">10.1261/rna.078238.120</pub-id>.</mixed-citation></ref>
<ref id="c116"><label>116.</label><mixed-citation publication-type="journal"><string-name><surname>Dumas</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Herviou</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Dassi</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Cammas</surname>, <given-names>A.</given-names></string-name> and <string-name><surname>Millevoi</surname>, <given-names>S</given-names></string-name>. (<year>2021</year>) <article-title>G-quadruplexes in RNA biology: recent advances and future directions</article-title>. <source>Trends Biochem Sci</source>, <volume>46</volume>, <fpage>270</fpage>–<lpage>283</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.tibs.2020.11.001</pub-id>.</mixed-citation></ref>
<ref id="c117"><label>117.</label><mixed-citation publication-type="journal"><string-name><surname>Edwards</surname>, <given-names>A.D.</given-names></string-name>, <string-name><surname>Marecki</surname>, <given-names>J.C.</given-names></string-name>, <string-name><surname>Byrd</surname>, <given-names>A.K.</given-names></string-name>, <string-name><surname>Gao</surname>, <given-names>J.</given-names></string-name> and <string-name><surname>Raney</surname>, <given-names>K.D</given-names></string-name>. (<year>2021</year>) <article-title>G-quadruplex loops regulate PARP-1 enzymatic activation</article-title>. <source>Nucleic Acids Res</source>, <volume>49</volume>, <fpage>416</fpage>–<lpage>431</lpage>. doi: <pub-id pub-id-type="doi">10.1093/nar/gkaa1172</pub-id>.</mixed-citation></ref>
<ref id="c118"><label>118.</label><mixed-citation publication-type="journal"><string-name><surname>Bleuzé</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Triaca</surname>, <given-names>V.</given-names></string-name> and <string-name><surname>Borreca</surname>, <given-names>A</given-names></string-name>. (<year>2021</year>) <article-title>FMRP-driven neuropathology in Autistic spectrum disorder and Alzheimer’s disease: A losing game</article-title>. <source>Front Mol Biosci</source>, <volume>8</volume>, <fpage>699613</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fmolb.2021.699613</pub-id>.</mixed-citation></ref>
<ref id="c119"><label>119.</label><mixed-citation publication-type="journal"><string-name><surname>Fyke</surname>, <given-names>W.</given-names></string-name> and <string-name><surname>Velinov</surname>, <given-names>M</given-names></string-name>. (<year>2021</year>) <article-title>Fmr1 and autism, an intriguing connection revisited</article-title>. <source>Genes (Basel)</source>, <volume>12</volume>, <fpage>1218</fpage>. doi: <pub-id pub-id-type="doi">10.3390/genes12081218</pub-id>.</mixed-citation></ref>
<ref id="c120"><label>120.</label><mixed-citation publication-type="journal"><string-name><surname>Davis</surname>, <given-names>J.K.</given-names></string-name> and <string-name><surname>Broadie</surname>, <given-names>K</given-names></string-name>. (<year>2017</year>) <article-title>Multifarious functions of the Fragile X mental retardation protein</article-title>. <source>Trends Genet</source>, <volume>33</volume>, <fpage>703</fpage>–<lpage>714</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.tig.2017.07.008</pub-id>.</mixed-citation></ref>
<ref id="c121"><label>121.</label><mixed-citation publication-type="journal"><string-name><surname>Darnell</surname>, <given-names>J.C.</given-names></string-name>, <string-name><surname>Warren</surname>, <given-names>S.T.</given-names></string-name> and <string-name><surname>Darnell</surname>, <given-names>R.B</given-names></string-name>. (<year>2004</year>) <article-title>The Fragile X mental retardation protein, FMRP, recognizes G-quartets</article-title>. <source>Ment Retard Dev Disabil Res Rev</source>, <volume>10</volume>, <fpage>49</fpage>–<lpage>52</lpage>. doi: <pub-id pub-id-type="doi">10.1002/mrdd.20008</pub-id>.</mixed-citation></ref>
<ref id="c122"><label>122.</label><mixed-citation publication-type="journal"><string-name><surname>Darnell</surname>, <given-names>J.C.</given-names></string-name> and <string-name><surname>Klann</surname>, <given-names>E</given-names></string-name>. (<year>2013</year>) <article-title>The translation of translational control by FMRP: therapeutic targets for FXS</article-title>. <source>Nat Neurosci</source>, <volume>16</volume>, <fpage>1530</fpage>–<lpage>1536</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nn.3379</pub-id>.</mixed-citation></ref>
<ref id="c123"><label>123.</label><mixed-citation publication-type="journal"><string-name><surname>Richter</surname>, <given-names>J.D.</given-names></string-name> and <string-name><surname>Zhao</surname>, <given-names>X</given-names></string-name>. (<year>2021</year>) <article-title>The molecular biology of FMRP: new insights into fragile X syndrome</article-title>. <source>Nat Rev Neurosci</source>, <volume>22</volume>, <fpage>209</fpage>–<lpage>222</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41583-021-00432-0</pub-id>.</mixed-citation></ref>
<ref id="c124"><label>124.</label><mixed-citation publication-type="journal"><string-name><surname>Chen</surname>, <given-names>H.H.</given-names></string-name>, <string-name><surname>Yu</surname>, <given-names>H.I.</given-names></string-name>, <string-name><surname>Chiang</surname>, <given-names>W.C.</given-names></string-name>, <string-name><surname>Lin</surname>, <given-names>Y. De</given-names></string-name>, <string-name><surname>Shia</surname>, <given-names>B.C.</given-names></string-name> and <string-name><surname>Tarn</surname>, <given-names>W.Y.</given-names></string-name> (<year>2012</year>) <article-title>hnRNP Q regulates Cdc42-mediated neuronal morphogenesis</article-title>. <source>Mol Cell Biol</source>, <volume>32</volume>, <fpage>2224</fpage>–<lpage>2238</lpage>. doi: <pub-id pub-id-type="doi">10.1128/mcb.06550-11</pub-id>.</mixed-citation></ref>
<ref id="c125"><label>125.</label><mixed-citation publication-type="journal"><string-name><surname>Duning</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Buck</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Barnekow</surname>, <given-names>A.</given-names></string-name> and <string-name><surname>Kremerskothen</surname>, <given-names>J</given-names></string-name>. (<year>2008</year>) <article-title>SYNCRIP, a component of dendritically localized mRNPs, binds to the translation regulator BC200 RNA</article-title>. <source>J Neurochem</source>, <volume>105</volume>, <fpage>351</fpage>–<lpage>359</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1471-4159.2007.05138.x</pub-id>.</mixed-citation></ref>
<ref id="c126"><label>126.</label><mixed-citation publication-type="journal"><string-name><surname>Khudayberdiev</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Soutschek</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Ammann</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Heinze</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Rust</surname>, <given-names>M.B.</given-names></string-name>, <string-name><surname>Baumeister</surname>, <given-names>S.</given-names></string-name> and <string-name><surname>Schratt</surname>, <given-names>G</given-names></string-name>. (<year>2021</year>) <article-title>The cytoplasmic SYNCRIP mRNA interactome of mammalian neurons</article-title>. <source>RNA Biol</source>, <volume>18</volume>, <fpage>1252</fpage>–<lpage>1264</lpage>. doi: <pub-id pub-id-type="doi">10.1080/15476286.2020.1830553</pub-id>.</mixed-citation></ref>
<ref id="c127"><label>127.</label><mixed-citation publication-type="journal"><string-name><surname>Titlow</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Robertson</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Järvelin</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Ish-Horowicz</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Smith</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Gratton</surname>, <given-names>E.</given-names></string-name> and <string-name><surname>Davis</surname>, <given-names>I</given-names></string-name>. (<year>2020</year>) <article-title>Syncrip/hnRNP Q is required for activity-induced Msp300/Nesprin-1 expression and new synapse formation</article-title>. <source>J Cell Biol</source>, <volume>219</volume>, <fpage>e201903135</fpage>. doi: <pub-id pub-id-type="doi">10.1083/jcb.201903135</pub-id>.</mixed-citation></ref>
<ref id="c128"><label>128.</label><mixed-citation publication-type="journal"><string-name><surname>Halstead</surname>, <given-names>J.M.</given-names></string-name>, <string-name><surname>Lin</surname>, <given-names>Y.Q.</given-names></string-name>, <string-name><surname>Durraine</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Hamilton</surname>, <given-names>R.S.</given-names></string-name>, <string-name><surname>Ball</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Neely</surname>, <given-names>G.G.</given-names></string-name>, <string-name><surname>Bellen</surname>, <given-names>H.J.</given-names></string-name> and <string-name><surname>Davis</surname>, <given-names>I</given-names></string-name>. (<year>2014</year>) <article-title>Syncrip/hnRNP Q influences synaptic transmission and regulates BMP signaling at the Drosophila neuromuscular synapse</article-title>. <source>Biol Open</source>, <volume>3</volume>, <fpage>839</fpage>–<lpage>849</lpage>. doi: <pub-id pub-id-type="doi">10.1242/bio.20149027</pub-id>.</mixed-citation></ref>
<ref id="c129"><label>129.</label><mixed-citation publication-type="journal"><string-name><surname>Sapir</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Kshirsagar</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Gorelik</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Olender</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Porat</surname>, <given-names>Z.</given-names></string-name>, <string-name><surname>Scheffer</surname>, <given-names>I.E.</given-names></string-name>, <string-name><surname>Goldstein</surname>, <given-names>D.B.</given-names></string-name>, <string-name><surname>Devinsky</surname>, <given-names>O.</given-names></string-name> and <string-name><surname>Reiner</surname>, <given-names>O</given-names></string-name>. (<year>2022</year>) <article-title>Heterogeneous nuclear ribonucleoprotein U (HNRNPU) safeguards the developing mouse cortex</article-title>. <source>Nat Commun</source>, <volume>13</volume>, <fpage>4209</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41467-022-31752-z</pub-id>.</mixed-citation></ref>
<ref id="c130"><label>130.</label><mixed-citation publication-type="journal"><string-name><surname>Lelieveld</surname>, <given-names>S.H.</given-names></string-name>, <string-name><surname>Reijnders</surname>, <given-names>M.R.F.</given-names></string-name>, <string-name><surname>Pfundt</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Yntema</surname>, <given-names>H.G.</given-names></string-name>, <string-name><surname>Kamsteeg</surname>, <given-names>E.J.</given-names></string-name>, <string-name><surname>De Vries</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>De Vries</surname>, <given-names>B.B.A.</given-names></string-name>, <string-name><surname>Willemsen</surname>, <given-names>M.H.</given-names></string-name>, <string-name><surname>Kleefstra</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Löhner</surname>, <given-names>K.</given-names></string-name>, <etal>et al.</etal> (<year>2016</year>) <article-title>Meta-analysis of 2, 104 trios provides support for 10 new genes for intellectual disability</article-title>. <source>Nat Neurosci</source>, <volume>19</volume>, <fpage>1194</fpage>–<lpage>1196</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nn.4352</pub-id>.</mixed-citation></ref>
<ref id="c131"><label>131.</label><mixed-citation publication-type="book"><string-name><surname>Balasubramanian</surname>, <given-names>M</given-names></string-name>. (<year>2022</year>) <chapter-title>HNRNPU-related neurodevelopmental disorder</chapter-title>. In <person-group person-group-type="editor"><string-name><surname>Adam</surname>, <given-names>M.P.</given-names></string-name>, <string-name><surname>Mirzaa</surname>, <given-names>G.M.</given-names></string-name>, <string-name><surname>Pagon</surname>, <given-names>R.A.</given-names></string-name>, <string-name><surname>Wallace</surname>, <given-names>S.E.</given-names></string-name>, <string-name><surname>Bean</surname>, <given-names>L.J.H.</given-names></string-name>, <string-name><surname>Gripp</surname>, <given-names>K.W.</given-names></string-name>, <string-name><surname>Amemiya</surname>, <given-names>A</given-names></string-name></person-group>. (eds), <source>GeneReviews® [Internet]</source>. <publisher-loc>Seattle (WA)</publisher-loc>: <publisher-name>University of Washington, Seattle</publisher-name>, pp. <fpage>1993</fpage>–<lpage>2023</lpage>.</mixed-citation></ref>
<ref id="c132"><label>132.</label><mixed-citation publication-type="journal"><string-name><surname>Bramswig</surname>, <given-names>N.C.</given-names></string-name>, <string-name><surname>Lüdecke</surname>, <given-names>H.J.</given-names></string-name>, <string-name><surname>Hamdan</surname>, <given-names>F.F.</given-names></string-name>, <string-name><surname>Altmüller</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Beleggia</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Elcioglu</surname>, <given-names>N.H.</given-names></string-name>, <string-name><surname>Freyer</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Gerkes</surname>, <given-names>E.H.</given-names></string-name>, <string-name><surname>Demirkol</surname>, <given-names>Y.K.</given-names></string-name>, <string-name><surname>Knupp</surname>, <given-names>K.G.</given-names></string-name>, <etal>et al.</etal> (<year>2017</year>) <article-title>Heterozygous HNRNPU variants cause early onset epilepsy and severe intellectual disability</article-title>. <source>Hum Genet</source>, <volume>136</volume>, <fpage>821</fpage>–<lpage>834</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00439-017-1795-6</pub-id>.</mixed-citation></ref>
<ref id="c133"><label>133.</label><mixed-citation publication-type="journal"><string-name><surname>Gillentine</surname>, <given-names>M.A.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Hoekzema</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Rosenfeld</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Liu</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Guo</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Kim</surname>, <given-names>C.N.</given-names></string-name>, <string-name><surname>De Vries</surname>, <given-names>B.B.A.</given-names></string-name>, <string-name><surname>Vissers</surname>, <given-names>L.E.L.M.</given-names></string-name>, <string-name><surname>Nordenskjold</surname>, <given-names>M.</given-names></string-name>, <etal>et al.</etal> (<year>2021</year>) <article-title>Rare deleterious mutations of HNRNP genes result in shared neurodevelopmental disorders</article-title>. <source>Genome Med</source>, <volume>13</volume>, <fpage>63</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s13073-021-00870-6</pub-id>.</mixed-citation></ref>
<ref id="c134"><label>134.</label><mixed-citation publication-type="journal"><string-name><surname>Wang</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Hoekzema</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Vecchio</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Wu</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Sulovari</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Coe</surname>, <given-names>B.P.</given-names></string-name>, <string-name><surname>Gillentine</surname>, <given-names>M.A.</given-names></string-name>, <string-name><surname>Wilfert</surname>, <given-names>A.B.</given-names></string-name>, <string-name><surname>Perez-Jurado</surname>, <given-names>L.A.</given-names></string-name>, <string-name><surname>Kvarnung</surname>, <given-names>M.</given-names></string-name>, <etal>et al.</etal> (<year>2020</year>) <article-title>Large-scale targeted sequencing identifies risk genes for neurodevelopmental disorders</article-title>. <source>Nat Commun</source>, <volume>11</volume>, <fpage>4932</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41467-020-18723-y</pub-id>.</mixed-citation></ref>
<ref id="c135"><label>135.</label><mixed-citation publication-type="journal"><string-name><surname>Bakkar</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Kovalik</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Lorenzini</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Spangler</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Lacoste</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Sponaugle</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Ferrante</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Argentinis</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Sattler</surname>, <given-names>R.</given-names></string-name> and <string-name><surname>Bowser</surname>, <given-names>R</given-names></string-name>. (<year>2018</year>) <article-title>Artificial intelligence in neurodegenerative disease research: use of IBM Watson to identify additional RNA-binding proteins altered in amyotrophic lateral sclerosis</article-title>. <source>Acta Neuropathol</source>, <volume>135</volume>, <fpage>227</fpage>–<lpage>247</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00401-017-1785-8</pub-id>.</mixed-citation></ref>
<ref id="c136"><label>136.</label><mixed-citation publication-type="journal"><string-name><surname>Huang</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Camacho</surname>, <given-names>C. V.</given-names></string-name>, <string-name><surname>Setlem</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Ryu</surname>, <given-names>K.W.</given-names></string-name>, <string-name><surname>Parameswaran</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Gupta</surname>, <given-names>R.K.</given-names></string-name> and <string-name><surname>Kraus</surname>, <given-names>W.L</given-names></string-name>. (<year>2020</year>) <article-title>Functional interplay between histone H2B ADP-ribosylation and phosphorylation controls adipogenesis</article-title>. <source>Mol Cell</source>, <volume>79</volume>, <fpage>934</fpage>–<lpage>949</lpage>.e14. doi: <pub-id pub-id-type="doi">10.1016/j.molcel.2020.08.002</pub-id>.</mixed-citation></ref>
<ref id="c137"><label>137.</label><mixed-citation publication-type="journal"><string-name><surname>Chou</surname>, <given-names>T.C</given-names></string-name>. (<year>2010</year>) <article-title>Drug combination studies and their synergy quantification using the chou-talalay method</article-title>. <source>Cancer Res</source>, <volume>70</volume>, <fpage>440</fpage>–<lpage>446</lpage>. doi: <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-09-1947</pub-id>.</mixed-citation></ref>
<ref id="c138"><label>138.</label><mixed-citation publication-type="journal"><string-name><surname>Szklarczyk</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Kirsch</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Koutrouli</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Nastou</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Mehryary</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Hachilif</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Gable</surname>, <given-names>A.L.</given-names></string-name>, <string-name><surname>Fang</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Doncheva</surname>, <given-names>N.T.</given-names></string-name>, <string-name><surname>Pyysalo</surname>, <given-names>S.</given-names></string-name>, <etal>et al.</etal> (<year>2023</year>) <article-title>The STRING database in 2023: protein–protein association networks and functional enrichment analyses for any sequenced genome of interest</article-title>. <source>Nucleic Acids Res</source>, <volume>51</volume>, <fpage>D638</fpage>–<lpage>D646</lpage>. doi: <pub-id pub-id-type="doi">10.1093/nar/gkac1000</pub-id>.</mixed-citation></ref>
<ref id="c139"><label>139.</label><mixed-citation publication-type="journal"><string-name><surname>Doncheva</surname>, <given-names>N.T.</given-names></string-name>, <string-name><surname>Morris</surname>, <given-names>J.H.</given-names></string-name>, <string-name><surname>Holze</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Kirsch</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Nastou</surname>, <given-names>K.C.</given-names></string-name>, <string-name><surname>Cuesta-Astroz</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Rattei</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Szklarczyk</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>von Mering</surname>, <given-names>C.</given-names></string-name> and <string-name><surname>Jensen</surname>, <given-names>L.J.</given-names></string-name> (<year>2023</year>) <article-title>Cytoscape stringApp 2.0: analysis and visualization of heterogeneous biological networks</article-title>. <source>J Proteome Res</source>, <volume>22</volume>, <fpage>637</fpage>–<lpage>646</lpage>. doi: <pub-id pub-id-type="doi">10.1021/acs.jproteome.2c00651</pub-id>.</mixed-citation></ref>
<ref id="c140"><label>140.</label><mixed-citation publication-type="journal"><string-name><surname>Puchalski</surname>, <given-names>R.B.</given-names></string-name>, <string-name><surname>Shah</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Miller</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Dalley</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Nomura</surname>, <given-names>S.R.</given-names></string-name>, <string-name><surname>Yoon</surname>, <given-names>J.G.</given-names></string-name>, <string-name><surname>Smith</surname>, <given-names>K.A.</given-names></string-name>, <string-name><surname>Lankerovich</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Bertagnolli</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Bickley</surname>, <given-names>K.</given-names></string-name>, <etal>et al.</etal> (<year>2018</year>) <article-title>An anatomic transcriptional atlas of human glioblastoma</article-title>. <source>Science</source>, <volume>360</volume>, <fpage>660</fpage>–<lpage>663</lpage>. doi: <pub-id pub-id-type="doi">10.1126/science.aaf2666</pub-id>.</mixed-citation></ref>
<ref id="c141"><label>141.</label><mixed-citation publication-type="journal"><string-name><surname>van de Leemput</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Boles</surname>, <given-names>N.C.</given-names></string-name>, <string-name><surname>Kiehl</surname>, <given-names>T.R.</given-names></string-name>, <string-name><surname>Corneo</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Lederman</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Menon</surname>, <given-names>V.</given-names></string-name>, <string-name><surname>Lee</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Martinez</surname>, <given-names>R.A.</given-names></string-name>, <string-name><surname>Levi</surname>, <given-names>B.P.</given-names></string-name>, <string-name><surname>Thompson</surname>, <given-names>C.L.</given-names></string-name>, <etal>et al.</etal> (<year>2014</year>) <article-title>CORTECON: a temporal transcriptome analysis of in vitro human cerebral cortex development from human embryonic stem cells</article-title>. <source>Neuron</source>, <volume>83</volume>, <fpage>51</fpage>–<lpage>68</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.neuron.2014.05.013</pub-id>.</mixed-citation></ref>
<ref id="c142"><label>142.</label><mixed-citation publication-type="journal"><string-name><surname>Fang</surname>, <given-names>H.</given-names></string-name> and <string-name><surname>Gough</surname>, <given-names>J</given-names></string-name>. (<year>2013</year>) <article-title>DcGO: database of domain-centric ontologies on functions, phenotypes, diseases and more</article-title>. <source>Nucleic Acids Res</source>, <volume>41</volume>, <fpage>D536</fpage>–<lpage>544</lpage>. doi: <pub-id pub-id-type="doi">10.1093/nar/gks1080</pub-id>.</mixed-citation></ref>
<ref id="c143"><label>143.</label><mixed-citation publication-type="journal"><string-name><surname>Sutphin</surname>, <given-names>G.L.</given-names></string-name>, <string-name><surname>Mahoney</surname>, <given-names>J.M.</given-names></string-name>, <string-name><surname>Sheppard</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Walton</surname>, <given-names>D.O.</given-names></string-name> and <string-name><surname>Korstanje</surname>, <given-names>R</given-names></string-name>. (<year>2016</year>) <article-title>WORMHOLE: novel least diverged ortholog prediction through machine learning</article-title>. <source>PLoS Comput Biol</source>, <volume>12</volume>, <fpage>e1005182</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pcbi.1005182</pub-id>.</mixed-citation></ref>
<ref id="c144"><label>144.</label><mixed-citation publication-type="journal"><string-name><surname>Kitts</surname>, <given-names>P.A.</given-names></string-name>, <string-name><surname>Church</surname>, <given-names>D.M.</given-names></string-name>, <string-name><surname>Thibaud-Nissen</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Choi</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Hem</surname>, <given-names>V.</given-names></string-name>, <string-name><surname>Sapojnikov</surname>, <given-names>V.</given-names></string-name>, <string-name><surname>Smith</surname>, <given-names>R.G.</given-names></string-name>, <string-name><surname>Tatusova</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Xiang</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Zherikov</surname>, <given-names>A.</given-names></string-name>, <etal>et al.</etal> (<year>2016</year>) <article-title>Assembly: a resource for assembled genomes at NCBI</article-title>. <source>Nucleic Acids Res</source>, <volume>44</volume>, <fpage>D73</fpage>–<lpage>D80</lpage>. doi: <pub-id pub-id-type="doi">10.1093/nar/gkv1226</pub-id>.</mixed-citation></ref>
<ref id="c145"><label>145.</label><mixed-citation publication-type="journal"><string-name><surname>Frankish</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Diekhans</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Jungreis</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Lagarde</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Loveland</surname>, <given-names>J.E.</given-names></string-name>, <string-name><surname>Mudge</surname>, <given-names>J.M.</given-names></string-name>, <string-name><surname>Sisu</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Wright</surname>, <given-names>J.C.</given-names></string-name>, <string-name><surname>Armstrong</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Barnes</surname>, <given-names>I.</given-names></string-name>, <etal>et al.</etal> (<year>2021</year>) <article-title>GENCODE 2021</article-title>. <source>Nucleic Acids Res</source>, <volume>49</volume>, <fpage>D916</fpage>–<lpage>D923</lpage>. doi: <pub-id pub-id-type="doi">10.1093/nar/gkaa1087</pub-id>.</mixed-citation></ref>
<ref id="c146"><label>146.</label><mixed-citation publication-type="journal"><string-name><surname>Dobin</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Davis</surname>, <given-names>C.A.</given-names></string-name>, <string-name><surname>Schlesinger</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Drenkow</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Zaleski</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Jha</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Batut</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Chaisson</surname>, <given-names>M.</given-names></string-name> and <string-name><surname>Gingeras</surname>, <given-names>T.R</given-names></string-name>. (<year>2013</year>) <article-title>STAR: ultrafast universal RNA-seq aligner</article-title>. <source>Bioinformatics</source>, <volume>29</volume>, <fpage>15</fpage>–<lpage>21</lpage>. doi: <pub-id pub-id-type="doi">10.1093/bioinformatics/bts635</pub-id>.</mixed-citation></ref>
<ref id="c147"><label>147.</label><mixed-citation publication-type="journal"><string-name><surname>Shen</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Park</surname>, <given-names>J.W.</given-names></string-name>, <string-name><surname>Lu</surname>, <given-names>Z.X.</given-names></string-name>, <string-name><surname>Lin</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Henry</surname>, <given-names>M.D.</given-names></string-name>, <string-name><surname>Wu</surname>, <given-names>Y.N.</given-names></string-name>, <string-name><surname>Zhou</surname>, <given-names>Q.</given-names></string-name> and <string-name><surname>Xing</surname>, <given-names>Y</given-names></string-name>. (<year>2014</year>) <article-title>rMATS: robust and flexible detection of differential alternative splicing from replicate RNA-Seq data</article-title>. <source>Proc Natl Acad Sci U S A</source>, <volume>111</volume>, <fpage>E5593</fpage>–<lpage>E5601</lpage>. doi: <pub-id pub-id-type="doi">10.1073/pnas.1419161111</pub-id>.</mixed-citation></ref>
<ref id="c148"><label>148.</label><mixed-citation publication-type="journal"><string-name><surname>Quinlan</surname>, <given-names>A.R.</given-names></string-name> and <string-name><surname>Hall</surname>, <given-names>I.M</given-names></string-name>. (<year>2010</year>) <article-title>BEDTools: a flexible suite of utilities for comparing genomic features</article-title>. <source>Bioinformatics</source>, <volume>26</volume>, <fpage>841</fpage>–<lpage>842</lpage>. doi: <pub-id pub-id-type="doi">10.1093/bioinformatics/btq033</pub-id>.</mixed-citation></ref>
<ref id="c149"><label>149.</label><mixed-citation publication-type="journal"><string-name><surname>Bray</surname>, <given-names>N.L.</given-names></string-name>, <string-name><surname>Pimentel</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Melsted</surname>, <given-names>P.</given-names></string-name> and <string-name><surname>Pachter</surname>, <given-names>L</given-names></string-name>. (<year>2016</year>) <article-title>Near-optimal probabilistic RNA-seq quantification</article-title>. <source>Nat Biotechnol</source>, <volume>34</volume>, <fpage>525</fpage>–<lpage>527</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nbt.3519</pub-id>.</mixed-citation></ref>
<ref id="c150"><label>150.</label><mixed-citation publication-type="journal"><string-name><surname>Soneson</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Love</surname>, <given-names>M.I.</given-names></string-name> and <string-name><surname>Robinson</surname>, <given-names>M.D</given-names></string-name>. (<year>2015</year>) <article-title>Differential analyses for RNA-seq: transcript-level estimates improve gene-level inferences</article-title>. <source>F1000Res</source>, <volume>4</volume>, <fpage>1521</fpage>. doi: <pub-id pub-id-type="doi">10.12688/f1000research.7563.1</pub-id>.</mixed-citation></ref>
<ref id="c151"><label>151.</label><mixed-citation publication-type="journal"><string-name><surname>Love</surname>, <given-names>M.I.</given-names></string-name>, <string-name><surname>Huber</surname>, <given-names>W.</given-names></string-name> and <string-name><surname>Anders</surname>, <given-names>S</given-names></string-name>. (<year>2014</year>) <article-title>Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2</article-title>. <source>Genome Biol</source>, <volume>15</volume>, <fpage>550</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s13059-014-0550-8</pub-id>.</mixed-citation></ref>
</ref-list>
</back>
<sub-article id="sa0" article-type="editor-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.98152.1.sa3</article-id>
<title-group>
<article-title>eLife Assessment</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Donlin-Asp</surname>
<given-names>Paul</given-names>
</name>
<role specific-use="editor">Reviewing Editor</role>
<aff>
<institution-wrap>
<institution>University of Edinburgh</institution>
</institution-wrap>
<city>Edinburgh</city>
<country>United Kingdom</country>
</aff>
</contrib>
</contrib-group>
<kwd-group kwd-group-type="evidence-strength">
<kwd>Incomplete</kwd>
<kwd>Solid</kwd>
</kwd-group>
<kwd-group kwd-group-type="claim-importance">
<kwd>Valuable</kwd>
</kwd-group>
</front-stub>
<body>
<p>This study reports <bold>valuable</bold> insights into the interactome of the RNA-binding protein SERBP1 and possible links through PARylation to a diverse set of processes including splicing, cell division, and ribosome biogenesis. The diversity of processes SERBP1 may regulate means this work would be of very broad interest to the cell biology community. However, whereas the proteomics data are <bold>solid</bold>, the functional connection to downstream processes and the link to Alzheimer's disease are still <bold>incomplete</bold>, as they rely on a very limited set of experiments and patient samples.</p>
</body>
</sub-article>
<sub-article id="sa1" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.98152.1.sa2</article-id>
<title-group>
<article-title>Reviewer #1 (Public Review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>Summary:</p>
<p>Here the authors convincingly identify and characterize the SERBP1 interactome and further define its role in the nucleus, where it is associated with complexes involved in splicing, cell division, chromosome structure, and ribosome biogenesis. Many of the SERBP1-associated proteins are RNA-binding proteins and SERBP1 exerts its impact, at least in part, through these players. SERBP1 is mostly disordered but along with its associated proteins displays a preference for G4 binding and can can bind to PAR and be PARylated. They present data that strongly suggest that complexes in which SERBP1 participates are assembled through G4 or PAR binding. The authors suggest that because SERBP1 lacks traditional functional domains yet is clearly involved in distinct regulatory complexes, SERBP1 likely acts in the early steps of assembly through the recognition of interacting sites present in RNA, DNA, and proteins.</p>
<p>Strengths:</p>
<p>The data is very convincing and demonstrated through multiple approaches.</p>
<p>Weaknesses:</p>
<p>No weaknesses were identified by this reviewer.</p>
</body>
</sub-article>
<sub-article id="sa2" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.98152.1.sa1</article-id>
<title-group>
<article-title>Reviewer #2 (Public Review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>Summary:</p>
<p>In this study the authors have used pull-down experiments in a cell line overexpressing tagged SERPINE1 mRNA binding protein 1 (SERBP1) followed by mass spectrometry-based proteomics, to establish its interactome. Extensive analyses are performed to connect the data to published resources. The authors attempt to connect SERBP1 to stress granules and Alzheimer's disease-associated tau pathology. Based on the interactome, the authors propose a cross-talk between SERBP1 and PARP1 functions.</p>
<p>Strengths:</p>
<p>The main strength of this study lies in the proteomics data analysis, and its effort to connect the data to published studies.</p>
<p>Weaknesses:</p>
<p>While the authors propose a feedback regulatory model for SERBP1 and PARP1 functions, strong evidence for PARylation modulating SERBP1 functions is lacking. PARP inhibition decreasing the amount of PARylated proteins associated with SERBP1 and likely all other PARylated proteins is expected. This study is also incomplete in its attempt to establish a connection to Alzheimer's disease related tauopathy. A single AD case is not sufficient, and frozen autopsy tissue shows unexplained punctate staining likely due to poor preservation of cellular structures for immunohistochemistry. There is a lack of essential demographic data, source of the tissue, brain regions shown, and whether there was an IRB protocol for the human brain tissue. The presence of phase-separated transient stress granules in an autopsy brain is unlikely, even if G3BP1 staining is present. Normally, stress granule proteins move to the cytoplasm under cellular stress, whereas SERBP1 becomes nuclear. The co-localization of abundant cytoplasmic G3BP1 and SERBP1 under normal conditions does not indicate an association with stress granules.</p>
</body>
</sub-article>
<sub-article id="sa3" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.98152.1.sa0</article-id>
<title-group>
<article-title>Reviewer #3 (Public Review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>Summary:</p>
<p>A survey of SERBP1-associated functions and their impact on the transcriptome upon gene depletion, as well as the identification of chemical inhibitors upon gene over-expression.</p>
<p>Strengths:</p>
<p>(1) Provides a valuable resource for the community, supported by statistical analyses.</p>
<p>(2) Offers a survey of different processes with correlation data, serving as a good starting point for the community to follow up.</p>
<p>Weaknesses:</p>
<p>(1) The authors provided numerous correlations on diverse topics, from cell division to RNA splicing and PARP1 association, but did not follow up their findings with experiments, offering little mechanistic insight into the actual role of SERBP1. The model in Figure 5D is entirely speculative and lacks data support in the manuscript.</p>
<p>(2) Following up with experiments to demonstrate that their findings are real (e.g., those related to splicing defects and the PARylation/PAR-binding association) would be beneficial. For example, whether the association between PARP1 and SERBP1 is sensitive to PAR-degrading enzymes is unclear.</p>
<p>(3) They did not clearly articulate how experiments were performed. For instance, the drug screen and even the initial experiment involving the pull-down were poorly described. Many in the community may not be familiar with vectors such as pSBP or pUltra without looking up details.</p>
<p>(4) The co-staining of SERBP1 with pTau, PARP1, and G3BP1 in the brain is interesting, but it would be beneficial to follow up with immunoprecipitation in normal and patient samples to confirm the increased physical association.</p>
<p>(5) The combination index of 0.7-0.9 for PJ34 + siSERBP1 is weak. Could this be due to the non-specific nature of the drug against other PARPs? Have the authors looked into this possibility?</p>
</body>
</sub-article>
</article>